Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
| Member | Definition | Class |
|---|
| (20s)-20-hydroxycholesterol | An oxysterol that is cholesterol substituted by a hydroxy group at position 20. | 20-hydroxycholesterol |
| 1-butanol | A primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It it produced in small amounts in humans by the gut microbes. | butan-1-ol |
| 1-butyl oleate | A fatty acid ester obtained by the formal condensation of the hydroxy group of butan-1-ol with the carboxy group of oleic acid. | n-butyl oleate |
| 1-hydroxyethyl radical | An organic anion that is the conjugate base of ethanol. | ethoxide |
| 1-methyladenosine | A methyladenosine carrying a methyl substituent at position 1. | 1-methyladenosine |
| 1-methylhistidine | A L-histidine derivative in which the methyl group is at N(tele)-position. | N(tele)-methyl-L-histidine zwitterion; N(tele)-methyl-L-histidine |
| 1-pentene-3-one | An enone that is pent-1-ene substituted by an oxo group at position 3. | 1-penten-3-one |
| 1-phenethylamine | A phenylethylamine that is ethylamine substituted by a phenyl group at position 1. | 1-phenylethylamine |
| 1-phospho-5-s-methylthioribulose | Dianion of S-methyl-5-thio-D-ribulose 1-phosphate. | S-methyl-5-thio-D-ribulose 1-phosphate(2-) |
| 1-tridecanol | A long-chain primary fatty alcohol that is tridecane substituted by a hydroxy group at position 1. | tridecan-1-ol |
| 1,1,3,3-tetramethylurea | A member of the class of ureas that is urea substituted by methyl groups at positions 1, 1, 3 and 3 respectively. Metabolite observed in cancer metabolism. | 1,1,3,3-tetramethylurea |
| 1,2-distearoylphosphatidylethanolamine | A phosphatidylethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 1,2-distearoylphosphatidylethanolamine. | 1,2-distearoylphosphatidylethanolamine zwitterion; 1,2-distearoylphosphatidylethanolamine |
| 1,23,25-trihydroxyvitamin d3 | A hydroxycalciol that consists of vitamin D3 (calciol) bearing additional hydroxy substituents at positions 1, 23 and 25 (with 1alpha,23S-configuration). An intermediate in the degradation pathway of 1alpha,25-(OH)2D3. | 1alpha,23(S),25-trihydroxyvitamin D3 |
| 1,25-dihydroxy-24-oxo-vitamin d3 | | (1S)-1,25-dihydroxy-24-oxocalciol |
| 1,5-anhydroglucitol | An anhydro sugar of D-glucitol. | 1,5-anhydro-D-glucitol |
| 1,5(10)-estradiene-3,4,17-trione | An o-quinone resulting from the formal oxidation of the dihydroxyphenyl moiety of 4-hydroxyestrone. | estra-1,5(10)-diene-3,4,17-trione |
| 1,6-anhydro-beta-glucopyranose | A anhydrohexose that is the 1,6-anhydro-derivative of beta-D-glucopyranose. | levoglucosan |
| 10-nitro-oleic acid | A nitro fatty acid that is (9E)-octadec-9-enoic (elaidic) acid substituted by a nitro group at position 10. | (9E)-10-nitrooctadecenoic acid |
| 11-cis-retinal | A retinal having 2E,4Z,6E,8E-double bond geometry. | 11-cis-retinal |
| 11-dehydro-thromboxane b2 | A thromboxane obtained by formal oxidation of the hemiacetal hydroxy function of thromboxane B2. | 11-dehydro-thromboxane B2 |
| 11-dehydrocorticosterone | An 11-oxo steroid that is corticosterone in which the hydroxy substituent at the 11beta position has been oxidised to give the corresponding ketone. | 11-dehydrocorticosterone |
| 11-ketotestosterone | A 3-oxo Delta(4)-steroid that is testosterone carrying an additional oxo substituent at position 11. | 11-oxotestosterone |
| 12-hydroxy-5,8,10,14-eicosatetraenoic acid | A HETE having a (12S)-hydroxy group and (5Z)-, (8Z)-, (10E)- and (14Z)-double bonds. | 12(S)-HETE |
| 12-hydroxydodecanoic acid | A medium-chain fatty acid that is the 12-hydroxylated derivative of lauric acid. | 12-hydroxylauric acid |
| 13-cis-retinal | A retinal in which the double bond alpha- to the aldehyde group has cis configuration, whilst the remaining acyclic double bonds have trans configuration. | 13-cis-retinal |
| 15-hydroxy-5,8,11,13-eicosatetraenoic acid | An optically active form of 15-HETE having 15(S)-configuration.. | 15(S)-HETE |
| 15-keto-5,8,11,13-eicosatetraenoic acid | An oxoicosatetraenoic acid having (5Z,8Z,11Z,13E) double bond stereochemistry, and an oxo group in position 15. | 15-oxo-ETE |
| 16-hydroxydehydroepiandrosterone | | 16alpha-hydroxydehydroepiandrosterone |
| 17-alpha-hydroxypregnenolone | A hydroxypregnenolone carrying an alpha-hydroxy group at position 17. | 17alpha-hydroxypregnenolone |
| 17-alpha-hydroxyprogesterone | A 17alpha-hydroxy steroid that is the 17alpha-hydroxy derivative of progesterone. | 17alpha-hydroxyprogesterone |
| 17-phenyltrinorprostaglandin e2 | A prostanoid that is 18,19,20-trinor-prostaglandin E2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group. | 17-phenyl-18,19,20-trinor-prostaglandin E2 |
| 18-hydroxycorticosterone | A 18-hydroxy steroid that is corticosterone substituted by a hydroxy group at position 18. | 18-hydroxycorticosterone |
| 19-oxo-delta(4) androstene-3,17-dione | An androstanoid that is androst-4-en-19-al substituted by oxo groups at positions 3 and 17. | 3,17-dioxoandrost-4-en-19-al |
| 2-(4-methyl-1,3-thiazol-5-yl)ethanol | A 1,3-thiazole that is thiazole substituted by a methyl group at position 4 and a 2-hydroxyethyl group at position 5. | 5-(2-hydroxyethyl)-4-methylthiazole |
| 2-amino-3-phosphonopropionic acid | A non-proteinogenc alpha-amino acid that is alanine in which one of the hydrogens of the terminal methyl group has been replaced by a dihydroxy(oxido)-lambda(5)-phosphanyl group. | 2-amino-3-phosphonopropanoic acid |
| 2-decenoic acid | A 2-decenoic acid having its double bond in the trans configuration. It is an intermediate metabolite in the fatty acid synthesis. | trans-2-decenoic acid |
| 2-ethylhydracrylic acid | A branched-chain saturated fatty acid that is butanoic acid substituted by a hydroxymethyl group at position 2. It is a metabolite derived from the isoleucine metabolism. | 2-ethylhydracrylic acid |
| 2-hexanol | A hexanol in which the hydroxy group is at position 2. | hexan-2-ol |
| 2-hydroxybutyric acid | A hydroxybutyric acid having a single hydroxyl group located at position 2; urinary secretion of 2-hydroxybutyric acid is increased with alcohol ingestion or vigorous physical exercise and is associated with lactic acidosis and ketoacidosis in humans and diabetes in animals. | 2-hydroxybutyric acid |
| 2-hydroxyestradiol | A 2-hydroxy steroid that consists of 17beta-estradiol having an additional hydroxy group at position 2. | 2-hydroxy-17beta-estradiol |
| 2-hydroxyestrone | A 2-hydroxy steroid that is estrone substituted by a hydroxy group at position 2. | 2-hydroxyestrone |
| 2-hydroxyhexadecanoic acid | A 2-hydroxy fatty acid comprising a C16 straight chain carrying a hydroxy substituent at position 2. | 2-hydroxyhexadecanoic acid |
| 2-hydroxyisovaleric acid | A valine derivative that is valine in which the amino group has been replaced by a hydroxy group. | 2-hydroxy-3-methylbutyric acid |
| 2-hydroxyphenethylamine | The simplest member of the class of phenylethanolamines that is 2-aminoethanol bearing a phenyl substituent at the 1-position. The parent of the phenylethanolamine class. | phenylethanolamine |
| 2-hydroxyphenylacetic acid | A hydroxy monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 2-hydroxyphenyl group. It is a metabolite of phenylalanine and is excreted in the urine of patients suffering from diseases like phenylketonuria. | (2-hydroxyphenyl)acetic acid |
| 2-keto-4-hydroxyglutarate | An oxo dicarboxylate obtained by deprotonation of both carboxy groups of 4-hydroxy-2-oxoglutaric acid. | 4-hydroxy-2-oxoglutarate(2-) |
| 2-keto-4-methylvalerate | A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease. | 4-methyl-2-oxopentanoic acid |
| 2-ketoarginine | A 2-oxo monocarboxylic acid that is 2-oxopentanoic acid in which one of the methyl hydrogens is substituted by a carbamimidamido group. | 5-guanidino-2-oxopentanoic acid zwitterion; 5-guanidino-2-oxopentanoic acid |
| 2-ketopentanoic acid | An oxopentanoic acid carrying an oxo group at position 2. | 2-oxopentanoic acid |
| 2-methoxyestradiol | A 17beta-hydroxy steroid, being 17beta-estradiol methoxylated at C-2. | 2-methoxy-17beta-estradiol |
| 2-methoxyestrone | A 17-oxo steroid that is estrone in which the hydrogen at position 2 has been replaced by a methoxy group. | 2-methoxyestrone |
| 2-methyl-3-oxovaleric acid | A 3-oxo monocarboxylic acid that is valeric acid substituted by a methyl group at position 2 and a keto group at position 3. | 2-methyl-3-ketovaleric acid |
| 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | An isoquinolinol that is norsalsolinol substituted by a methyl group at position 2. It is present in normal human brain and also identified in the cerebrospinal fluid of patients with Parkinson's disease. | N-methylnorsalsolinol |
| 2-methylbutanoic acid | A methylbutyric acid comprising a butyric acid core carrying a 2-methyl substituent. Produced from amino acid leucine during nutrient starvation in bacteria. | 2-methylbutyric acid |
| 2-methylbutyrylglycine | A N-acylglycine that is glycine substituted by a 2-methylbutanoyl group at the N atom. | N-(2-methylbutanoyl)glycine |
| 2-oxo-3-methylvalerate | A 2-oxo monocarboxylic acid that is valeric acid carrying oxo- and methyl substituents at C-2 and C-3, respectively. An alpha-keto acid analogue and metabolite of isoleucine in man, animals and bacteria. Used as a clinical marker for maple syrup urine disease (MSUD). | 3-methyl-2-oxovaleric acid |
| 2-phenylglycine | An amino acid with a structure in which a phenyl ring is bonded to the alpha-carbon of glycine. | alpha-phenylglycine |
| 2-pinene oxide | An epoxide of alpha-pinene. | alpha-pinene oxide |
| 2,3-diphosphoglycerate | A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3. | 2,3-bisphosphoglyceric acid |
| 2,3-oxidosqualene | A 2,3-epoxysqualene in which the chiral centre has S configuration. It is converted into lanosterol by lanosterol synthase (EC 5.4.99.7) in a key rate-limiting step in the biosynthesis of chloesterol, steroid hormones, and vitamin D. | (S)-2,3-epoxysqualene |
| 2,5-dihydroxybenzaldehyde | A dihydroxybenzaldehyde carrying hydroxy groups at positions 2 and 5. | 2,5-dihydroxybenzaldehyde |
| 2,5-dihydroxybenzoic acid | A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions. | 2,5-dihydroxybenzoic acid |
| 2'-deoxyadenosine | A purine 2'-deoxyribonucleoside having adenine as the nucleobase. | 2'-deoxyadenosine |
| 2'-deoxyadenosine triphosphate | A purine 2'-deoxyribonucleoside 5'-diphosphate having adenine as the nucleobase. | dADP |
| 2'-deoxycytidine 5'-triphosphate | A 2'-deoxycytidine phosphate having cytosine as the nucleobase. | dCTP |
| 2'-deoxycytidine diphosphate | A 2'-deoxycytidine phosphate that is the 2'- deoxy derivative of cytidine 5'-diphosphate (CDP). | dCDP |
| 20-alpha-dihydroprogesterone | | (20S)-20-hydroxypregn-4-en-3-one |
| 20-hydroxy-5,8,11,14-eicosatetraenoic acid | A HETE that consists of arachidonic acid bearing a hydroxy substituent at position 20. | 20-HETE |
| 20,22-dihydroxycholesterol | An oxysterol that is cholesterol substituted by hydroxy groups at positions 20 and 22 (the 20R,22R-stereoisomer). | (20R,22R)-20,22-dihydroxycholesterol |
| 24,25-dihydrolanosterol | A 3beta-sterol formed from lanosterol by reduction across the C-24-C-25 double bond. | 24,25-dihydrolanosterol |
| 25-hydroxycholesterol | | 25-hydroxycholesterol |
| 27-hydroxycholesterol | A 26-hydroxycholesterol in which the 25-position has R-configuration. | (25R)-cholest-5-ene-3beta,26-diol |
| 3-c-methylerythritol | A tetritol that is erythritol substituted by a methyl group at position 2. | 2-methylerythritol |
| 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid | A furoic acid that is furan-3-carboxylic acid substituted by a methyl group at position 4, a propyl group at position 5 and a 2-carboxyethyl group at position 2. It is a potent uremic toxin that has been found to accumulate in human serum of patients with chronic kidney diseases. | 2-(2-carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic acid |
| 3-chloro-L-tyrosine | A chloroamino acid comprising a tyrosine core with a chloro- substituent ortho to the phenolic hydroxy group. | 3-chloro-L-tyrosine zwitterion; 3-chloro-L-tyrosine |
| 3-hydroxy-3-methyl-hexanoic acid | A 3-hydroxy monocarboxylic acid that is hexanoic acid substituted by a hydroxy group and a methyl group at position 3. It is a metabolite found in human sweat. | 3-hydroxy-3-methylhexanoic acid |
| 3-hydroxy-3-methylglutaryl-coenzyme a | A 3-hydroxy-3-methylglutaryl-CoA where the 3-hydroxy-3-methylglutaryl component has (S)-configuration. | (3S)-3-hydroxy-3-methylglutaryl-CoA |
| 3-hydroxy-4-methoxyphenethylamine | A monomethoxybenzene that is dopamine in which the hydroxy group at position 4 is replaced by a methoxy group. | 4-methoxytyramine |
| 3-hydroxyanthranilic acid | An aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan. | 3-hydroxyanthranilic acid |
| 3-hydroxybutyric acid | A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics. | 3-hydroxybutyric acid |
| 3-hydroxybutyric acid | The R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics. It is a sex pheremone in the European spider Linyphia triangularis. | (R)-3-hydroxybutyric acid |
| 3-hydroxyisovalerylcarnitine | An O-acylcarnitine having 3-hydroxyisovaleryl as the acyl substituent. | 3-hydroxyisovalerylcarnitine |
| 3-hydroxykynurenine | A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3. | 3-hydroxykynurenine |
| 3-hydroxymandelic acid | A 2-hydroxy monocarboxylic acid that is mandelic acid substituted by a hydroxy group at position 3'. | 3-hydroxymandelic acid |
| 3-hydroxyproline | A D-proline derivative that is D-proline monohydroxylated at position 3 (the cis-3-hydroxy-diastereomer). | cis-3-hydroxy-D-proline zwitterion; cis-3-hydroxy-D-proline |
| 3-mercaptopyruvic acid | A 2-oxo monocarboxylic acid that is pyruvic acid substituted by a sulfanyl group at position 3. | 3-mercaptopyruvic acid |
| 3-methoxytyrosine | A L-tyrosine derivative that is the 3-methoxy derivative of L-dopa. | 3-O-methyldopa zwitterion; 3-O-methyldopa |
| 3-methoxytyrosine | An aromatic L-alpha-amino acid zwitterion resulting from transfer of a proton from the carboxy to the amino group of 3-O-methyldopa. Major species at pH 7.3 | 3-O-methyldopa zwitterion; 3-O-methyldopa |
| 3-methylbutyrylcarnitine | A C5-acylcarnitine having isovaleryl as the acyl substituent. | O-isovalerylcarnitine |
| 3-methylhexane | An alkane that is hexane substituted by a methyl group at position 3. | 3-methylhexane |
| 3-methylhistidine | A L-histidine derivative that is L-histidine substituted by a methyl group at position 3 on the imidazole ring. | N(pros)-methyl-L-histidine zwitterion; N(pros)-methyl-L-histidine |
| 3-methylpentane | An alkane that is pentane which is substituted by a methyl group at position 3. It is used as a solvent in organic synthesis, as a lubricant and as a raw material for producing carbon black. | 3-methylpentane |
| 3-oxoadipic acid | An oxo dicarboxylic acid consisting of adipic acid having a single oxo group at the 3-position. | 3-oxoadipic acid |
| 3-phenyllactic acid | A 2-hydroxy monocarboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a phenyl group. | 3-phenyllactic acid |
| 3-phenylpropionic acid | A monocarboxylic acid that is propionic acid substituted at position 3 by a phenyl group. | 3-phenylpropionic acid |
| 3,3'-diiodothyronine | | 3,3'-diiodo-L-thyronine zwitterion; 3,3'-diiodo-L-thyronine |
| 3,3',5'-triiodothyronine | | 3,3',5'-triiodothyronine |
| 3,4-dihydroxybutanoic acid | A omega-hydroxy fatty acid that is butyric acid substituted by hydroxy groups at positions 3 and 4 respectively. | 3,4-dihydroxybutyric acid |
| 3,4-dihydroxymandelic acid | A catechol that is the 3,4-dihydroxy derivative of mandelic acid; a metabolite of L-dopa. | 3,4-dihydroxymandelic acid |
| 3,4-dihydroxyphenylacetaldehyde | A phenylacetaldehyde in which the 3 and 4 positions of the phenyl group are substituted by hydroxy groups. | 3,4-dihydroxyphenylacetaldehyde |
| 3,4-dihydroxyphenylacetic acid | A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine. | (3,4-dihydroxyphenyl)acetic acid |
| 3,4-dihydroxyphenylglycolaldehyde | A hydroxyaldehyde consisting of phenylacetaldehyde having three hydroxy substituents located at the alpha-, 3- and 4-positions. It is a metabolite of noradrenaline. | 3,4-dihydroxymandelaldehyde |
| 3,7,12-trihydroxycholestan-26-oic acid | A steroid acid that is 5beta-cholestan-26-oic acid which is substituted by hydroxy groups as the 3alpha, 7alpha, and 12alpha positions. | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oic acid |
| 3,7,12-trihydroxycoprostane | | 5beta-cholestane-3alpha,7alpha,12alpha-triol |
| 3,7,12-trihydroxycoprostanic acid | | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestane-5-carboxylic acid |
| 4-cresol | A cresol that consists of toluene substituted by a hydroxy group at position 4. It is a metabolite of aromatic amino acid metabolism produced by intestinal microflora in humans and animals. | p-cresol |
| 4-cresol sulfate | An aryl sulfate that is p-cresol in which the phenolic hydrogen has been replaced by a sulfo group. | p-cresol sulfate |
| 4-hydroxyphenylacetaldehyde | | (4-hydroxyphenyl)acetaldehyde |
| 4-hydroxyphenylacetic acid | A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group. | 4-hydroxyphenylacetic acid |
| 4-hydroxyphenyllactic acid | A 2-hydroxy carboxylic acid that is lactic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group. | 3-(4-hydroxyphenyl)lactic acid |
| 4-hydroxyphenylpyruvic acid | A 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group. | 4-hydroxyphenylpyruvic acid |
| 4-hydroxyretinoic acid | A retinoid that consists of all-trans-retinoic acid bearing a hydroxy substituent at position 4 on the cyclohexenyl ring. | all-trans-4-hydroxyretinoic acid |
| 4-methoxyestradiol | A 17beta-hydroxy steroid that is 17beta-estradiol in which the hydrogen at position 4 has been replaced by a methoxy group. | 4-methoxy-17beta-estradiol |
| 4-methylcatechol | A methylcatechol having a single methyl substituent at the 4-position. It has been isolated from Picea abies. | 4-methylcatechol |
| 4-nitrophenyl sulfate | An aryl sulfate the mono 4-nitrophenyl ester of sulfuric acid. | 4-nitrophenyl hydrogen sulfate |
| 4-oxo-2-nonenal | The enal that is (E)-non-2-enal substituted with an oxo group at C-4. | (E)-4-oxonon-2-enal |
| 4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol | A 3beta-sterol formed formally by loss of a methyl group from the 14-position of lanosterol. | 14-demethyllanosterol |
| 4,4-dimethylcholesta-8,14,24-trienol | | 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol |
| 5 alpha-androstane-3 alpha,17 beta-diol | The 5alpha-stereoisomer of androstane-3alpha,17beta-diol. | 5alpha-androstane-3alpha,17beta-diol |
| 5 alpha-androstane-3 beta,17 beta-diol | An androstane-3,17-diol that is 5alpha-androstane substituted by beta-hydroxy groups at positions 3 and 17. It is a metabolite of dihydrotestosterone. | 5alpha-androstane-3beta,17beta-diol |
| 5-alpha-dihydroprogesterone | A C21-steroid hormone that is 5alpha-pregnane substituted by oxo groups at positions 3 and 20. It is a metabolite of progestrone. | 5alpha-pregnane-3,20-dione |
| 5-aminovaleric acid | A delta-amino acid comprising pentanoic acid with an amino substituent at C-5; a methylene homologue of gamma-aminobutyric acid (GABA) that is a weak GABA agonist. | 5-aminopentanoic acid zwitterion; 5-aminopentanoic acid |
| 5-diphosphomevalonic acid | The 5-diphospho derivative of (R)-mevalonic acid. | (R)-5-diphosphomevalonic acid |
| 5-formyluracil | A pyrimidone resulting from the formal oxidation of the alcoholic hydroxy group of 5-hydroxymethyluracil to the corresponding aldehyde. It is a major one-electron photooxidation product of thymine in oligodeoxynucleotides. | 5-formyluracil |
| 5-hydroxy-6,8,11,14-eicosatetraenoic acid | A HETE having a (5S)-hydroxy group and (6E)-, (8Z)-, (11Z)- and (14Z)-double bonds. | 5(S)-HETE |
| 5-hydroxybenzimidazole | A member of the class of benzimidazoles that is 1H-benzimidazole carrying a single hydroxy substituent at position 5. | 5-hydroxybenzimidazole |
| 5-hydroxyindole | A member of the class of hydroxyindoles that is 1H-indole in which the hydrogen at position 5 has been replaced by a hydroxy group. | 5-hydroxyindole |
| 5-hydroxyisourate | An oxopurine that is 5,7-dihydro-1H-purine-2,6,8(9H)-trione in which the hydrogen at position 5 is substituted by a hydroxy group. | 5-hydroxyisouric acid |
| 5-hydroxymethylcytosine | A nucleobase analogue that is cytosine in which the hydrogen at position 5 is replaced by a hydroxymethyl group. | 5-(hydroxymethyl)cytosine |
| 5-hydroxymethyluracil | A primary alcohol that is uracil bearing a hydroxymethyl substituent at the 5-position. | 5-hydroxymethyluracil |
| 5-hydroxytryptophan | A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5. | 5-hydroxytryptophan |
| 5-hydroxytryptophan | The L-enantiomer of 5-hydroxytryptophan. | 5-hydroxy-L-tryptophan zwitterion; 5-hydroxy-L-tryptophan |
| 5-methoxytryptamine | A member of the class of tryptamines that is the methyl ether derivative of serotonin. | 5-methoxytryptamine |
| 5-methyl-2-furfural | | 5-methyl-2-furaldehyde |
| 5-methylcytosine | A pyrimidine that is a derivative of cytosine, having a methyl group at the 5-position. | 5-methylcytosine |
| 5-oxo-6,8,11,14-eicosatetraenoic acid | An oxoicosatetraenoic acid having a 5-oxo group; and (6E)-, (8Z), (11Z)- and (14Z)-double bonds. | 5-oxo-ETE |
| 5,6-dihydrothymine | A pyrimidone obtained by formal addition of hydrogen across the 5,6-position of thymine. | 5,6-dihydrothymine |
| 5,6-dimethylbenzimidazole | A dimethylbenzimidazole carrying methyl substituents at positions 5 and 6. | 5,6-dimethylbenzimidazole |
| 5'-deoxyadenosine | A 5'-deoxyribonucleoside compound having adenosine as the nucleobase. | 5'-deoxyadenosine |
| 5'-methylthioadenosine | Adenosine with the hydroxy group at C-5' substituted with a methylthio (methylsulfanyl) group. | 5'-S-methyl-5'-thioadenosine |
| 5beta-pregnane-3,20-dione | A C21-steroid that is 5beta-pregnane with oxo groups at positions 3 and 20. | 5beta-pregnane-3,20-dione |
| 6 beta-hydroxycortisol | A C21-steroid that is cortisol bearing an additional hydroxy substituent at the 6beta-position. In humans, it is produced as a metabolite of cortisol by cytochrome p450-3A4 (CYP3A4, an important enzyme involved in the metabolism of a variety of exogenous and endogenous compounds) and can be used to detect moderate and potent CYP3A4 inhibition in vivo. | 6beta-hydroxycortisol |
| 6-ketoprostaglandin f1 alpha | A prostaglandin Falpha that is prostaglandin F1alpha bearing a keto substituent at the 6-position. | 6-oxoprostaglandin F1alpha |
| 6-methyladenine | A methyladenine that is 9H-purin-6-amine substituted by a methyl group at the amino nitrogen. | 6-methyladenine |
| 6-phosphogluconolactone | Dianion of 6-O-phosphono-D-glucono-1,5-lactone arising from deprotonation of the phosphate OH groups; major species at pH 7.3. | 6-O-phosphonato-D-glucono-1,5-lactone(2-) |
| 7 alpha-hydroxy-4-cholesten-3-one | A cholestanoid consisting of a cholesterol core having an oxo group at the 3-position, a C=C bond at the 4,5-position and an alpha-hydroxy group at the 7-position. | 7alpha-hydroxycholest-4-en-3-one |
| 7-dehydrocholesterol | | cholesta-5,7-dien-3beta-ol |
| 7-ketolithocholic acid | A bile acid that is lithocholic acid carrying an additional oxo substituent at position 7. | 7-oxolithocholic acid |
| 7,8-dihydroneopterin | A neopterin where positions C-7 and C-8 have been hydrogenated. | 7,8-dihydroneopterin |
| 8-hydroxyadenine | An oxopurine that is adenine bearing a single oxo substituent at position 8. | 8-hydroxyadenine; 8-oxoadenine |
| 8-hydroxyadenine | A nucleobase analogue that is adenine bearing a single hydroxy substituent at position 8. | 8-hydroxyadenine; 8-oxoadenine |
| 8-isoprostaglandin e2 | A prostanoid that is prostaglandin E2 having inverted stereochemistry at the 8-position. | 8-epi-prostaglandin E2 |
| 8-nitroguanosine 3',5'-cyclic monophosphate | A 3',5'-cyclic purine nucleotide that is guanosine 3',5'-cyclic monophosphate in which the hydrogen at position 8 on the purine fragment has been replaced by a nitro group. | 8-nitroguanosine 3',5'-cyclic monophosphate |
| 8,11,14-eicosatrienoic acid | An icosatrienoic acid having three cis double bonds at positions 8, 11 and 14. | all-cis-icosa-8,11,14-trienoic acid |
| 9-deoxy-delta-9-prostaglandin d2 | A member of the class of prostaglandins J that consists of prosta-5,9,13-trien-1-oic acid substituted by an oxo group at position 11 and a hydroxy group at position 15 (the 5Z,13E,15S stereoisomer). | prostaglandin J2 |
| 9-hydroxy-10,12-octadecadienoic acid | A HODE that consists of (10E,12Z)-octadecadienoic acid with the hydroxy substituent located at position 9. | 9-HODE; alpha-dimorphecolic acid |
| 9-PAHSA | A FAHFA (fatty acid ester of a hydroxy fatty acid) obtained by formal condensation of the carboxy group of palmitic acid with the hydroxy group of 9-hydroxyoctadecanoic acid (9-hydroxystearic acid). | 9-PAHSA |
| 9,10-epoxystearic acid | An epoxy fatty acid consisting of octadecanoic (stearic) acid with a single epoxide located between positions 9 and 10. | 9,10-epoxyoctadecanoic acid |
| 9,11-linoleic acid | An octadeca-9,11-dienoic acid having 9-trans,11-trans-stereochemistry. | (9E,11E)-octadecadienoic acid |
| aceglutamide | An N(2)-acetylglutamine that has L-configuration. | N-acetyl-L-glutamine |
| acetaldehyde | The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke. | acetaldehyde |
| acetol | A propanone that is acetone in which one of the methyl hydrogens is replaced by a hydroxy group. | hydroxyacetone |
| acetone | A methyl ketone that consists of propane bearing an oxo group at C2. | acetone |
| aceturic acid | An N-acylglycine where the acyl group is specified as acetyl. | N-acetylglycine |
| acetyl adenylate | | 5'-acetylphosphoadenosine |
| acetyl phosphate | An acyl monophosphate in which the acyl group specified is acetyl. | acetyl dihydrogen phosphate |
| acetylcarnitine | An O-acylcarnitine having acetyl as the acyl substituent. | O-acetylcarnitine |
| acetylcarnitine | An O-acyl-L-carnitine where the acyl group specified is acetyl. It facilitates movement of acetyl-CoA into the matrices of mammalian mitochondria during the oxidation of fatty acids. | O-acetyl-L-carnitine |
| acetylcysteine | An N-acetyl-L-amino acid that is the N-acetylated derivative of the natural amino acid L-cysteine. | N-acetyl-L-cysteine |
| acetylgalactosamine | The D-enantiomer of N-acetylgalactosamine. | N-acetyl-D-galactosamine |
| adenine | The parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6. | adenine |
| adenosine | A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond. | adenosine |
| adenosine diphosphate | A purine ribonucleoside 5'-diphosphate having adenine as the nucleobase. | ADP |
| adenosine diphosphate | A nucleoside 5'-diphosphate(3-) arising from deprotonation of all three diphosphate OH groups of adenosine 5'-diphosphate (ADP); major species present at pH 7.3. | ADP(3-) |
| adenosine diphosphate glucose | A nucleotide-sugar oxoanion resutling from the deprotonation of both free OH groups of the diphosphate group of ADP alpha-D-glucoside. | ADP alpha-D-glucoside(2-) |
| adenosine monophosphate | A nucleoside 5'-monophosphate(2-) that results from the removal of two protons from the phosphate group of adenosine 5'-monophosphate (AMP). | adenosine 5'-monophosphate(2-) |
| adenosine triphosphate | A nucleoside triphosphate(4-) obtained by global deprotonation of the triphosphate OH groups of ATP; major species present at pH 7.3. | ATP(4-) |
| aflatoxin b1 | An aflatoxin having a tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene skeleton with oxygen functionality at positions 1, 4 and 11. | aflatoxin B1 |
| aflatoxin b1-2,3-oxide | | aflatoxin B1 exo-8,9-epoxide |
| aica ribonucleotide | A 1-(phosphoribosyl)imidazolecarboxamide that is acadesine in which the hydroxy group at the 5' position has been converted to its monophosphate derivative. | AICA ribonucleotide |
| aldosterone | A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney. | aldosterone |
| allantoin | An imidazolidine-2,4-dione that is 5-aminohydantoin in which a carbamoyl group is attached to the exocyclic nitrogen. | allantoin |
| allocholic acid | An allo-bile acid that is 5alpha-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12. | allocholic acid |
| allysine | An optically active form of allysine having L-configuration. | L-allysine zwitterion; L-allysine |
| alpha-glycerophosphoric acid | A glycerol monophosphate having the phosphate group located at position 1. | glycerol 1-phosphate |
| alpha-keto-delta-guanidinovaleric acid | A 2-oxo monocarboxylic acid that is 2-oxopentanoic acid in which one of the methyl hydrogens is substituted by a carbamimidamido group. | 5-guanidino-2-oxopentanoic acid zwitterion; 5-guanidino-2-oxopentanoic acid |
| alpha-ketoisovalerate | A 2-oxo monocarboxylic acid that is the 2-oxo derivative of isovaleric acid. | 3-methyl-2-oxobutanoic acid |
| alprostadil | | prostaglandin E1 |
| aminoethylphosphonic acid | A phosphonic acid in which the hydrogen attached to the phosphorus of phosphonic acid is substituted by a 2-aminoethyl group. | (2-aminoethyl)phosphonic acid zwitterion; (2-aminoethyl)phosphonic acid |
| aminolevulinic acid | The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp. | 5-aminolevulinic acid; 5-ammoniolevulinate |
| aminomalonic acid | An amino dicarboxylic acid that is malonic acid in which one of the methylene hydrogens has been replaced by an amino group. | aminomalonic acid |
| androstenediol | A 3beta-hydroxy-Delta(5)-steroid that is 3beta-hydroxyandrost-5-ene carrying an additional hydroxy group at position 17beta. | androst-5-ene-3beta,17beta-diol |
| androstenedione | A 3-oxo Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17. It is a steroid hormone synthesized in the adrenal glands and gonads. | androst-4-ene-3,17-dione |
| androsterone | An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone . | androsterone |
| androsterone glucuronide | A steroid glucosiduronic acid having androsterone as the steroid component. | androsterone 3-glucosiduronic acid |
| androsterone sulfate | A steroid sulfate that is the 3-sulfate of androsterone. | androsterone sulfate |
| angiotensin i | A nine amino acid peptide which is formed when angiotensin converting enzyme 2 (ACE2) hydrolyzes the carboxy terminal leucine from angiotensin I. It is a anti-cardiac hypertrophy agent. | angiotensin (1-9) dizwitterion; angiotensin (1-9) |
| angiotensin i | A peptide zwitterion that is the dizwitterionic form of angiotensin (1-9) having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3. | angiotensin (1-9) dizwitterion; angiotensin (1-9) |
| angiotensin i | A ten amino acid peptide formed by renin cleavage of angiotensinogen. Angiotensin I has no direct biological function except that high levels can stimulate catecholamine production. It is metabolized to its biologically active byproduct angiotensin II, a potent vasoconstrictor, by angiotensin converting enzyme (ACE) through cleavage of the two terminal amino acids. | angiotensin I dizwitterion; angiotensin I |
| angiotensin i | A peptide zwitterion that is the dizwitterionic form of angiotensin I having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3. | angiotensin I dizwitterion; angiotensin I |
| angiotensin i, ile(5)- | A ten amino acid peptide formed by renin cleavage of angiotensinogen. Angiotensin I has no direct biological function except that high levels can stimulate catecholamine production. It is metabolized to its biologically active byproduct angiotensin II, a potent vasoconstrictor, by angiotensin converting enzyme (ACE) through cleavage of the two terminal amino acids. | angiotensin I dizwitterion; angiotensin I |
| angiotensin i, ile(5)- | A peptide zwitterion that is the dizwitterionic form of angiotensin I having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3. | angiotensin I dizwitterion; angiotensin I |
| angiotensin ii | An angiotensin II that acts on the central nervous system (PDB entry: 1N9V). | Ile(5)-angiotensin II dizwitterion; Ile(5)-angiotensin II |
| angiotensin ii | An amino acid zwitterion that is the dizwitterionic form of Ile(5)-angiotensin II having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. | Ile(5)-angiotensin II dizwitterion; Ile(5)-angiotensin II |
| anthranilic acid | An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system. | anthranilic acid |
| apelin-12 peptide | A 12 amino acid oligopeptide fragment of apelin-13 lacking the terminal L-phenylalanine residue. | apelin-12 |
| apelin-13 peptide | A 13 amino acid oligopeptide which is the ligand for the apelin receptor (also known as the APJ receptor). It exhibits hypotensive and neuroprotective effects, and may be a potential prognostic biomarker for acute ischemic stroke and multiple sclerosis. | apelin-13 |
| arachidonic acid | A long-chain fatty acid that is a C20, polyunsaturated fatty acid having four (Z)-double bonds at positions 5, 8, 11 and 14. | arachidonic acid |
| arachidonoylserotonin | An N-acylserotonin obtained by formal condensation of the carboxy group of arachidonic acid with the primary amino group of serotonin. | N-arachidonoylserotonin |
| arachidoyl-coenzyme a | A very long-chain fatty acyl-CoA that is the S-icosanoyl derivative of coenzyme A. | icosanoyl-CoA |
| asparagine | An optically active form of asparagine having L-configuration. | L-asparagine zwitterion; L-asparagine |
| beta carotene | A cyclic carotene obtained by dimerisation of all-trans-retinol. A strongly-coloured red-orange pigment abundant in plants and fruit and the most active and important provitamin A carotenoid. | beta-carotene |
| beta-alanine | A naturally-occurring beta-amino acid comprising propionic acid with the amino group in the 3-position. | beta-alanine zwitterion; beta-alanine |
| beta-citrylglutamic acid | An N-acyl-L-glutamic acid in which the acyl group is specified as beta-citryl. | beta-citrylglutamic acid |
| beta-hydroxyisovaleric acid | A 3-hydroxy monocarboxylic acid that is isovaleric acid substituted at position 3 by a hydroxy group. Used as indicator of biotin deficiency. | 3-hydroxyisovaleric acid |
| beta-hydroxymyristic acid | A 3-hydroxy fatty acid that is tetradecanoic (myristic) acid substituted at position 3 by a hydroxy group | 3-hydroxytetradecanoic acid |
| beta-leucine | A beta-amino acid that is pentanoic acid substituted at positions 3 and 4 by amino and methyl groups respectively. | beta-leucine |
| beta-ureidoisobutyric acid | A ureidocarboxylic acid that is 2-methylpropanoic acid substituted by a carbamoylamino group at position 3. | 3-ureidoisobutyric acid |
| betaine aldehyde | A quaternary ammonium ion that is nitrogen substituted by three methyl groups and a 2-oxoethyl group. It is an intermediate in the metabolism of amino acids like glycine, serine and threonine. | betaine aldehyde |
| bilirubin | A member of the class of biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin. | bilirubin IXalpha |
| biotin | An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thieno[3,4-d]imidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins. | biotin |
| biotinamide | A monocarboxylic acid amide derived from biotin. | biotin amide |
| biotinate | Conjugate base of biotin arising from deprotonation of the carboxy group. | biotinate |
| bradykinin, des-phe(8)-des-arg(9)- | A seven-membered oligopeptide comprising Arg, Pro, Pro, Gly, Phe, Ser, and Pro residues joined in sequence by peptide bonds. It is a metabolite of bradykinin lacking the Phe residue at position 8 and the Arg residue at position 9. | [des-Phe(8), des-Arg(9)]-bradykinin |
| brassicasterol | An 3beta-sterol that is (22E)-ergosta-5,22-diene substituted by a hydroxy group at position 3beta. It is a phytosterol found in marine algae, fish, and rapeseed oil. | brassicasterol |
| brexanolone | A 3-hydroxy-5alpha-pregnan-20-one in which the hydroxy group at position 3 has alpha-configuration. It is a metabolite of the sex hormone progesterone and used for the treatment of postpartum depression in women. | brexanolone |
| calcifediol | A hydroxycalciol that is calciol in which the hydrogen at position 25 has been replaced by a hydroxy group. A prehormone resulting from the oxidation of calciol in the liver, it is further hydroxylated in the kidney to give calcitriol, the active form of vitamin D3. | calcidiol |
| calcitriol | A hydroxycalciol that is calcidiol in which the pro-S hydrogen of calcidiol is replaced by a hydroxy group. It is the active form of vitamin D3, produced fom calciol via hydoxylation in the liver to form calcidiol, which is subsequently oxidised in the kidney to give calcitriol. | calcitriol |
| caprylates | A straight-chain saturated fatty acid anion that is the conjugate base of octanoic acid (caprylic acid); believed to block adipogenesis. | octanoate |
| carbon monoxide | A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas. | carbon monoxide |
| carnitine | An amino-acid betaine that is butanoate substituted with a hydroxy group at position C-3 and a trimethylammonium group at C-4. | carnitine |
| carnosine | A dipeptide that is the N-(beta-alanyl) derivative of L-histidine. | carnosine zwitterion; carnosine |
| cerium | The (9Z,12Z)-stereoisomer of cholesteryl octadeca-9,12-dienoate. | cholesteryl linoleate |
| cerotate | The conjugate base of cerotic acid. | cerotate |
| cetyl alcohol | A long-chain primary fatty alcohol that is hexadecane substituted by a hydroxy group at position 1. | hexadecan-1-ol |
| chenodeoxycholic acid | A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 7 respectively. | chenodeoxycholic acid |
| chlorine | A halide anion formed when chlorine picks up an electron to form an an anion. | chloride |
| cholecalciferol | A hydroxy seco-steroid that is (5Z,7E)-9,10-secocholesta-5,7,10(19)-triene in which the pro-S hydrogen at position 3 has been replaced by a hydroxy group. It is the inactive form of vitamin D3, being hydroxylated in the liver to calcidiol (25-hydroxyvitamin D3), which is then further hydroxylated in the kidney to give calcitriol (1,25-dihydroxyvitamin D3), the active hormone. | calciol |
| cholest-4-en-3-one | A cholestanoid that is cholest-4-ene substituted by an oxo group at position 3. | cholest-4-en-3-one |
| cholest-5-ene-3 beta,26-diol | An oxysterol that is cholesterol substituted at position 26 by a hydroxy group. | 26-hydroxycholesterol |
| cholestane-3,7,12,26-tetrol | | 5beta-cholestane-3alpha,7alpha,12alpha,26-tetrol |
| cholesterol acetate | A cholesterol ester obtained by formal acylation of the hydroxy group of cholesterol by acetic acid. | cholesteryl acetate |
| cholesteryl palmitate | A cholesterol ester obtained by the formal condensation of cholesterol with palmitic acid. | cholesteryl palmitate |
| cholesteryl sulfate | A steroid sulfate that is cholesterol substituted by a sulfoxy group at position 3. | cholesterol sulfate |
| cholic acid | A bile acid that is 5beta-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12. | cholic acid |
| choline | A choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function. | choline |
| citraconic acid | A dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position. | citraconic acid |
| citramalate | A dicarboxylic acid dianion that is obtained by removal of a proton from both of the carboxylic acid groups of citramalic acid. | citramalate(2-) |
| citrulline | The L-enantiomer of citrulline. | L-citrulline zwitterion; L-citrulline |
| citrulline | Zwitterionic form of L-citrulline having an anionic carboxy group and a protonated amino group; major species at pH 7.3. | L-citrulline zwitterion; L-citrulline |
| cob(ii)alamin | A cobalamin in which the central cobalt atom has an oxidation state of +2. | cob(II)alamin |
| coenzyme q10 | A ubiquinone having a side chain of 10 isoprenoid units. In the naturally occurring isomer, all isoprenyl double bonds are in the E- configuration. | coenzyme Q10 |
| corticosterone | A 21-hydroxy steroid that consists of pregn-4-ene substituted by hydroxy groups at positions 11 and 21 and oxo groups at positions 3 and 20. Corticosterone is a 21-carbon steroid hormone of the corticosteroid type produced in the cortex of the adrenal glands. | corticosterone |
| cortisol 21-sulfate | A steroid sulfate obtained by the formal condensation of hydroxy group at position 21 of cortisol with sulfuric acid. | cortisol 21-sulfate |
| cortisone | A C21-steroid that is pregn-4-ene substituted by hydroxy groups at positions 17 and 21 and oxo group at positions 3, 11 and 20. | cortisone |
| cortodoxone | A deoxycortisol that is cortisol in which the hydroxy group at position 11 has been replaced by a hydrogen. | 11-deoxycortisol |
| coumarin | A chromenone having the keto group located at the 2-position. | coumarin |
| creatine | A glycine derivative having methyl and amidino groups attached to the nitrogen. | creatine zwitterion; creatine |
| creatinine | A lactam obtained by formal cyclocondensation of creatine. It is a metabolite of creatine. | creatinine |
| cyclic 3',5'-thymidine monophosphate | A 3',5'-cyclic pyrimidine nucleotide derived from thymidine monophosphate. | 3',5'-cyclic dTMP |
| cyclic amp | An organophosphate oxoanion that is the conjugate base of 3',5'-cyclic AMP arising from deprotonation of the free phosphate OH group; major species at pH 7.3. | 3',5'-cyclic AMP(1-) |
| cyclic cmp | A 3',5'-cyclic pyrimidine nucleotide having cytosine as the nucleobase. | 3',5'-cyclic CMP |
| cyclic gmp | A 3',5'-cyclic purine nucleotide in which the purine nucleobase is specified as guanidine. | 3',5'-cyclic GMP |
| cysteamine | An amine that consists of an ethane skeleton substituted with a thiol group at C-1 and an amino group at C-2. | cysteamine |
| cysteine | An optically active form of cysteine having L-configuration. | L-cysteine zwitterion; L-cysteine |
| cysteine sulfinic acid | The organosulfinic acid arising from oxidation of the sulfhydryl group of L-cysteine. | 3-sulfino-L-alanine |
| cysteinylglycine | A dipeptide consisting of glycine having an L-cysteinyl attached to its alpha-amino group. It is an intermediate metabolite in glutathione metabolism. | L-cysteinylglycine zwitterion; L-cysteinylglycine |
| cysteinylglycine | The zwitterion of L-cysteinylglycine resulting from the transfer of a proton from the hydroxy group of glycine to the amino group of cysteine. Major microspecies at pH 7.3. | L-cysteinylglycine zwitterion; L-cysteinylglycine |
| cystine | The L-enantiomer of the sulfur-containing amino acid cystine. | L-cystine zwitterion; L-cystine |
| cytidine | A pyrimidine nucleoside in which cytosine is attached to ribofuranose via a beta-N(1)-glycosidic bond. | cytidine |
| cytidine diphosphate choline | A member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. | CDP-choline |
| cytidine diphosphate choline | A member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. | CDP-choline |
| cytidine monophosphate | A pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase. | cytidine 5'-monophosphate |
| cytosine | An aminopyrimidine that is pyrimidin-2-one having the amino group located at position 4. | cytosine |
| D-alanine | The D-enantiomer of alanine. | D-alanine zwitterion; D-alanine |
| d-lactic acid | An optically active form of lactic acid having (R)-configuration. | (R)-lactic acid |
| D-serine | The R-enantiomer of serine. | D-serine zwitterion; D-serine |
| debrisoquin | | debrisoquin |
| decane-1,2-diol | A glycol that is decane bearing two hydroxy substituents located at positions 1 and 2. | decane-1,2-diol |
| decanoic acid | A C10, straight-chain saturated fatty acid. | decanoic acid |
| dehydroalanine | A 2,3-dehydroamino acid that is alanine which has been dehydrogenated to introduce a double bond between positions 2 and 3. | 2-aminoacrylic acid; 2-ammonioprop-2-enoate |
| dehydroepiandrosterone | An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands. | dehydroepiandrosterone |
| dehydroepiandrosterone sulfate | A steroid sulfate that is the 3-sulfooxy derivative of dehydroepiandrosterone. | dehydroepiandrosterone sulfate |
| deoxycytidine | A pyrimidine 2'-deoxyribonucleoside having cytosine as the nucleobase. | 2'-deoxycytidine |
| deoxyguanosine | A purine 2'-deoxyribonucleoside having guanine as the nucleobase. | 2'-deoxyguanosine |
| deoxyguanosine triphosphate | A purine 2'-deoxyribonucleoside 5'-triphosphate having guanine as the nucleobase. | dGTP |
| deoxyhypusine | An L-lysine derivative in which the N(6) of the lysine is substituted with a 4-aminobutyl group. | deoxyhypusine |
| deoxyinosine | A purine 2'-deoxyribonucleoside that is inosine in which the hydroxy group at position 2' is replaced by a hydrogen. | 2'-deoxyinosine |
| deoxyinosine monophosphate | A deoxyinosine phosphate that is 5'-inosinic acid in which the hydroxy group at position 2' by a hydrogen atom. | 2'-deoxyinosine-5'-monophosphate |
| deoxyribose | A deoxypentose that is D-ribose in which the hydroxy group at position C-2 is replaced by hydrogen. | 2-deoxy-D-ribose |
| deoxyuridine | A pyrimidine 2'-deoxyribonucleoside having uracil as the nucleobase. | 2'-deoxyuridine |
| deoxyuridine triphosphate | A deoxyuridine phosphate having a triphosphate group at the 5'-position. | dUTP |
| dephosphocoenzyme a | An adenosine 5'-phosphate that is coenzyme A in which the phosphate group at position 3' has been replaced by a hydrogen atom. It is an intermediate metabolite in pantothenate and CoA biosynthesis. | 3'-dephospho-CoA |
| desmosterol | A cholestanoid that is cholesta-5,24-diene substituted by a beta-hydroxy group at position 3. It is an intermediate metabolite obtained during the synthesis of cholesterol. | desmosterol |
| desoxycorticosterone | A mineralocorticoid that is progesterone substituted at position 21 by a hydroxy group. | 11-deoxycorticosterone |
| diadenosine tetraphosphate | Tetraanion of P(1),P(4)-bis(5'-adenosyl) tetraphosphate arising from deprotonation of the tetraphosphate OH groups; major species at pH 7.3. | P(1),P(4)-bis(5'-adenosyl) tetraphosphate(4-) |
| dibenzo(a,l)pyrene | | dibenzo[a,l]pyrene |
| dihydrolipoamide | | dihydrolipoamide |
| dihydrolipoic acid | A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects. | dihydrolipoic acid |
| dihydrotestosterone | A 17beta-hydroxy steroid that is testosterone in which the 4,5 double bond has been reduced to a single bond with alpha-configuration at position 5. | 17beta-hydroxy-5alpha-androstan-3-one |
| dihydrouracil | A pyrimidine obtained by formal addition of hydrogen across the 5,6-position of uracil. | 5,6-dihydrouracil |
| dihydroxyacetone | A ketotriose consisting of acetone bearing hydroxy substituents at positions 1 and 3. The simplest member of the class of ketoses and the parent of the class of glycerones. | dihydroxyacetone |
| dihydroxyacetone phosphate | A member of the class of glycerone phosphates that consists of glycerone bearing a single phospho substituent. | dihydroxyacetone phosphate |
| dihydroxycoprostane | | 5beta-cholestane-3alpha,7alpha-diol |
| dihydroxyphenylalanine | A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring. | dopa |
| diiodotyrosine | A diiodotyrosine that is L-tyrosine carrying iodo-substituents at positions C-3 and C-5 of the benzyl group. It is an intermediate in the thyroid hormone synthesis. | 3,5-diiodo-L-tyrosine |
| dimethylacetamide | A member of the class of acetamides that is acetamide in which the hydrogens attached to the N atom have been replaced by two methyl groups respectively. Metabolite observed in cancer metabolism. | N,N-dimethylacetamide |
| dimethylglycine | An N-methylglycine that is glycine carrying two N-methyl substituents. | N,N-dimethylglycine zwitterion; N,N-dimethylglycine |
| dinoprost | A prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is a naturally occurring prostaglandin used to induce labor. | prostaglandin F2alpha |
| dinoprostone | Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins. | prostaglandin E2 |
| dithiothreitol | The threo-diastereomer of 1,4-dimercaptobutane-2,3-diol. | 1,4-dimercaptobutane-2,3-diol; 1,4-dithiothreitol |
| docosahexaenoate | A docosahexaenoic acid having six cis-double bonds at positions 4, 7, 10, 13, 16 and 19. | all-cis-docosa-4,7,10,13,16,19-hexaenoic acid |
| docosapentaenoic acid | The all-cis-isomer of a C22 polyunsaturated fatty acid having five double bonds in the 7-, 10-, 13-, 16- and 19-positions. | (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid |
| dodecanedioic acid | An alpha,omega-dicarboxylic acid that is dodecane in which the methyl groups have been oxidised to the corresponding carboxylic acids. | dodecanedioic acid |
| dopaquinone | An L-phenylalanine derivative in which the phenyl group of L-phenylalanine is replaced by a 3,4-dioxocyclohexa-1,5-dien-1-yl group. | L-dopaquinone zwitterion; L-dopaquinone |
| dyspropterin | A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one substituted by a 2-oxopropanoyl group at position 6. | dyspropterin |
| enkephalin, leucine | A pentapeptide comprising L-tyrosine, glycine, glycine, L-phenylalanine and L-leucine residues joined in sequence by peptide linkages. It is an endogenous opioid peptide produced in vertebrate species, including rodents, primates and humans that results from decomposition of proenkephalin or dynorphin and exhibits antinociceptive properties. | Leu-enkephalin zwitterion; Leu-enkephalin |
| enkephalin, methionine | A pentapeptide comprising L-tyrosine, glycine, glycine, L-phenylalanine and L-methionine residues joined in sequence by peptide linkages. It is an endogenous opioid peptide with antitumor, analgesic, and immune-boosting properties. | Met-enkephalin zwitterion; Met-enkephalin |
| epiandrosterone | A 3beta-hydroxy steroid that is (5alpha)-androstane substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. | epiandrosterone |
| epitestosterone | An androstanoid that is the C-17 epimer of testosterone. | epitestosterone |
| erucyl amide | A primary fatty amide resulting from the formal condensation of the carboxy group of erucic acid with ammonia. It is commonly used as a slip additive in the plastic manufacturing industry. | erucamide |
| erythritol | The meso-diastereomer of butane-1,2,3,4-tetrol. | erythritol |
| erythrose 4-phosphate | An erythrose phosphate that is D-erythrose carrying a phosphate group at position 4. It is an intermediate in the pentose phosphate pathway and Calvin cycle. | D-erythrose 4-phosphate |
| estetrol | A 3-hydroxy steroid that is 17beta-estradiol which has been substituted at the 15alpha and 16alpha positions by two additional hydroxy groups. It is a natural estrogen produced exclusively during pregnancy by the fetal liver. | estetrol |
| estra-1(10),4-diene-2,3,17-trione | An o-quinone resulting from the formal oxidation of the dihydroxyphenyl moiety of 2-hydroxyestrone. | estra-1(10),4-diene-2,3,17-trione |
| estradiol-3-glucuronide | A steroid glucosiduronic acid that consists of 17beta-estradiol having a beta-glucuronyl residue attached at position 3 via a glycosidic linkage. | 17beta-estradiol 3-glucosiduronic acid |
| estriol | A 3-hydroxy steroid that is estra-1,3,5(10)-trien-3-ol substituted by additional hydroxy groups at positions 16 and 17 (16alpha,17beta-stereoisomer). | estriol |
| estrone | A 17-oxo steroid that is estra-1,3,5(10)-triene substituted by an hydroxy group at position 3 and an oxo group at position 17. | estrone |
| estrone sulfate | A steroid sulfate that is the 3-sulfate of estrone. | estrone 3-sulfate |
| estrone-3-glucuronide | The 3-beta-D-glucuronide of estrone. | estrone 3-O-(beta-D-glucuronide) |
| ethanolamine | A member of the class of ethanolamines that is ethane with an amino substituent at C-1 and a hydroxy substituent at C-2, making it both a primary amine and a primary alcohol. | ethanolamine |
| ethylamine | A two-carbon primary aliphatic amine. | ethylamine |
| ethylmalonic acid | A dicarboxylic acid obtained by substitution of one of the methylene hydrogens of malonic acid by an ethyl group. | ethylmalonic acid |
| etiocholanolone | An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals. | 3alpha-hydroxy-5beta-androstan-17-one |
| flavin mononucleotide | A flavin mononucleotide that is riboflavin (vitamin B2) in which the primary hydroxy group has been converted to its dihydrogen phosphate ester. | FMN |
| flavin-adenine dinucleotide | A flavin adenine dinucleotide in which the substituent at position 10 of the flavin nucleus is a 5'-adenosyldiphosphoribityl group. | FAD |
| folic acid | An N-acyl-amino acid that is a form of the water-soluble vitamin B9. Its biologically active forms (tetrahydrofolate and others) are essential for nucleotide biosynthesis and homocysteine remethylation. | folic acid |
| fructose 2,6-diphosphate | A D-fructofuranose 2,6-bisphosphate with a beta-configuration at the anomeric centre. | beta-D-fructofuranose 2,6-bisphosphate |
| fructosyl-glycine | | fructosylglycine |
| fuculose | A a deoxyketohexose comprising L-tagatose with the hydroxy group at position 6 replaced by hydrogen. | L-fuculose |
| fuculose 1-phosphate | | L-fucopyranose 1-phosphate |
| fumarates | A C4-dicarboxylate that is the E-isomer of but-2-enedioate(2-) | fumarate(2-) |
| furoylglycine | A glycine derivative that is the carboxamide obtained by the formal condensation of the amino group of glycine with 2-furoic acid. | N-(2-furoyl)glycine |
| galactaric acid | A hexaric acid resulting from formal oxidative ring cleavage of galactose. | galactaric acid |
| galactitol | An optically inactive hexitol having meso-configuration. | galactitol |
| gamma-aminobutyric acid | A gamma-amino acid that is butanoic acid with the amino substituent located at C-4. | gamma-aminobutyric acid zwitterion; gamma-aminobutyric acid |
| gamma-butyrobetaine | An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups. | 4-(trimethylammonio)butanoate |
| gamma-glutamyl-leucine | A glutamyl-L-amino acid obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of leucine. | gamma-Glu-Leu |
| gamma-glutamylcysteine | A molecular entity formed when L-cysteine amino group binds to the gamma-carbonyl of L-glutamic acid. | L-gamma-glutamyl-L-cysteine |
| gamma-glutamylglutamate | A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of another glutamic acid. | gamma-Glu-Glu |
| gamma-glutamylglutamine | A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of glutamine | gamma-Glu-Gln |
| gamma-glutamyltyrosine | A dipeptide composed of L-glutamic acid and L-tyrosine joined by a peptide linkage. | gamma-Glu-Tyr |
| gamma-glutamylvaline | A glutamyl-L-amino acid that is the N-(L-gamma-glutamyl) derivative of L-leucine. | gamma-Glu-Val |
| gamma-linolenic acid | A C18, omega-6 acid fatty acid comprising a linolenic acid having cis- double bonds at positions 6, 9 and 12. | gamma-linolenic acid |
| glucosamine 6-phosphate | A 2-amino-2-deoxy-D-glucopyranose 6-phosphate that has an alpha-configuration at the anomeric position. | alpha-D-glucosamine 6-phosphate |
| glucose-1,6-bisphosphate | A D-glucose 1,6-bisphosphate in which both phosphate groups are monophosphates. | alpha-D-glucose 1,6-bisphosphate |
| glutamate | An alpha-amino-acid anion that is the conjugate base of L-glutamic acid, having anionic carboxy groups and a cationic amino group | L-glutamate(1-) |
| glutamine | An optically active form of glutamine having L-configuration. | L-glutamine zwitterion; L-glutamine |
| glutaric acid | An alpha,omega-dicarboxylic acid that is a linear five-carbon dicarboxylic acid. | glutaric acid |
| glutaurine | A dipeptide resulting from the formal condensation of the amino group of taurine with the gamma-carboxy group of L-glutamic acid. It was initially found in the parathyroid in 1980 and later in the brain of mammals. | glutaurine zwitterion; glutaurine |
| glycerol | A triol with a structure of propane substituted at positions 1, 2 and 3 by hydroxy groups. | glycerol |
| glyceryl 2-arachidonate | An endocannabinoid and an endogenous agonist of the cannabinoid receptors (CB1 and CB2). It is an ester formed from omega-6-arachidonic acid and glycerol. | 2-arachidonoylglycerol |
| glycerylphosphorylcholine | A member of the class of phosphocholines that is the choline ester of sn-glycero-3-phosphate. It is one of the major osmolyte in the renal medullary cells. | choline alfoscerate |
| glycochenodeoxycholic acid | A bile acid glycine conjugate having 3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl as the bile acid component. | glycochenodeoxycholic acid |
| glycocholic acid | A bile acid glycine conjugate having cholic acid as the bile acid component. | glycocholic acid |
| glycocyamine | The N-amidino derivative of glycine. | guanidinoacetic acid zwitterion; guanidinoacetic acid |
| glycodeoxycholic acid | A bile acid glycine conjugate of deoxycholic acid. | glycodeoxycholic acid |
| glycolaldehyde | The glycolaldehyde derived from ethylene glycol. The parent of the class of glycolaldehydes. | glycolaldehyde |
| glycyl-l-phenylalanine | A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Gly-Phe. | Gly-Phe zwitterion; Gly-Phe |
| glycylglycine | A dipeptide formed from glycine residues. | glycylglycine zwitterion; glycylglycine |
| glycylglycine | The zwitterion from the dipeptide glycylglycine formed by proton transfer from the OH of the carboxy group to the terminal amino group. | glycylglycine zwitterion; glycylglycine |
| glycylvaline | A dipeptide formed from glycine and L-valine residues. | Gly-Val |
| glyoxylic acid | A 2-oxo monocarboxylic acid that is acetic acid bearing an oxo group at the alpha carbon atom. | glyoxylic acid |
| guanine | A 2-aminopurine carrying a 6-oxo substituent. | guanine |
| guanosine diphosphate mannose | The alpha-anomer of GDP-D-mannose. | GDP-alpha-D-mannose |
| hexadecanal | | hexadecanal |
| hexadecanedioic acid | An alpha,omega-dicarboxylic acid that is the 1,14-dicarboxy derivative of tetradecane. | hexadecanedioic acid |
| hexanoic acid | A C6, straight-chain saturated fatty acid. | hexanoic acid |
| hexanoyl-coenzyme a | A medium-chain fatty acyl-CoA having hexanoyl as the S-acyl group. | hexanoyl-CoA |
| hexanoylcarnitine | An O-acylcarnitine compound having hexanoyl as the acyl substituent. | O-hexanoylcarnitine |
| histamine | A member of the class of imidazoles that is 1H-imidazole substituted at position C-4 by a 2-aminoethyl group. | histamine |
| histidine | The L-enantiomer of the amino acid histidine. | L-histidine zwitterion; L-histidine |
| histidinol | An amino alcohol that is propanol substituted by 1H-imidazol-4-yl group at position 3 and an amino group at position 2 (the 2S stereoisomer). | L-histidinol |
| homoarginine | An L-lysine derivative that is the L-enantiomer of homoarginine. | L-homoarginine |
| homocarnosine | A homocarnosine that has S configuration. | L-homocarnosine zwitterion; L-homocarnosine |
| homocitrulline | A L-lysine derivative that is L-lysine having a carbamoyl group at the N(6)-position. It is found in individuals with urea cycle disorders. | L-homocitrulline zwitterion; L-homocitrulline |
| homocitrulline | An amino acid zwitterion of L-homocitrulline arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3. | L-homocitrulline zwitterion; L-homocitrulline |
| homocystine | An organic disulfide obtained by oxidative dimerisation of homocysteine. | homocystine zwitterion; homocystine |
| homocystine | Dizwitterionic form of homocystine arising from transfer of two protons from the carboxy to the amino groups; major species at pH 7.3. | homocystine zwitterion; homocystine |
| homogentisic acid | A dihydroxyphenylacetic acid having the two hydroxy substituents at the 2- and 5-positions. | homogentisic acid |
| homoserine | The L-enantiomer of homoserine. | L-homoserine zwitterion; L-homoserine |
| homovanillic acid | A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite. | homovanillic acid |
| hordenine | | hordenine |
| hydracrylic acid | A 3-hydroxy monocarboxylic acid that is propionic acid in which one of the hydrogens attached to the terminal carbon is replaced by a hydroxy group. | 3-hydroxypropionic acid |
| hydrogen | An elemental molecule consisting of two hydrogens joined by a single bond. | dihydrogen |
| hydrogen carbonate | The carbon oxoanion resulting from the removal of a proton from carbonic acid. | hydrogencarbonate |
| hydrogen cyanide | A one-carbon compound consisting of a methine group triple bonded to a nitrogen atom | hydrogen cyanide |
| hydrogen sulfite | | hydrogensulfite |
| hydroxyindoleacetaldehyde | An aldehyde that is acetaldehyde substituted by a 5-hydroxyindol-3-yl group. | (5-hydroxyindol-3-yl)acetaldehyde |
| hydroxyindoleacetic acid | A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5. | (5-hydroxyindol-3-yl)acetic acid |
| hydroxylysine | A 5-hydroxylysine consisting of L-lysine having an (R)-hydroxy group at the 5-position. | erythro-5-hydroxy-L-lysine |
| hydroxyproline | An optically active form of 4-hydroxyproline having L-trans-configuration. | trans-4-hydroxy-L-proline zwitterion; trans-4-hydroxy-L-proline |
| hydroxypyruvic acid | A 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is substituted by a hydroxy group. It is an intermediate involved in the glycine and serine metabolism. | 3-hydroxypyruvic acid |
| hyodeoxycholic acid | A member of the class of 5beta-cholanic acids that is (5beta)-cholan-24-oic acid substituted by alpha-hydroxy groups at positions 3 and 6. | hyodeoxycholic acid |
| hypochlorous acid | A chlorine oxoacid with formula HOCl; a weak, unstable acid, it is the active form of chlorine in water. | hypochlorous acid |
| hypotaurine | An aminosulfinic acid comprising ethylamine having the sulfo group at the 2-position. | hypotaurine zwitterion; hypotaurine |
| hypothiocyanite ion | A sulfur oxoacid that is sulfenic acid in which the hydrogen attached to the sulfur has been replaced by a cyano group. | hypothiocyanous acid |
| iditol | The L-enantiomer of iditol. | L-iditol |
| indican | An aryl sulfate that is indoxyl in which the hydroxyl hydrogen is substituted by a sulfo group. | indoxyl sulfate |
| indole-3-acetaldehyde | An indoleacetaldehyde that is acetaldehyde in which one of the methyl hydrogens are replaced by a indol-3-yl group. It is an intermediate metabolite in the metabolism of tryptophan. | indol-3-ylacetaldehyde |
| indole-3-carboxylic acid | An indole-3-carboxylic acid carrying a carboxy group at position 3. | indole-3-carboxylic acid |
| indole-3-lactic acid | A hydroxy monocarboxylic acid that is lactic acid substituted by a 1H-indol-3-yl group at position 3. It is a metabolite of tryptophan. | 3-(indol-3-yl)lactic acid |
| indoleacetic acid | A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1H-indol-3-yl group. | indole-3-acetic acid |
| indolepropionic acid | An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3. | 3-(1H-indol-3-yl)propanoic acid |
| inosine | A purine nucleoside in which hypoxanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond. | inosine |
| inosine triphosphate | The inosine phosphate that has a triphosphate group at the 5'-position. It is an intermediate in the metabolism of purine. | ITP |
| inosinic acid | A purine ribonucleoside 5'-monophosphate having hypoxanthine as the nucleobase. | IMP |
| inositol 1,3,4-trisphosphate | The hexaanion of 1D-myo-inositol 1,3,4-trisphosphate. | 1D-myo-inositol 1,3,4-trisphosphate(6-) |
| inositol 3,4-bisphosphate | | 1D-myo-inositol 3,4-bisphosphate |
| iodine | | iodide |
| iron | | iron(2+) |
| isethionic acid | An alkanesulfonic acid in which the sulfo group is directly linked to a 2-hydroxyethyl group. | isethionic acid |
| isobutyryl-1-carnitine | An optically active form of O-isobutyrylcarnitine having (R)-configuration. | O-isobutyryl-L-carnitine |
| isobutyryl-coenzyme a | A short-chain, methyl-branched fatty acyl-CoA that is the S-isobutyryl derivative of coenzyme A. | isobutyryl-CoA |
| isocaproaldehyde | | 4-methylpentanal |
| isocaproic acid | A methyl-branched fatty acid that is pentanoic acid with a methyl group substituent at position 4. It is a metabolite of 20 alpha-hydroxycholesterol | isocaproic acid |
| isoleucine | The L-enantiomer of isoleucine. | L-isoleucine zwitterion; L-isoleucine |
| isomaltose | A glycosylglucose consisting of two D-glucopyranose units connected by an alpha-(1->6)-linkage. | isomaltose |
| isonicotinic acid | A pyridinemonocarboxylic acid in which the carboxy group is at position 4 of the pyridine ring. | isonicotinic acid |
| isopropyl palmitate | A fatty acid ester obtained by the formal condensation of carboxy group of palmitic acid with propan-2-ol. Metabolite observed in cancer metabolism. | isopropyl palmitate |
| isospaglumic acid | A dipeptide composed of N-acetyl-L-aspartic acid and L-glutamic acid joined by a peptide linkage. | Ac-Asp-Glu |
| isoursodeoxycholic acid | A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by beta-hydroxy groups at positions 3 and 7. | isoursodeoxycholic acid |
| itaconic acid | A dicarboxylic acid that is methacrylic acid in which one of the methyl hydrogens is substituted by a carboxylic acid group. | itaconic acid |
| kinetensin | An oligopeptide comprising of nine amino acids with sequence L-Ile-L-Ala-L-Arg-L-Arg-L-His-L-Pro-L-Tyr-L-Phe-L-Leu. It was originally isolated from pepsin-treated human plasma and shares some sequence homology with the C-terminal end of neurotensin. It is a potent histamine releaser and may serve as an inflammatory mediator. | kinetensin |
| kynurenic acid | A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4. | kynurenic acid |
| kynurenine | A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group. | kynurenine |
| kynurenine | A kynurenine that has L configuration. | L-kynurenine zwitterion; L-kynurenine |
| L-2-aminoadipic acid | The L-enantiomer of 2-aminoadipic acid. | L-2-aminoadipic acid |
| l-lactic acid | An optically active form of lactic acid having (S)-configuration. | (S)-lactic acid |
| lanosten-3-ol-32-al | A tetracyclic triterpenoid that is lanost-8-ene carrying hydroxy and oxo substituents at positions 3beta and 30 respectively. | 3beta-hydroxylanost-8-en-32-al |
| lanosterol | A tetracyclic triterpenoid that is lanosta-8,24-diene substituted by a beta-hydroxy group at the 3beta position. It is the compound from which all steroids are derived. | lanosterol |
| lathosterol | A cholestanoid that is (5alpha)-cholest-7-ene substituted by a beta-hydroxy group at position 3. | 5alpha-cholest-7-en-3beta-ol |
| leucine | The L-enantiomer of leucine. | L-leucine zwitterion; L-leucine |
| leucylleucine | A dipeptide formed from two L-leucine residues. | Leu-Leu zwitterion; Leu-Leu |
| leukotriene a4 | A leukotriene that is the (5S,6S)-epoxy derivative of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid. | leukotriene A4 |
| leukotriene b4 | A leukotriene composed of (6Z,8E,10E,14Z)-icosatetraenoic acid having (5S)- and (12R)-hydroxy substituents. It is a lipid mediator of inflammation that is generated from arachidonic acid via the 5-lipoxygenase pathway. | leukotriene B4 |
| leukotriene c4 | A leukotriene that is (5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid in which a glutathionyl group is attached at position 6 via a sulfide linkage. | leukotriene C4 |
| leukotriene d4 | A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and a L-cysteinylglycinyl group at position 6 (6R). | leukotriene D4 |
| leukotriene f-4 | A leukotriene composed of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid having (5S)-hydroxy and (6R)-(L-gamma-glutamyl-L-cystein-S-yl) substituents. | leukotriene F4 |
| levodopa | An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease | L-dopa zwitterion; L-dopa |
| lignoceric acid | A C24 straight-chain saturated fatty acid. | tetracosanoic acid |
| lignoceroyl-coenzyme a | A very long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of tetracosanoic (lignoceric) acid. It is an intermediate in the biosynthesis of unsaturated fatty acids. | tetracosanoyl-CoA |
| limonene | A monoterpene that is cyclohex-1-ene substituted by a methyl group at position 1 and a prop-1-en-2-yl group at position 4 respectively. | limonene |
| linoleamide | A fatty amide obtained from linoleic acid. | linoleamide |
| lipoamide | A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of lipoic acid with ammonia. | lipoamide |
| lipoxin a4 | A C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds. | lipoxin A4 |
| lithocholic acid | A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action. | lithocholic acid |
| lugdunin | A thiazolidine-containing homodetic cyclic peptide that is isolated from human nasal bacteria. Exhibits bactericidal activity against many major pathogens including methicillin-resistant Staphylococcus aureus (MRSA). | lugdunin |
| lysine | An L-alpha-amino acid; the L-isomer of lysine. | L-lysine zwitterion; L-lysine |
| lysine | An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of L-lysine; major species at pH 7.3. | L-lysine zwitterion; L-lysine |
| malonic acid | An alpha,omega-dicarboxylic acid in which the two carboxy groups are separated by a single methylene group. | malonic acid |
| maltotriose | A maltotriose trisaccharide in which the glucose residue at the reducing end is in the pyranose ring form and has alpha configuration at the anomeric carbon atom.. | alpha-maltotriose |
| mannitol-1-phosphate | An alditol 1-phosphate that is the 1-O-phospho derivative of mannitol with D-configuration. | D-mannitol 1-phosphate |
| mannose 1-phosphate | A mannose phosphate that is D-mannose carrying a phosphate group at position 1. | D-mannose 1-phosphate |
| meglutol | A dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura. | 3-hydroxy-3-methylglutaric acid |
| melatonin | A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. | melatonin |
| menatetrenone | A menaquinone whose side-chain contains 4 isoprene units in an all-trans-configuration. | menaquinone-4 |
| mephentermine | A 2-aminooctadecane-1,3-diol having (2S,3R)-configuration. | sphinganine |
| methanol | The primary alcohol that is the simplest aliphatic alcohol, comprising a methyl and an alcohol group. | methanol |
| methionine | The L-enantiomer of methionine. | L-methionine zwitterion; L-methionine |
| methylcyclohexane | A cycloalkane that is cyclohexane substituted by a single methyl group. | methylcyclohexane |
| methylcyclopentane | A cycloalkane that is cyclopentane substituted by a single methyl group. | methylcyclopentane |
| methylmalonic acid | A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group. | methylmalonic acid |
| methylmercaptan | | methanethiol |
| monoacetylcadaverine | An N-substituted cadaverine that is cadaverine in which one of the amino groups has been converted to the corresponding acetamide. | N-acetylcadaverine |
| monoiodotyrosine | The monoiodotyrosine that is L-tyrosine carrying an iodo-substituent at position C-3 of the benzyl group. | 3-iodo-L-tyrosine zwitterion; 3-iodo-L-tyrosine |
| monolinolein | A rac-1-monoacylglycerol that is composed of equal amounts of 1-linoleoyl-sn-glycerol and 3-linoleoyl-sn-glycerol. | 1-monolinolein; rac-1-monolinoleoylglycerol |
| myristic acid | A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat. | tetradecanoic acid |
| n-acetyl-l-arginine | An N-acetyl-L-amino acid that is L-arginine in which one of the hydrogens attached to the nitrogen is replaced by an acetyl group. | N(alpha)-acetyl-L-arginine |
| n-acetylalanine | An N-acetyl-L-amino acid that is L-alanine in which one of the hydrogens attached to the nitrogen is replaced by an acetyl group. | N-acetyl-L-alanine |
| n-acetylaspartic acid | An N-acyl-L-aspartic acid in which the acyl group is specified as acetyl. | N-acetyl-L-aspartic acid |
| n-acetylgalactosamine-1-phosphate | A D-galactosamine 1-phosphate compound having an N-acetyl substituent. | N-acetyl-D-galactosamine 1-phosphate |
| n-acetylglucosamine-1-phosphate | A N-acetyl-D-glucosamine 1-phosphate that is 2-deoxy-D-glucopyranose 1-(dihydrogen phosphate) substituted by an acetamido group at position 2. | 2-acetamido-2-deoxy-D-glucopyranose 1-phosphate |
| n-acetylglutamic acid | An N-acyl-L-amino acid that is L-glutamic acid in which one of the amine hydrogens is substituted by an acetyl group. | N-acetyl-L-glutamic acid |
| n-acetylhistamine | A member of the class of acetamides that is acetamide comprising histamine having an acetyl group attached to the side-chain amino function. | N-acetylhistamine |
| n-acetylneuraminic acid | An N-acylneuraminic acid where the N-acyl group is specified as acetyl. | N-acetylneuraminic acid |
| n-acetylserine | An N-acetyl-L-amino acid in which the amino acid specified is L-serine. Metabolite observed in cancer metabolism. | N-acetyl-L-serine |
| n-acetylserotonin | An N-acylserotonin resulting from the formal condensation of the primary amino group of serotonin with the carboxy group of acetic acid. | N-acetylserotonin |
| n-carbamylglutamate | A glutamic acid derivative that is glutamic acid substituted by a carbamoyl group at the nitrogen atom. | N-carbamoylglutamic acid |
| n-epsilon-acetyllysine | An N(6)-acyl-L-lysine where the N(6)-acyl group is specified as acetyl. | N(6)-acetyl-L-lysine zwitterion; N(6)-acetyl-L-lysine |
| n-methylphenylethanolamine | An alkaloid that is ethanolamine having the phenyl group at the 1-position and a methyl group attached to the nitrogen. It has been isolated from Halostachys caspica. | N-methylphenylethanolamine |
| n-methylproline | An L-proline derivative obtained by replacement of the amino hydrogen by a methyl group. | N-methylproline zwitterion; N-methylproline |
| n-methylproline | An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of N-methylproline; major species at pH 7.3. | N-methylproline zwitterion; N-methylproline |
| n-methylserotonin | A member of the class of tryptamines that is serotonin in which one of the hydrogens attached to the primary amino group is replaced by a methyl group. | N-methylserotonin |
| n-palmitoylglycine | An N-acylglycine in which the acyl group is specified as hexadecanoyl (palmitoyl). | N-hexadecanoylglycine |
| n-pentanol | A short-chain primary fatty alcohol that is pentane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It has been isolated from Melicope ptelefolia. | pentan-1-ol |
| n'-acetylspermine | An acetylspermine carrying an acetyl group at position N(1). | N(1)-acetylspermine |
| n'-formylkynurenine | | N-formyl-L-kynurenine zwitterion; N-formyl-L-kynurenine |
| n(2),n(2)-dimethylguanosine | A guanosine where the hydrogens of the amine group at C-2 are substituted by methyl groups. | N(2),N(2)-dimethylguanosine |
| n(6)-(n-threonylcarbonyl)adenosine | An N-(adenosin-N(6)-ylcarbonyl)threonine in which the threonine portion has L-configuration. | N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine |
| n(8)-acetylspermidine | An acetylspermidine that is 1,8-diamino-4-azaoctane in which one of the hydrogens of the amino group attached to C-8 is replaced by an acetyl group. | N(8)-acetylspermidine |
| n(alpha)-acetyllysine | An acetyl-L-lysine where the acetyl group is located at the N(2)-posiiton. | N(2)-acetyl-L-lysine zwitterion; N(2)-acetyl-L-lysine |
| n(alpha)-acetyllysine | An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of N(2)-acetyl-L-lysine; major species at pH 7.3. | N(2)-acetyl-L-lysine zwitterion; N(2)-acetyl-L-lysine |
| nad | An anionic form of nicotinamide adenine dinucleotide arising from deprotonation of the two OH groups of the diphosphate moiety. | NAD(1-) |
| nandrolone | A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17. | nandrolone |
| neurotensin | A 13 amino acid peptide hormone which is found in the central nervous system and the gastrointestinal tract. It behaves as a neurotransmitter in the brain, as a hormone in the gut, and also as a neuromodulator. It is implicated in the pathophysiology of several CNS disorders (including schizophrenia, Parkinson's disease, drug abuse, pain, cancer, inflammation, eating disorders and central control of blood pressure) due to its association with a wide variety of neurotransmitter systems such as dopaminergic, sertonergic, glutamatergic, GABAergic, and cholinergic systems. | neurotensin |
| neurotensin (1-8) | An 8 amino acid peptide fragment of neurotensin. | neurotensin (1-8) dizwitterion; neurotensin (1-8) |
| nicotinamide-beta-riboside | A pyridine nucleoside consisting of nicotinamide with a beta-D-ribofuranosyl moiety at the 1-position. | N-ribosylnicotinamide |
| nicotinate mononucleotide | Dianion of nicotinic acid D-ribonucleotide arising from deprotonation of carboxylic acid and phosphate functions. | nicotinate D-ribonucleotide(2-) |
| nicotinate ribonucleoside | Conjugate base of D-ribosylnicotinic acid. | D-ribosylnicotinate |
| nicotinic acid adenine dinucleotide | | deamido-NAD(+) |
| nifedipine | | nifedipine |
| ninhydrin | A member of the class of indanones that is indane-1,3-dione bearing two additional hydroxy substituents at position 2. | ninhydrin |
| nitrites | The nitrogen oxoanion formed by loss of a proton from nitrous acid. | nitrite |
| nociceptin | A seventenn-membered polypeptide consisting of Phe, Gly, Gly, Phe, Thr, Gly, Ala, Arg, Lys, Ser, Ala, Arg, Lys, Leu, Ala, Asn and Gln residue joined in sequence. | nociceptin |
| nonanal | A saturated fatty aldehyde formally arising from reduction of the carboxy group of nonanoic acid. Metabolite observed in cancer metabolism. | nonanal |
| nordazepam | A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety. | nordazepam |
| norsalsolinol | An isoquinolinol that is 1,2,3,4-tetrahydroisoquinoline substituted by hydroxy groups at positions 6 and 7. It is present in the dopamine-rich areas of the human brain, including the substantia nigra. | norsalsolinol |
| o-4-methylthymine | A methylthymine in which the methyl group is located at the O4-position. | O(4)-methylthymine |
| octanoic acid | A straight-chain saturated fatty acid that is heptane in which one of the hydrogens of a terminal methyl group has been replaced by a carboxy group. Octanoic acid is also known as caprylic acid. | octanoic acid |
| octanoylcarnitine | The L-enantiomer of an O-octanoylcarnitine. | O-octanoyl-L-carnitine |
| oleoylcarnitine | An O-acyl-L-carnitine in which the acyl group is specified as oleoyl. | (R)-oleoylcarnitine |
| oleylamide | A fatty amide derived from oleic acid. | oleamide |
| omega-aminocaprylic acid | An omega-amino fatty acid that is octanoic acid which carries an amino group at position 8. | 8-aminooctanoic acid |
| ophthalmic acid | A L-glutamine derivative that is L-glutamine substituted by a 1-[(carboxymethyl)amino]-1-oxobutan-2-yl at the terminal amino nitrogen atom. | ophthalmic acid |
| orotidylic acid | A pyrimidine ribonucleoside 5'-monophosphate having 6-carboxyuracil as the nucleobase. | orotidine 5'-phosphate |
| oxalic acid | An alpha,omega-dicarboxylic acid that is ethane substituted by carboxyl groups at positions 1 and 2. | oxalic acid |
| oxidopamine | A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease). | oxidopamine |
| p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | A thirteen-membered polypeptide consisting of p-Glu, Arg, Pro, Arg, Leu, Ser, His, Lys, Gly, Pro, Met, Pro and Phe residues joined in sequence. | p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe |
| paclitaxel | A tetracyclic diterpenoid isolated originally from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name 'taxol' is now limited, as Taxol is a registered trade mark. | paclitaxel |
| palmitoylcarnitine | An O-acyl-L-carnitine in which the acyl group is specified as palmitoyl (hexadecanoyl). | O-palmitoyl-L-carnitine |
| pantetheine | An amide obtained by formal condensation of the carboxy group of pantothenic acid and the amino group of cysteamine. | pantetheine |
| parabanic acid | An imidazolidinone that is imidazolidine which is substituted by oxo groups at positions 2, 4 and 5. | parabanic acid |
| perillaldehyde | An aldehyde that is cyclohex-1-ene-1-carbaldehyde substituted by a prop-1-en-2-yl group at position 4. | perillyl aldehyde |
| perillic acid | | perillic acid |
| phenethylamine | A phenylethylamine having the phenyl substituent at the 2-position. | 2-phenylethylamine |
| phenylacetaldehyde | An aldehyde that consists of acetaldehyde bearing a methyl substituent; the parent member of the phenylacetaldehyde class of compounds. | phenylacetaldehyde |
| phenylacetic acid | A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group. | phenylacetic acid |
| phenylacetylglutamine | An a N(2)-phenylacetylglutamine having L-configuration. | N(2)-phenylacetyl-L-glutamine |
| phenylacetylglycine | A N-acylglycine that is glycine substituted on nitrogen with a phenylacetyl group. | phenylacetylglycine |
| phosphocreatine | A phosphoamino acid consisting of creatine having a phospho group attached at the primary nitrogen of the guanidino group. | N-phosphocreatine |
| phosphoribosyl pyrophosphate | A derivative of alpha-D-ribose having a phosphate group at the 5-position and a diphosphate at the 1-position. | 5-O-phosphono-alpha-D-ribofuranosyl diphosphate |
| phosphoric acid | A phosphorus oxoacid that consists of one oxo and three hydroxy groups joined covalently to a central phosphorus atom. | phosphoric acid |
| phosphorylcholine | The phosphate of choline; and the parent compound of the phosphocholine family. | phosphocholine |
| phosphorylethanolamine | The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain. | O-phosphoethanolamine |
| phosphoserine | A serine derivative that is serine substituted at the oxygen atom by a phosphono group. | O-phosphoserine |
| phthioic acid | A methyl-branched fatty acid that is tricosanoic acid substituted by a methyl group at positions 3, 13 and 19. | 3,13,19-trimethyltricosanoic acid |
| picolinic acid | A pyridinemonocarboxylic acid in which the carboxy group is located at position 2. It is an intermediate in the metabolism of tryptophan. | picolinic acid |
| piperidine | An azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. It is a metabolite of cadaverine, a polyamine found in the human intestine. | piperidine |
| plasmenylserine | The L-enantiomer of O-phosphoserine. | O-phospho-L-serine |
| potassium | A monoatomic monocation obtained from potassium. | potassium(1+) |
| pregnanolone | The 3alpha-stereoisomer of 3-hydroxy-5beta-pregnan-20-one. | 3alpha-hydroxy-5beta-pregnan-20-one |
| pregnenolone | A 20-oxo steroid that is pregn-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 20. | pregnenolone |
| pregnenolone sulfate | | pregnenolone sulfate |
| previtamin d(3) | A hydroxy seco-steroid which is an intermediate in the production of vitamin D3 in human skin. | previtamin D3 |
| pristanal | | pristanal |
| pristanic acid | A branched, long-chain saturated fatty acid composed of pentadecanoic acid having methyl substituents at the 2-, 6-, 10- and 14-positions. | pristanic acid |
| propionylcarnitine | An O-acylcarnitine compound having propanoyl as the acyl substituent. | O-propanoylcarnitine |
| prostaglandin a2 | | prostaglandin A2 |
| prostaglandin b1 | A member of the class of prostaglandins B that is prosta-8(12),13-dien-1-oic acid carrying oxo and hydroxy substituents at positions 9 and 15 respectively (the 13E,15S-stereoisomer). | prostaglandin B1 |
| prostaglandin b2 | | prostaglandin B2 |
| prostaglandin d2 | A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- stereoisomer). | prostaglandin D2 |
| prostaglandin d3 | A member of the class of prostaglandins D that is prosta-5,13,17-trien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,13E,15S,17Z-stereoisomer). | prostaglandin D3 |
| prostaglandin e3 | | prostaglandin E3 |
| prostaglandin f1 | | prostaglandin F1alpha |
| prostaglandin f2beta | A prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is the 9beta-hydroxy epimer of prostaglandin F2alpha. | prostaglandin F2beta |
| prostaglandin g2 | | prostaglandin G2 |
| psychosine | A glycosylsphingoid consisting of sphingosine having a beta-D-galactosyl residue attached at the 1-position. | psychosine |
| pyridoxal | A pyridinecarbaldehyde that is pyridine-4-carbaldehyde bearing methyl, hydroxy and hydroxymethyl substituents at positions 2, 3 and 5 respectively. The 4-carboxyaldehyde form of vitamin B6, it is converted into pyridoxal phosphate, a coenzyme for the synthesis of amino acids, neurotransmitters, sphingolipids and aminolevulinic acid. | pyridoxal |
| pyridoxal phosphate | The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal. | pyridoxal 5'-phosphate |
| pyridoxamine | A monohydroxypyridine that is pyridine substituted by a hydroxy group at position 3, an aminomethyl group at position 4, a hydroxymethyl group at position 5 and a methyl group at position 2. The 4-aminomethyl form of vitamin B6, it is used (in the form of the hydrochloride salt) for treatment of diabetic nephropathy. | pyridoxamine |
| pyridoxamine dihydrochloride | A hydrochloride obtained by combining pyridoxamine with two molar equivalents of hydrochloric acid. Used for treatment of diabetic nephropathy. | pyridoxamine dihydrochloride |
| pyridoxamine phosphate | A vitamin B6 phosphate that is the phosphoric ester derivative of pyridoxamine. | pyridoxamine 5'-phosphate |
| pyridoxine | A hydroxymethylpyridine with hydroxymethyl groups at positions 4 and 5, a hydroxy group at position 3 and a methyl group at position 2. The 4-methanol form of vitamin B6, it is converted intoto pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters, sphingolipids and aminolevulinic acid. | pyridoxine |
| pyrrolidonecarboxylic acid | An oxoproline having the oxo group placed at the 5-position. It is an intermediate metabolite in the glutathione cycle. | 5-oxoproline |
| pyruvaldehyde | A 2-oxo aldehyde derived from propanal. | methylglyoxal |
| quinaldic acid | A quinolinemonocarboxylic acid having the carboxy group at the 2-position. | quinaldic acid |
| quinolinic acid | A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan. | quinolinic acid |
| retinaldehyde | A retinal in which all four exocyclic double bonds have E- (trans-) geometry. | all-trans-retinal |
| retinoic acid | A retinoid consisting of 3,7-dimethylnona-2,4,6,8-tetraenoic acid substituted at position 9 by a 2,6,6-trimethylcyclohex-1-en-1-yl group (geometry of the four exocyclic double bonds is not specified). | retinoic acid |
| retinol | A retinol in which all four exocyclic double bonds have E- (trans-) geometry. | all-trans-retinol |
| retinoyl beta-glucuronide | A retinoid that is retinoic acid in which the carboxy proton has been replaced by a beta-D-glucuronyl residue. | 1-O-all-trans-retinoyl-beta-glucuronic acid |
| ribothymidine | A methyluridine having a single methyl substituent at the 5-position on the uracil ring. | ribothymidine |
| ribulose | The D-stereoisomer of ribulose. | D-ribulose |
| s-(1,2-dicarboxyethyl)cysteine | An L-cysteine thioether that is L-cysteine in which the hydrogen of the thiol group has been replaced by a 1,2-dicarboxyethyl group. It is a chemical modification which occurs in tissue proteins and formed by a Michael addition of cysteine to fumaric acid. | S-(2-succinyl)-L-cysteine |
| s-adenosylmethionine | A sulfonium betaine that is a conjugate base of S-adenosyl-L-methionine obtained by the deprotonation of the carboxy group. | S-adenosyl-L-methioninate |
| s-adenosylmethionine | A sulfonium compound that is the S-adenosyl derivative of L-methionine. It is an intermediate in the metabolic pathway of methionine. | S-adenosyl-L-methionine zwitterion; S-adenosyl-L-methionine |
| s-sulphocysteine | An S-substituted L-cysteine where the S-substituent is specified as a sulfo group. | S-sulfo-L-cysteine |
| saccharopine | The N(6)-(1,3-dicarboxypropan-1-yl) derivative of L-lysine. | L-saccharopine |
| sapropterin | A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one in which a hydrogen at position 6 is substituted by a 1,2-dihydroxypropyl group (6R,1'R,2'S-enantiomer). | sapropterin |
| sarcosine | A N-alkylglycine that is the N-methyl derivative of glycine. It is an intermediate in the metabolic pathway of glycine. | sarcosine zwitterion; sarcosine |
| sebacic acid | An alpha,omega-dicarboxylic acid that is the 1,8-dicarboxy derivative of octane. | sebacic acid |
| sedoheptulose 7-phosphate | A ketoheptose phosphate consisting of sedoheptulose having a phosphate group at the 7-position. It is an intermediate metabolite in the pentose phosphate pathway. | sedoheptulose 7-phosphate |
| selenomethylselenocysteine | An alpha-amino acid compound having methylselanylmethyl as the side-chain. | Se-methylselenocysteine |
| serine | The L-enantiomer of serine. | L-serine zwitterion; L-serine |
| skatole | A methylindole carrying a methyl substituent at position 3. It is produced during the anoxic metabolism of L-tryptophan in the mammalian digestive tract. | skatole |
| sodium taurodeoxycholate | A bile acid taurine conjugate of deoxycholic acid. | taurodeoxycholic acid |
| sorbitol | The D-enantiomer of glucitol (also known as D-sorbitol). | D-glucitol |
| sphingosine | A sphing-4-enine in which the double bond is trans. | sphingosine |
| squalene | A triterpene consisting of 2,6,10,15,19,23-hexamethyltetracosane having six double bonds at the 2-, 6-, 10-, 14-, 18- and 22-positions with (all-E)-configuration. | squalene |
| stearic acid | A C18 straight-chain saturated fatty acid component of many animal and vegetable lipids. As well as in the diet, it is used in hardening soaps, softening plastics and in making cosmetics, candles and plastics. | octadecanoic acid |
| stearyl alcohol | A long-chain primary fatty alcohol consisting of a hydroxy function at C-1 of an unbranched saturated chain of 18 carbon atoms. | octadecan-1-ol |
| suberic acid | An alpha,omega-dicarboxylic acid that is the 1,6-dicarboxy derivative of hexane. | suberic acid |
| succinylacetoacetate | An alpha,omega-dicarboxylic acid that is suberic acid which oxo groups replace the hydrogens at positions 3 and 5. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia. | 3,5-dioxooctanedioic acid |
| succinylacetone | A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia. | 4,6-dioxoheptanoic acid |
| sucrose | A glycosyl glycoside formed by glucose and fructose units joined by an acetal oxygen bridge from hemiacetal of glucose to the hemiketal of the fructose. | sucrose |
| taurine | An amino sulfonic acid that is the 2-amino derivative of ethanesulfonic acid. It is a naturally occurring amino acid derived from methionine and cysteine metabolism. An abundant component of fish- and meat-based foods, it has been used as an oral supplement in the treatment of disorders such as cystic fibrosis and hypertension. | taurine zwitterion; taurine |
| taurochenodeoxycholic acid | A bile acid taurine conjugate of chenodeoxycholic acid. | taurochenodeoxycholic acid |
| taurocholic acid | A bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals. | taurocholic acid |
| taurolithocholic acid | The bile acid taurine conjugate of lithocholic acid. | taurolithocholic acid |
| taurolithocholic acid 3-sulfate | A steroid sulfate oxoanion arising from deprotonation of both sulfo groups of taurolithocholic acid sulfate; major species at pH 7.3. | taurolithocholic acid sulfate(2-) |
| tele-methylhistamine | A primary amino compound that is the N(tele)-methyl derivative of histamine. | N(tele)-methylhistamine |
| testosterone 17-glucosiduronate | A steroid glucosiduronic that is testosterone carrying a glucosiduronic acid residue at position 17. | testosterone 17-glucosiduronic acid |
| testosterone acetate | An androstanoid that is the acetate derivative of testosterone. | testosterone acetate |
| tetragastrin | A tetrapeptide composed of L-tryptophan, L-methione, L-aspartic acid and L-phenylalaninamide residues joined in sequence. | tetragastrin |
| tetrahydropapaveroline | | norlaudanosoline |
| tetraiodothyroacetic acid | A monocarboxylic acid that is thyroacetic acid carrying four iodo substituents at positions 3, 3', 5 and 5'. | 3,3',5,5'-tetraiodothyroacetic acid |
| thiamine | A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively. | thiamine(1+) |
| thiamine pyrophosphate | Trianion of thiamine(1+) diphosphate arising from deprotonation of the four OH groups of the triphosphate. | thiamine(1+) triphosphate(4-) |
| thiocyanate | A pseudohalide anion obtained by deprotonation of the thiol group of thiocyanic acid. | thiocyanate |
| thiocysteine | An S-substituted L-cysteine where the S-substituent is specified as sulfanyl. | 3-disulfanyl-L-alanine zwitterion; 3-disulfanyl-L-alanine |
| thiosulfates | A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid. | thiosulfate(2-) |
| threitol | The D-enantiomer of threitol. | D-threitol |
| threonine | An optically active form of threonine having L-configuration. | L-threonine zwitterion; L-threonine |
| thromboxane b2 | A member of the class of thromboxanes B that is (5Z,13E)-thromboxa-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. | thromboxane B2 |
| thromboxane b3 | A member of the class of thromboxanes B that is (5Z,13E,17Z)-thromboxa-5,13,17-trien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. | thromboxane B3 |
| thymidine | A pyrimidine 2'-deoxyribonucleoside having thymine as the nucleobase. | thymidine |
| thymine | A pyrimidine nucleobase that is uracil in which the hydrogen at position 5 is replaced by a methyl group. | thymine |
| thyrotropin-releasing hormone | A tripeptide composed of L-pyroglutamyl, L-histidyl and L-prolinamide residues joined in sequence. | protirelin |
| thyroxine | The L-enantiomer of thyroxine. | L-thyroxine zwitterion; L-thyroxine |
| ticrynafen | Trianion of 2-phosphoglycolic acid arising from deprotonation of the carboxy and phosphate groups; major species at pH 7.3. | 2-phosphonatoglycolate(3-) |
| tocotrienol, alpha | A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 5, 7 and 8 and a farnesyl chain at position 2. It has been found in palm oil derived from Elaeis guineensis. | alpha-tocotrienol |
| tolbutamide | An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position. | tolbutamide |
| trehalose | A trehalose in which both glucose residues have alpha-configuration at the anomeric carbon. | alpha,alpha-trehalose |
| tretinoin | A retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry. | all-trans-retinoic acid |
| tricosanoic acid | A very long-chain fatty acid that is tricosane in which one of the methyl groups has been oxidised to the corresponding carboxylic acid. | tricosanoic acid |
| triiodothyronine | An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism. | 3,3',5-triiodo-L-thyronine zwitterion; 3,3',5-triiodo-L-thyronine |
| triiodothyronine | The amino acid zwitterion formed from 3,3',5-triiodo-L-thyronine by tranfer of a proton from the carboxy group to the amino group. It is the major species at pH 7.3. | 3,3',5-triiodo-L-thyronine zwitterion; 3,3',5-triiodo-L-thyronine |
| triiodothyronine | A thiolactone arising from formal condensation of the mercapto (sulfanyl) and carboxylic acid groups of L-homocysteine. | L-homocysteine thiolactone |
| triiodothyronine sulfate | | 3,3',5-triiodo-L-thyronine sulfate |
| trimethylenediamine | An alkane-alpha,omega-diamine comprising a propane skeleton with amino substituents at positions 1 and 3. | trimethylenediamine |
| trimethyllysine | An alpha-amino-acid cation that is the N(6)-trimethyl derivative of L-lysine. | N(6),N(6),N(6)-trimethyl-L-lysine zwitterion; N(6),N(6),N(6)-trimethyl-L-lysine |
| tryptamine | An aminoalkylindole consisting of indole having a 2-aminoethyl group at the 3-position. | tryptamine |
| tryptophan | The L-enantiomer of tryptophan. | L-tryptophan zwitterion; L-tryptophan |
| tryptophanamide | An amino acid amide that is the carboxamide of L-tryptophan. | L-tryptophanamide |
| tyramine | A primary amino compound obtained by formal decarboxylation of the amino acid tyrosine. | tyramine |
| tyrosine o-sulfate | An O-sulfoamino acid that is L-tyrosine in which the phenolic hydrogen has been replaced by a sulfo group. | O(4')-sulfo-L-tyrosine |
| ubiquinone 9 | | ubiquinone-9 |
| ubiquinone-o | A derivative of benzoquinone carrying a 5-methyl substituent; and methoxy substituents at positions 2 and 3. The core structure of the ubiquinone group of compounds. | ubiquinone-0 |
| undecanoic acid | A straight-chain, eleven-carbon saturated medium-chain fatty acid found in body fluids; the most fungitoxic of the C7:0 - C18:0 fatty acid series. | undecanoic acid |
| uracil | A common and naturally occurring pyrimidine nucleobase in which the pyrimidine ring is substituted with two oxo groups at positions 2 and 4. Found in RNA, it base pairs with adenine and replaces thymine during DNA transcription. | uracil |
| urea | A carbonyl group with two C-bound amine groups. The commercially available fertilizer has an analysis of 46-0-0 (N-P2O5-K2O). | carbamimidic acid; urea |
| ureidosuccinic acid | An N-carbamoylamino acid that is aspartic acid with one of its amino hydrogens replaced by a carbamoyl group. | N-carbamoylaspartic acid |
| uric acid | An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8. | 1H-purine-2,6,8-triol; 2,6-dihydroxy-7,9-dihydro-8H-purin-8-one; 6-hydroxy-1H-purine-2,8(7H,9H)-dione; 7,9-dihydro-1H-purine-2,6,8(3H)-trione; 7H-purine-2,6,8-triol; 9H-purine-2,6,8-triol |
| uridine | A ribonucleoside composed of a molecule of uracil attached to a ribofuranose moiety via a beta-N(1)-glycosidic bond. | uridine |
| uridine diphosphate | A nucleoside 5'-diphosphate(3-) arising from deprotonation of the diphosphate OH groups of uridine 5'-diphosphate (UDP); major species at pH 7.3. | UDP(3-) |
| uridine diphosphate glucuronic acid | A UDP-sugar having alpha-D-glucuronic acid as the sugar component. | UDP-alpha-D-glucuronic acid |
| uridine diphosphate n-acetylgalactosamine | Dianion of UDP-N-acetyl-D-galactosamine arising from deprotonation of the diphosphate OH groups; major species at pH 7.3. | UDP-N-acetyl-D-galactosamine(2-) |
| uridine monophosphate | A pyrimidine ribonucleoside 5'-monophosphate having uracil as the nucleobase. | uridine 5'-monophosphate |
| urobilinogen | A member of the class of bilanes that is a colourless product formed in the intestine by the reduction of bilirubin. | urobilinogen |
| urocanic acid | A urocanic acid in which the double bond of the carboxyethene moiety has E configuration. | trans-urocanic acid |
| ursodeoxycholic acid | A bile acid found in the bile of bears (Ursidae) as a conjugate with taurine. Used therapeutically, it prevents the synthesis and absorption of cholesterol and can lead to the dissolution of gallstones. | ursodeoxycholic acid |
| ursodoxicoltaurine | A bile acid taurine conjugate derived from ursoodeoxycholic acid. | tauroursodeoxycholic acid |
| valine | The L-enantiomer of valine. | L-valine zwitterion; L-valine |
| vanilmandelic acid | An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid. | vanillylmandelic acid |
| vitamin k 1 | A member of the class of phylloquinones that consists of 1,4-naphthoquinone having methyl and phytyl groups at positions 2 and 3 respectively. The parent of the class of phylloquinones. | phylloquinone |
| vitamin mk 8 | A menaquinone whose side-chain contains 8 isoprene units in an all-trans-configuration. | menaquinone-8 |
| xanthosine | A purine nucleoside in which xanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond. | xanthosine |
| xylulose | The D-enantiomer of xylulose. | D-xylulose |
| zymostenol | A cholestanoid that is 5alpha-cholestane substituted by a beta-hydroxy group at position 3. | 5alpha-cholest-8-en-3beta-ol |
| zymosterol | | zymosterol |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | IC50 | 120.0000 | 1 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | Homo sapiens (human) | IC50 | 120.0000 | 1 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | Homo sapiens (human) | IC50 | 120.0000 | 1 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | Homo sapiens (human) | IC50 | 120.0000 | 1 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | IC50 | 8.3760 | 2 | 2 |
| 10 kDa chaperonin | Escherichia coli | IC50 | 35.1000 | 2 | 10 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 26.1600 | 1 | 5 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | IC50 | 0.3790 | 5 | 6 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | Ki | 4.7515 | 2 | 2 |
| 2-dehydropantoate 2-reductase | Escherichia coli K-12 | Ki | 14,025.0000 | 1 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | IC50 | 2.1500 | 2 | 2 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | Ki | 0.0235 | 1 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Rattus norvegicus (Norway rat) | IC50 | 1.1200 | 1 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Rattus norvegicus (Norway rat) | IC50 | 1.1200 | 1 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | Homo sapiens (human) | IC50 | 5,000.0000 | 1 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | IC50 | 115.0000 | 1 | 1 |
| 4-hydroxy-tetrahydrodipicolinate synthase | Escherichia coli K-12 | Ki | 358.0000 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.0020 | 3 | 3 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 8.1333 | 7 | 9 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | Ki | 0.0198 | 1 | 2 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 1.8418 | 3 | 6 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | Ki | 0.0332 | 2 | 2 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 8.4762 | 4 | 4 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 2.6035 | 10 | 13 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 6.9940 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 4.4520 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.7025 | 7 | 10 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 18.2730 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 2.4867 | 2 | 4 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.6841 | 8 | 11 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 18.2730 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 9.5720 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Homo sapiens (human) | Ki | 0.1362 | 2 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.1060 | 2 | 3 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | IC50 | 35.1000 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 0.0419 | 3 | 4 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.0009 | 1 | 1 |
| 5'-nucleotidase | Rattus norvegicus (Norway rat) | Ki | 0.0009 | 1 | 1 |
| 60 kDa chaperonin | Escherichia coli K-12 | IC50 | 250.0000 | 1 | 5 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 35.1000 | 2 | 10 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 26.1600 | 1 | 5 |
| 72 kDa type IV collagenase | Homo sapiens (human) | IC50 | 115.0000 | 1 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 3.7575 | 2 | 2 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 603.6224 | 4 | 5 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | Ki | 3,114.0033 | 6 | 6 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 18.6500 | 1 | 2 |
| Acetylcholinesterase | Mus musculus (house mouse) | Ki | 18.6500 | 1 | 2 |
| Acetylcholinesterase | Bos taurus (cattle) | IC50 | 0.1000 | 2 | 3 |
| Adenosine deaminase | Bos taurus (cattle) | Ki | 325.0000 | 1 | 2 |
| Adenosine kinase | Toxoplasma gondii | Ki | 8.9000 | 1 | 1 |
| Adenosine receptor A1 | Homo sapiens (human) | IC50 | 2.7047 | 2 | 3 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | IC50 | 5.4867 | 2 | 3 |
| Adenosine receptor A1 | Homo sapiens (human) | Ki | 1.8482 | 2 | 3 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Ki | 3.2278 | 10 | 12 |
| Adenosine receptor A2a | Homo sapiens (human) | Ki | 48.2117 | 6 | 6 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 7.9736 | 7 | 9 |
| Adenosine receptor A2b | Homo sapiens (human) | Ki | 11.0500 | 2 | 2 |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | Ki | 0.0210 | 2 | 2 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 17.6440 | 3 | 5 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 4.6605 | 5 | 8 |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | Ki | 1.4650 | 2 | 2 |
| Adenosylhomocysteinase | Homo sapiens (human) | Ki | 925.0000 | 1 | 1 |
| Adenylate cyclase type 10 | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | Rattus norvegicus (Norway rat) | Ki | 89,500.0000 | 2 | 2 |
| Adenylate kinase isoenzyme 1 | Rattus norvegicus (Norway rat) | Ki | 33,860.0000 | 3 | 3 |
| Albumin | Homo sapiens (human) | Ki | 39,810,700,000.0000 | 1 | 1 |
| Aldehyde oxidase | Homo sapiens (human) | Ki | 30.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 144.0400 | 3 | 5 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | Ki | 107.5722 | 1 | 9 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | Ki | 0.0002 | 1 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens (human) | IC50 | 5.0000 | 1 | 3 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | IC50 | 115.0000 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 4.3049 | 2 | 4 |
| Alpha-1A adrenergic receptor | Bos taurus (cattle) | Ki | 0.0004 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 11.2169 | 3 | 8 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.7397 | 1 | 3 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 11.2169 | 3 | 8 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 16.0002 | 2 | 5 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 522,325,000,024.7500 | 3 | 4 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 522,325,000,024.7500 | 3 | 4 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 522,325,000,024.7500 | 3 | 4 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Alpha-synuclein | Homo sapiens (human) | IC50 | 29.0600 | 3 | 8 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | IC50 | 40.7380 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | IC50 | 12.0226 | 1 | 1 |
| Amino acid transporter | Rattus norvegicus (Norway rat) | IC50 | 1,234.8188 | 6 | 16 |
| Aminopeptidase N | Sus scrofa (pig) | IC50 | 100.0000 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 0.1800 | 1 | 3 |
| Androgen receptor | Homo sapiens (human) | IC50 | 6.3503 | 30 | 30 |
| Androgen receptor | Mus musculus (house mouse) | IC50 | 0.0010 | 1 | 1 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 28.1050 | 9 | 21 |
| Androgen receptor | Homo sapiens (human) | Ki | 0.0014 | 19 | 19 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 0.9159 | 6 | 9 |
| Angiotensin-converting enzyme | Homo sapiens (human) | IC50 | 3,262.1893 | 2 | 4 |
| Apelin receptor | Homo sapiens (human) | IC50 | 33.3006 | 2 | 2 |
| Apelin receptor | Homo sapiens (human) | Ki | 0.0007 | 6 | 6 |
| Apelin receptor | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | GI50 | 10.0000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | IC50 | 15.0100 | 4 | 6 |
| Aromatase | Homo sapiens (human) | Ki | 0.8650 | 4 | 5 |
| Aryl hydrocarbon receptor | Homo sapiens (human) | Ki | 21.6000 | 1 | 1 |
| Asc-type amino acid transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 28.5000 | 1 | 2 |
| Aspartate-semialdehyde dehydrogenase | Helicobacter pylori 26695 | IC50 | 0.1800 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 119.7375 | 1 | 8 |
| ATP-citrate synthase | Rattus norvegicus (Norway rat) | Ki | 1,000.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 109.7566 | 7 | 7 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 327.0000 | 1 | 1 |
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | IC50 | 0.0020 | 1 | 1 |
| Bcl-2-like protein 1 | Homo sapiens (human) | GI50 | 10.0000 | 1 | 1 |
| bcl-2-related protein A1 | Mus musculus (house mouse) | IC50 | 20.0000 | 1 | 1 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 1 | 2 |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 1 | 2 |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 1 | 2 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 10.8000 | 1 | 1 |
| Beta-galactoside alpha-2,6-sialyltransferase 1 | Rattus norvegicus (Norway rat) | Ki | 64.0000 | 1 | 1 |
| Beta-glucuronidase | Escherichia coli K-12 | IC50 | 253.9500 | 1 | 2 |
| Beta-glucuronidase | Homo sapiens (human) | IC50 | 77.9000 | 1 | 1 |
| Beta-lactamase | Klebsiella pneumoniae | IC50 | 2,000.0000 | 1 | 1 |
| Beta-lactamase | Aeromonas hydrophila | Ki | 311.2833 | 5 | 6 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 638.0000 | 2 | 2 |
| Beta-tubulin | Leishmania donovani | IC50 | 1.0000 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | IC50 | 500.0000 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Bile acid receptor | Homo sapiens (human) | IC50 | 3.9392 | 2 | 2 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 404.6456 | 9 | 39 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 681.8000 | 1 | 3 |
| Bile salt export pump | Homo sapiens (human) | Ki | 15.3333 | 1 | 3 |
| Botulinum neurotoxin type A | Clostridium botulinum | IC50 | 5.2000 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 21.1667 | 3 | 3 |
| C-8 sterol isomerase | Saccharomyces cerevisiae S288C | Ki | 100.0000 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | IC50 | 2.1910 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | Ki | 0.8470 | 1 | 1 |
| C-C chemokine receptor type 6 | Homo sapiens (human) | IC50 | 20.9000 | 1 | 2 |
| C-terminal-binding protein 2 | Homo sapiens (human) | IC50 | 300.0000 | 1 | 1 |
| C-X-C chemokine receptor type 5 isoform 1 | Homo sapiens (human) | IC50 | 32.4940 | 1 | 1 |
| Calcium dependent protein kinase | Zea mays | IC50 | 116.0000 | 1 | 1 |
| Calcium-dependent protein kinase 1 | Plasmodium falciparum 3D7 | IC50 | 1.0000 | 1 | 1 |
| Calcium-dependent protein kinase 4 | Plasmodium falciparum 3D7 | IC50 | 1.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 0.0021 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | Ki | 2.0976 | 1 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | Ki | 1.9953 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 0.0980 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 8 |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 5.4800 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 0.6055 | 4 | 4 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 0.4490 | 5 | 5 |
| Cannabinoid receptor 2 | Mus musculus (house mouse) | Ki | 0.0002 | 1 | 1 |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | Ki | 0.1000 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 1.3750 | 4 | 4 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 1.0200 | 1 | 1 |
| Carbonic anhydrase | Methanosarcina thermophila | Ki | 55,072.5000 | 2 | 8 |
| Carbonic anhydrase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 27,800.0000 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 860.0000 | 1 | 1 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 0.9000 | 1 | 1 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 11.4000 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 580.0000 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 12,170.4248 | 23 | 53 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 264.5250 | 8 | 8 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 600.0000 | 2 | 2 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 34.6000 | 2 | 2 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 89.0160 | 3 | 3 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 23,990.8840 | 2 | 25 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 5,000.0000 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 19,731.9209 | 24 | 54 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 102.8000 | 2 | 2 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 20,859.7103 | 6 | 29 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 116.8800 | 5 | 5 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 55.0500 | 4 | 4 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 45.4212 | 4 | 6 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 1,745.2290 | 6 | 6 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 225.8693 | 14 | 14 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | IC50 | 4.8230 | 1 | 1 |
| Carboxylic ester hydrolase | Equus caballus (horse) | IC50 | 0.1000 | 1 | 1 |
| Carboxypeptidase A1 | Bos taurus (cattle) | Ki | 350.0000 | 1 | 1 |
| Carboxypeptidase A1 | Homo sapiens (human) | Ki | 350.0000 | 1 | 1 |
| Caspase-1 | Homo sapiens (human) | IC50 | 6.7600 | 1 | 1 |
| Catechol O-methyltransferase | Homo sapiens (human) | Ki | 5,400.0000 | 1 | 1 |
| Cathepsin K | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Cationic amino acid transporter 3 | Homo sapiens (human) | IC50 | 158.0000 | 1 | 1 |
| Cationic trypsin | Bos taurus (cattle) | Ki | 11.0000 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | IC50 | 26.5400 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | Ki | 1.1340 | 1 | 1 |
| Cdk-related protein kinase 6 | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1.0000 | 1 | 1 |
| Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | IC50 | 0.5233 | 3 | 3 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | IC50 | 2.4000 | 1 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | IC50 | 2.4000 | 1 | 1 |
| Chain A, ADENOSINE DEAMINASE | Mus musculus (house mouse) | Ki | 0.0000 | 1 | 2 |
| Chain A, ADENOSINE RECEPTOR A2A | Homo sapiens (human) | Ki | 0.0309 | 1 | 2 |
| Chain A, Aminopeptidase | Streptomyces griseus | Ki | 11,166.6667 | 1 | 3 |
| Chain A, Anopheles gambiae adenosine kinase | Anopheles gambiae (African malaria mosquito) | Ki | 0.8600 | 1 | 1 |
| Chain A, Arginase 1 | Rattus norvegicus (Norway rat) | Ki | 3,600.0000 | 1 | 1 |
| Chain A, Biotin carboxylase | Escherichia coli K-12 | IC50 | 10,000.0000 | 1 | 1 |
| Chain A, Biotin carboxylase | Escherichia coli K-12 | Ki | 16,000.0000 | 1 | 4 |
| Chain A, Cytidine Deaminase | Escherichia coli | Ki | 800.0000 | 1 | 1 |
| Chain A, Cytotoxin L | Paeniclostridium sordellii | IC50 | 30.0000 | 1 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | Homo sapiens (human) | Ki | 92.0000 | 1 | 3 |
| Chain A, Fructose-bisphosphatase | Shigella boydii | Ki | 94.0000 | 1 | 1 |
| Chain A, Glucosamine 6-phosphate Synthase | Escherichia coli | Ki | 350.0000 | 1 | 1 |
| Chain A, Glutamate carboxypeptidase III | Homo sapiens (human) | Ki | 270.0000 | 1 | 3 |
| Chain A, Glutamate receptor 4 | Rattus norvegicus (Norway rat) | Ki | 0.1710 | 1 | 1 |
| Chain A, Glutamate receptor ionotropic, kainate 2 | Homo sapiens (human) | Ki | 0.2900 | 1 | 2 |
| Chain A, Glutamate receptor, ionotropic kainate 1 | Homo sapiens (human) | Ki | 0.2900 | 1 | 18 |
| Chain A, Glutamate receptor, ionotropic kainate 3 | Rattus norvegicus (Norway rat) | Ki | 7.4300 | 1 | 1 |
| Chain A, Glutaminyl-peptide cyclotransferase | Homo sapiens (human) | Ki | 13.2493 | 1 | 3 |
| Chain A, HEXOKINASE | Sulfurisphaera tokodaii | Ki | 18.0000 | 1 | 1 |
| Chain A, Hypoxanthine Phosphoribosyltransferase | Escherichia coli | Ki | 247.0000 | 1 | 2 |
| Chain A, Hypoxanthine-guanine phosphoribosyltransferase | Caldanaerobacter subterraneus subsp. tengcongensis MB4 | Ki | 45.0000 | 1 | 1 |
| Chain A, Kinesin-like protein KIF11 | Homo sapiens (human) | IC50 | 0.4500 | 1 | 1 |
| Chain A, Kinesin-like protein KIF1A, Kinesin heavy chain isoform 5C | Mus musculus (house mouse) | Ki | 350.0000 | 1 | 1 |
| Chain A, Leucine Aminopeptidase | Bos taurus (cattle) | Ki | 0.0600 | 1 | 1 |
| Chain A, Leukotriene A-4 hydrolase | Homo sapiens (human) | IC50 | 2,000.0000 | 1 | 17 |
| Chain A, Maltodextrin Binding Protein | Escherichia coli K-12 | Ki | 0.1600 | 1 | 1 |
| Chain A, Maltodextrin-binding Protein | Escherichia coli K-12 | Ki | 0.1600 | 1 | 2 |
| Chain A, Methionine aminopeptidase | Pyrococcus furiosus | Ki | 150,000.0000 | 1 | 1 |
| Chain A, MTA/SAH nucleosidase | Escherichia coli | Ki | 300.0000 | 1 | 1 |
| Chain A, N-methyl-D-aspartate Receptor Subunit 1 | Rattus norvegicus (Norway rat) | Ki | 7.0200 | 1 | 3 |
| Chain A, Nuclear Receptor ROR-beta | Rattus norvegicus (Norway rat) | Ki | 0.2800 | 1 | 1 |
| Chain A, orotidine 5'-monophosphate decarboxylase | Archaea | Ki | 200.0000 | 1 | 1 |
| Chain A, orotidine 5'-monophosphate decarboxylase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 200.0000 | 1 | 1 |
| Chain A, orotidine monophosphate decarboxylase | Methanothermobacter thermautotrophicus | Ki | 200.0000 | 1 | 1 |
| Chain A, orotidine monophosphate decarboxylase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 200.0000 | 1 | 1 |
| Chain A, P-30 protein | Lithobates pipiens (northern leopard frog) | Ki | 590.0000 | 1 | 1 |
| Chain A, Penicillin Amidohydrolase | Escherichia coli | Ki | 3,029.0000 | 1 | 21 |
| Chain A, Phosphoenolpyruvate carboxykinase | Gallus gallus (chicken) | Ki | 50,000.0000 | 1 | 1 |
| Chain A, Phosphoenolpyruvate carboxykinase, cytosolic [GTP] | Rattus norvegicus (Norway rat) | Ki | 1,172.5000 | 1 | 8 |
| Chain A, Phosphoenolpyruvate-protein phosphotransferase | Escherichia coli | Ki | 280.0000 | 1 | 1 |
| Chain A, Phosphonopyruvate hydrolase | Variovorax sp. Pal2 | Ki | 17.0000 | 1 | 1 |
| Chain A, Phosphoribosylformylglycinamidine synthase | Salmonella enterica subsp. enterica serovar Typhimurium | Ki | 11.0000 | 1 | 1 |
| Chain A, Porphobilinogen Synthase | Escherichia coli | IC50 | 111.4000 | 1 | 5 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | Homo sapiens (human) | IC50 | 40,000.0000 | 1 | 52 |
| Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE | Pseudomonas putida | Ki | 5,000.0000 | 1 | 6 |
| Chain A, Pyruvate kinase, M2 isozyme | Homo sapiens (human) | Ki | 24.0000 | 1 | 1 |
| Chain A, retinol dehydratase | Spodoptera frugiperda (fall armyworm) | Ki | 0.1100 | 1 | 1 |
| Chain A, RIBONUCLEASE PANCREATIC | Bos taurus (cattle) | Ki | 842.3382 | 1 | 11 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | Pisum sativum (garden pea) | Ki | 36,600.0000 | 1 | 2 |
| Chain A, Saccharopine dehydrogenase [NAD+, L-lysine-forming | Saccharomyces cerevisiae (brewer's yeast) | Ki | 55.0000 | 1 | 1 |
| Chain A, Saccharopine dehydrogenase, NAD+, L-lysine-forming | Saccharomyces cerevisiae (brewer's yeast) | Ki | 55.0000 | 1 | 1 |
| Chain A, Seminal ribonuclease | Bos taurus (cattle) | Ki | 1,046.4000 | 1 | 5 |
| Chain A, Serine acetyltransferase | Haemophilus influenzae | Ki | 1.0000 | 1 | 1 |
| Chain A, Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | IC50 | 38.0000 | 1 | 1 |
| Chain A, TRIOSE PHOSPHATE ISOMERASE | Leishmania mexicana | Ki | 50.0000 | 1 | 1 |
| Chain A, TRIOSEPHOSPHATE ISOMERASE GLYCOSOMAL | Trypanosoma brucei brucei | Ki | 284.0000 | 1 | 5 |
| Chain A, TRYPSIN | Bos taurus (cattle) | Ki | 11,000.0000 | 1 | 6 |
| Chain A, Uracil-DNA Glycosylase | Thermus thermophilus | Ki | 0.0880 | 1 | 1 |
| Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with cellobiose | Synechocystis sp. PCC 6803 | Ki | 26,000.0000 | 1 | 1 |
| Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with maltose | Synechocystis sp. PCC 6803 | Ki | 26,000.0000 | 1 | 1 |
| Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with trehalose | Synechocystis sp. PCC 6803 | Ki | 26,000.0000 | 1 | 1 |
| Chain B, orotidine 5'-monophosphate decarboxylase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 200.0000 | 1 | 1 |
| Chain B, orotidine monophosphate decarboxylase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 200.0000 | 1 | 1 |
| Chain B, Penicillin Amidohydrolase | Escherichia coli | Ki | 3,029.0000 | 1 | 21 |
| Chain B, Seminal ribonuclease | Bos taurus (cattle) | Ki | 1,046.4000 | 1 | 5 |
| Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN) | Mus musculus (house mouse) | IC50 | 0.0210 | 1 | 3 |
| Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN) | Mus musculus (house mouse) | IC50 | 0.0210 | 1 | 3 |
| Chain M, Protocatechuate 3,4-dioxygenase | Pseudomonas putida | Ki | 5,000.0000 | 1 | 6 |
| Chain X, Glutaminyl-peptide cyclotransferase-like protein | Homo sapiens (human) | Ki | 5.7480 | 1 | 3 |
| Cholecystokinin receptor type A | Homo sapiens (human) | IC50 | 11.3800 | 1 | 1 |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | Ki | 36.1330 | 2 | 2 |
| Cholecystokinin receptor type A | Homo sapiens (human) | Ki | 1.2890 | 2 | 2 |
| Cholesterol 24-hydroxylase | Homo sapiens (human) | Ki | 2.5000 | 1 | 1 |
| Choline O-acetyltransferase | Rattus norvegicus (Norway rat) | Ki | 47,000.0000 | 1 | 1 |
| Choline trimethylamine-lyase | Oleidesulfovibrio alaskensis G20 | IC50 | 26.0000 | 1 | 1 |
| Cholinesterase | Equus caballus (horse) | IC50 | 0.0160 | 1 | 1 |
| Cholinesterase | Homo sapiens (human) | IC50 | 0.5833 | 2 | 3 |
| Chymotrypsinogen A | Bos taurus (cattle) | Ki | 5,250.0000 | 1 | 4 |
| CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase | Rattus norvegicus (Norway rat) | Ki | 65.0000 | 1 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | IC50 | 115.0000 | 1 | 1 |
| Coagulation factor VII | Homo sapiens (human) | IC50 | 60.0000 | 1 | 4 |
| core protein, partial | | IC50 | 35.9842 | 3 | 4 |
| Corticosteroid-binding globulin | Homo sapiens (human) | Ki | 3.8155 | 1 | 18 |
| Cruzipain | Trypanosoma cruzi | IC50 | 109.0000 | 2 | 2 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | IC50 | 0.0038 | 2 | 2 |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | Ki | 0.0004 | 2 | 2 |
| Cystine/glutamate transporter | Homo sapiens (human) | IC50 | 116.0000 | 1 | 1 |
| Cystine/glutamate transporter | Homo sapiens (human) | Ki | 59.0000 | 1 | 1 |
| Cytidine deaminase | Homo sapiens (human) | Ki | 0.0000 | 1 | 1 |
| Cytochrome P450 1A1 | Rattus norvegicus (Norway rat) | IC50 | 97.3618 | 2 | 2 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 83.0000 | 3 | 4 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 0.3000 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 9.1460 | 2 | 2 |
| Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 66.3333 | 2 | 3 |
| Cytochrome P450 2A13 | Homo sapiens (human) | Ki | 16.0000 | 1 | 1 |
| Cytochrome P450 2A5 | Mus musculus (house mouse) | IC50 | 3.0000 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | IC50 | 4.4100 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Ki | 1.7000 | 1 | 1 |
| Cytochrome P450 2B1 | Rattus norvegicus (Norway rat) | IC50 | 180.9850 | 2 | 2 |
| Cytochrome P450 2C11 | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | Ki | 0.0001 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 0.9633 | 4 | 4 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 70.0000 | 1 | 1 |
| Cytochrome P450 2D1 | Rattus norvegicus (Norway rat) | IC50 | 529.0000 | 1 | 1 |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | IC50 | 107.0000 | 1 | 1 |
| Cytochrome P450 2D3 | Rattus norvegicus (Norway rat) | IC50 | 1,754.0000 | 1 | 1 |
| Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | IC50 | 747.0000 | 1 | 1 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 65.4000 | 2 | 2 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 0.0002 | 2 | 2 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 3.0600 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 718.8447 | 4 | 4 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 0.0001 | 1 | 1 |
| Cytosolic phospholipase A2 gamma | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| D-amino-acid oxidase | Homo sapiens (human) | IC50 | 10,000.0000 | 2 | 2 |
| D-aspartate oxidase | Homo sapiens (human) | IC50 | 1,117.0000 | 2 | 2 |
| D-aspartate oxidase | Homo sapiens (human) | Ki | 153.0000 | 1 | 1 |
| D-aspartate oxidase | Mus musculus (house mouse) | Ki | 1,220.0000 | 1 | 1 |
| D-aspartate oxidase | Rattus norvegicus (Norway rat) | Ki | 1,562.0000 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 390.0000 | 1 | 2 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 160.0000 | 1 | 1 |
| Delta-aminolevulinic acid dehydratase | Escherichia coli K-12 | Ki | 18,800.0000 | 1 | 1 |
| Delta-type opioid receptor | Homo sapiens (human) | IC50 | 2.1042 | 2 | 2 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 0.0139 | 6 | 10 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1290 | 2 | 2 |
| Delta-type opioid receptor | Homo sapiens (human) | Ki | 1.2580 | 15 | 17 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 0.0046 | 3 | 3 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0040 | 5 | 5 |
| Dihydrofolate reductase | Homo sapiens (human) | IC50 | 3,412.5000 | 2 | 2 |
| Dihydrofolate reductase | Homo sapiens (human) | Ki | 2,800.0000 | 1 | 1 |
| Dihydroorotate dehydrogenase | Leishmania major | IC50 | 636.5285 | 1 | 2 |
| Disabled homolog 2-interacting protein | Homo sapiens (human) | Ki | 1.2600 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | IC50 | 1.6600 | 1 | 1 |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | IC50 | 0.7790 | 1 | 1 |
| Dynamin-1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Ecdysone receptor | Drosophila melanogaster (fruit fly) | IC50 | 41.6869 | 1 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Homo sapiens (human) | IC50 | 10.3000 | 1 | 1 |
| Egl nine homolog 1 | Homo sapiens (human) | IC50 | 59.0000 | 2 | 2 |
| Endoplasmin | Canis lupus familiaris (dog) | IC50 | 11.4470 | 1 | 1 |
| Endoplasmin | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | IC50 | 53.7720 | 2 | 2 |
| Ephrin type-A receptor 2 | Mus musculus (house mouse) | IC50 | 69.3333 | 2 | 3 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 401.5760 | 5 | 5 |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | IC50 | 44.0000 | 2 | 3 |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | Ki | 31.5000 | 1 | 2 |
| Equilibrative nucleoside transporter 2 | Homo sapiens (human) | IC50 | 170.0000 | 1 | 2 |
| Equilibrative nucleoside transporter 2 | Homo sapiens (human) | Ki | 174.0000 | 1 | 2 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 1.1158 | 8 | 11 |
| Estrogen receptor | Homo sapiens (human) | Ki | 0.0013 | 1 | 2 |
| Estrogen receptor beta | Homo sapiens (human) | IC50 | 0.2832 | 7 | 8 |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | IC50 | 376.0000 | 1 | 1 |
| Excitatory amino acid transporter 3 | Homo sapiens (human) | IC50 | 161.0000 | 1 | 1 |
| Exportin-1 | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Fatty acid synthase | Homo sapiens (human) | Ki | 75,750.0000 | 1 | 2 |
| Fatty acid-binding protein 5 | Homo sapiens (human) | Ki | 5.6567 | 1 | 3 |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | IC50 | 2.7500 | 1 | 1 |
| Fatty acid-binding protein, liver | Mus musculus (house mouse) | Ki | 0.0610 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | IC50 | 40.3200 | 5 | 5 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 4.3675 | 3 | 4 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | Ki | 0.0269 | 1 | 1 |
| Fe(3+)-Zn(2+) purple acid phosphatase | Phaseolus vulgaris | Ki | 2,000.0000 | 1 | 1 |
| Fibrinogen C domain-containing protein 1 | Homo sapiens (human) | IC50 | 4,500.0000 | 1 | 2 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| fMet-Leu-Phe receptor | Homo sapiens (human) | IC50 | 66.7000 | 1 | 1 |
| Fructose-1,6-bisphosphatase 1 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| G-protein coupled bile acid receptor 1 | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| G-protein coupled bile acid receptor 1 | Mus musculus (house mouse) | IC50 | 5.3000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | IC50 | 39.0000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | Ki | 137.0000 | 1 | 1 |
| G-protein coupled receptor 84 | Homo sapiens (human) | Ki | 5.7732 | 1 | 6 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | IC50 | 0.0483 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.2835 | 14 | 23 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 0.2917 | 15 | 23 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | IC50 | 27,334.2555 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 0.2917 | 15 | 23 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | IC50 | 35,479.0073 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | IC50 | 35,479.0073 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | IC50 | 35,479.0073 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 0.2840 | 15 | 23 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | IC50 | 35,479.0073 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 0.2917 | 15 | 23 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | IC50 | 35,479.0073 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | IC50 | 35,479.0073 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 0.2954 | 14 | 22 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Ki | 366.6801 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit rho-1 | Homo sapiens (human) | IC50 | 12.9000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | IC50 | 35,479.0073 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 0.1165 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | Ki | 73.0000 | 1 | 3 |
| Gamma-aminobutyric acid type B receptor subunit 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0292 | 4 | 4 |
| Gamma-aminobutyric acid type B receptor subunit 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0292 | 4 | 4 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | Ki | 0.0742 | 4 | 5 |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | Ki | 0.0930 | 2 | 2 |
| Genome polyprotein | | IC50 | 1.0000 | 1 | 1 |
| Ghrelin O-acyltransferase | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 2 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 10.5785 | 2 | 4 |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 2 | 2 |
| Glucocorticoid receptor | Homo sapiens (human) | Ki | 6.3293 | 1 | 3 |
| Glucose transporter | Leishmania mexicana | IC50 | 12.0000 | 1 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | IC50 | 44.1960 | 4 | 10 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | Ki | 7.3800 | 3 | 5 |
| Glucose-6-phosphate 1-dehydrogenase | Trypanosoma brucei | Ki | 0.9375 | 2 | 4 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 48.2500 | 1 | 2 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 34.3733 | 3 | 6 |
| Glutamate carboxypeptidase 2 | Homo sapiens (human) | IC50 | 523.0000 | 2 | 2 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 100.5000 | 2 | 2 |
| Glutamate receptor 1 | Homo sapiens (human) | Ki | 4,847.5000 | 1 | 4 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 100.5000 | 2 | 2 |
| Glutamate receptor 2 | Homo sapiens (human) | Ki | 4,847.5000 | 1 | 4 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | IC50 | 100.5000 | 2 | 2 |
| Glutamate receptor 3 | Homo sapiens (human) | Ki | 4,847.5000 | 1 | 4 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 100.5000 | 2 | 2 |
| Glutamate receptor 4 | Homo sapiens (human) | Ki | 4,847.5000 | 1 | 4 |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | Ki | 4,847.5000 | 1 | 4 |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 61.2439 | 8 | 13 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Ki | 2.7001 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 72.5334 | 6 | 9 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 72.5334 | 6 | 9 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | IC50 | 63.5000 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 72.5334 | 6 | 9 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | IC50 | 66.5000 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 72.5334 | 6 | 9 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 72.5334 | 6 | 9 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 72.5334 | 6 | 9 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Glutamine synthetase | Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 | Ki | 40.0000 | 1 | 1 |
| Glutaminyl-peptide cyclotransferase | Homo sapiens (human) | Ki | 974.4923 | 2 | 7 |
| Glutaminyl-peptide cyclotransferase | Mus musculus (house mouse) | Ki | 9,671.0000 | 1 | 2 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | IC50 | 42.3000 | 1 | 2 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | Ki | 36.0000 | 1 | 2 |
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | IC50 | 26,209.4257 | 9 | 9 |
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | Ki | 2,500.0000 | 1 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | Trypanosoma cruzi | IC50 | 691.8300 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 13.9247 | 1 | 3 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 6.3293 | 1 | 3 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 13.9247 | 1 | 3 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 6.3293 | 1 | 3 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 13.9247 | 1 | 3 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 6.3293 | 1 | 3 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 13.9247 | 1 | 3 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 6.3293 | 1 | 3 |
| green fluorescent protein, partial | Aequorea victoria | IC50 | 67.5880 | 1 | 1 |
| Guanine deaminase | Homo sapiens (human) | Ki | 4.3400 | 1 | 1 |
| guanine nucleotide-binding protein subunit alpha-15 | Homo sapiens (human) | IC50 | 29.9020 | 1 | 1 |
| Heat shock 70 kDa protein 1A | Homo sapiens (human) | IC50 | 280.2500 | 1 | 2 |
| Heat shock protein 75 kDa, mitochondrial | Homo sapiens (human) | IC50 | 55.5940 | 1 | 1 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | IC50 | 59.3080 | 1 | 1 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | Ki | 3.0000 | 1 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | IC50 | 3,010.5398 | 3 | 4 |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 12.0000 | 1 | 1 |
| High affinity choline transporter 1 | Mus musculus (house mouse) | IC50 | 1.6000 | 1 | 1 |
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | IC50 | 0.3851 | 2 | 2 |
| Histamine H1 receptor | Homo sapiens (human) | IC50 | 0.1585 | 1 | 2 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1585 | 1 | 3 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | Ki | 12.5892 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | Ki | 1,440,809,206.6944 | 11 | 11 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | Ki | 15,848,900,000.0000 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | Ki | 13.7162 | 7 | 7 |
| Histamine H3 receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0001 | 1 | 1 |
| Histamine H3 receptor | Homo sapiens (human) | Ki | 1.1824 | 17 | 18 |
| Histamine H3 receptor | Mus musculus (house mouse) | Ki | 0.0680 | 1 | 1 |
| Histamine H4 receptor | Homo sapiens (human) | Ki | 0.5926 | 18 | 19 |
| Histamine H4 receptor | Mus musculus (house mouse) | Ki | 0.0607 | 2 | 2 |
| Histamine H4 receptor | Rattus norvegicus (Norway rat) | Ki | 0.0996 | 2 | 2 |
| Histamine H4 receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0060 | 1 | 1 |
| Histamine N-methyltransferase | Rattus norvegicus (Norway rat) | Ki | 0.0144 | 1 | 1 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 1 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 11 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 11 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 2 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 7 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Histone lysine demethylase PHF8 | Homo sapiens (human) | IC50 | 2.3000 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 2 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 77.0000 | 1 | 2 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Hypoxanthine-guanine phosphoribosyltransferase | Homo sapiens (human) | Ki | 5.4000 | 1 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Ileal sodium/bile acid cotransporter | Homo sapiens (human) | Ki | 28.5167 | 1 | 6 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | IC50 | 498.7000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Mus musculus (house mouse) | IC50 | 173.6500 | 1 | 2 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | Ki | 158.0000 | 2 | 2 |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | IC50 | 15.1000 | 1 | 2 |
| Indolethylamine N-methyltransferase | Homo sapiens (human) | Ki | 700.0000 | 1 | 2 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | IC50 | 24.3800 | 1 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | Ki | 4.0600 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | Ki | 50.1250 | 2 | 2 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Ki | 50.1250 | 2 | 2 |
| integrase, partial | Human immunodeficiency virus 1 | IC50 | 0.5939 | 2 | 2 |
| Integrin alpha-V | Homo sapiens (human) | IC50 | 0.0482 | 2 | 2 |
| Integrin beta-3 | Homo sapiens (human) | IC50 | 0.0482 | 2 | 2 |
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | IC50 | 4.1700 | 1 | 1 |
| Intestinal-type alkaline phosphatase | Homo sapiens (human) | IC50 | 5.0000 | 1 | 3 |
| Isocitrate lyase 1 | Mycobacterium tuberculosis CDC1551 | IC50 | 29.4000 | 1 | 1 |
| Kappa-type opioid receptor | Mus musculus (house mouse) | IC50 | 0.0417 | 2 | 2 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1290 | 2 | 2 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 10.0000 | 1 | 2 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 3.3309 | 8 | 8 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 10.0000 | 1 | 2 |
| Kinesin-like protein KIF11 | Homo sapiens (human) | IC50 | 63.0000 | 1 | 1 |
| Kynurenine--oxoglutarate transaminase 1 | Homo sapiens (human) | IC50 | 180.0000 | 2 | 4 |
| L-lactate dehydrogenase A chain | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| L-lactate dehydrogenase A chain | Rattus norvegicus (Norway rat) | IC50 | 500.0000 | 1 | 1 |
| L-lactate dehydrogenase B chain | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | IC50 | 200.0000 | 1 | 3 |
| Large neutral amino acids transporter small subunit 1 | Homo sapiens (human) | IC50 | 129.2857 | 4 | 14 |
| large T antigen | Betapolyomavirus macacae | IC50 | 49.6160 | 1 | 5 |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | IC50 | 0.5939 | 2 | 2 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | IC50 | 15.8090 | 1 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | Ki | 6.7150 | 1 | 1 |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | IC50 | 1,500.0000 | 2 | 2 |
| Leukotriene B4 receptor 1 | Homo sapiens (human) | IC50 | 0.0019 | 1 | 1 |
| Leukotriene B4 receptor 1 | Homo sapiens (human) | Ki | 0.0022 | 3 | 3 |
| Leukotriene B4 receptor 2 | Homo sapiens (human) | Ki | 0.0019 | 1 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | Homo sapiens (human) | Ki | 13.0000 | 1 | 1 |
| Lysine--tRNA ligase | Plasmodium falciparum 3D7 | IC50 | 2.5000 | 1 | 1 |
| Lysine-specific demethylase 2A | Homo sapiens (human) | IC50 | 0.5700 | 1 | 1 |
| Lysine-specific demethylase 4C | Homo sapiens (human) | IC50 | 2,070.0000 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | IC50 | 2,511.9500 | 2 | 2 |
| Lysine-specific demethylase 5C | Homo sapiens (human) | IC50 | 4.5000 | 1 | 1 |
| Lysine-specific demethylase 6B | Homo sapiens (human) | IC50 | 16.5000 | 1 | 1 |
| Lysyl oxidase homolog 2 | Homo sapiens (human) | IC50 | 60.1000 | 1 | 1 |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | IC50 | 2.6000 | 1 | 1 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | IC50 | 73.6000 | 1 | 1 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | Ki | 62.0000 | 1 | 1 |
| Malate dehydrogenase, mitochondrial | Homo sapiens (human) | IC50 | 43.6000 | 1 | 1 |
| Matrilysin | Homo sapiens (human) | IC50 | 115.0000 | 1 | 1 |
| Melanocortin receptor 5 | Homo sapiens (human) | IC50 | 17.1330 | 1 | 1 |
| Melanocortin receptor 5 | Homo sapiens (human) | Ki | 16.0720 | 1 | 1 |
| Melatonin receptor type 1A | Homo sapiens (human) | IC50 | 0.0025 | 18 | 18 |
| Melatonin receptor type 1A | Gallus gallus (chicken) | Ki | 0.0007 | 7 | 8 |
| Melatonin receptor type 1A | Homo sapiens (human) | Ki | 0.0003 | 67 | 69 |
| Melatonin receptor type 1B | Homo sapiens (human) | IC50 | 0.0035 | 12 | 12 |
| Melatonin receptor type 1B | Gallus gallus (chicken) | Ki | 0.0007 | 8 | 9 |
| Melatonin receptor type 1B | Homo sapiens (human) | Ki | 0.0004 | 62 | 64 |
| Melatonin receptor type 1C | Gallus gallus (chicken) | Ki | 0.0007 | 7 | 8 |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0004 | 2 | 2 |
| Metabotropic glutamate receptor 1 | Homo sapiens (human) | Ki | 1,000.0000 | 1 | 1 |
| Metabotropic glutamate receptor 2 | Homo sapiens (human) | Ki | 35.0000 | 1 | 1 |
| Metabotropic glutamate receptor 4 | Homo sapiens (human) | Ki | 3,000.0000 | 1 | 1 |
| Metabotropic glutamate receptor 5 | Homo sapiens (human) | Ki | 1,000.0000 | 1 | 1 |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | Ki | 0.0052 | 1 | 1 |
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | Ki | 140.0000 | 1 | 1 |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | IC50 | 1.0715 | 2 | 4 |
| Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 0.1232 | 3 | 3 |
| Mitogen-activated protein kinase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1.0000 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 0.5760 | 1 | 1 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Ki | 1,300.0000 | 1 | 1 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | Ki | 1,300.0000 | 1 | 1 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | Ki | 1,300.0000 | 1 | 1 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Ki | 1,300.0000 | 1 | 1 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | IC50 | 3.1570 | 1 | 1 |
| Monocarboxylate transporter 2 | Rattus norvegicus (Norway rat) | Ki | 533.3333 | 1 | 3 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 290.0615 | 2 | 4 |
| Mu-type opioid receptor | Homo sapiens (human) | IC50 | 4.7565 | 2 | 2 |
| Mu-type opioid receptor | Mus musculus (house mouse) | IC50 | 0.0308 | 3 | 4 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1290 | 2 | 2 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.1934 | 2 | 2 |
| Mu-type opioid receptor | Danio rerio (zebrafish) | Ki | 1.0005 | 1 | 2 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 1.0615 | 9 | 10 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0151 | 6 | 6 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 21.4000 | 1 | 1 |
| Multidrug resistance associated protein | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | Ki | 0.4500 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 120.7842 | 6 | 19 |
| Muscarinic acetylcholine receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0002 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Ki | 0.0200 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | Ki | 0.0200 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | Ki | 0.0200 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | Ki | 0.0200 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | Ki | 0.0200 | 1 | 1 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 2.6250 | 1 | 2 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | IC50 | 2.0200 | 1 | 1 |
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | Homo sapiens (human) | IC50 | 68.0000 | 1 | 1 |
| N-formyl peptide receptor 2 | Homo sapiens (human) | IC50 | 0.0119 | 6 | 6 |
| N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | Homo sapiens (human) | Ki | 900.0000 | 1 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | Homo sapiens (human) | Ki | 2,350.0000 | 1 | 2 |
| NAD-dependent histone deacetylase SIR2 | Saccharomyces cerevisiae S288C | IC50 | 150.0000 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 870.0000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-10 | Rattus norvegicus (Norway rat) | Ki | 42.0000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 34.0000 | 2 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 42.2500 | 3 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 38.7500 | 3 | 4 |
| Neuronal acetylcholine receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 42.0000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 42.0000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | IC50 | 7.0000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | Rattus norvegicus (Norway rat) | Ki | 42.0000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-9 | Rattus norvegicus (Norway rat) | Ki | 42.0000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 35.2000 | 4 | 5 |
| Neuronal acetylcholine receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 42.0000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | Rattus norvegicus (Norway rat) | Ki | 41.5000 | 3 | 4 |
| Neurotensin receptor type 1 | Homo sapiens (human) | IC50 | 0.0013 | 11 | 11 |
| Neurotensin receptor type 1 | Homo sapiens (human) | Ki | 0.0017 | 6 | 6 |
| Neurotensin receptor type 1 | Rattus norvegicus (Norway rat) | Ki | 0.0014 | 2 | 2 |
| Neurotensin receptor type 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0582 | 3 | 3 |
| Neurotensin receptor type 2 | Homo sapiens (human) | Ki | 0.0046 | 3 | 3 |
| Neurotensin receptor type 2 | Rattus norvegicus (Norway rat) | Ki | 0.0226 | 3 | 3 |
| Neutral amino acid transporter A | Homo sapiens (human) | IC50 | 1,741.0000 | 2 | 6 |
| Neutral amino acid transporter B(0) | Homo sapiens (human) | IC50 | 2,070.8333 | 2 | 6 |
| Nicotinate phosphoribosyltransferase | Homo sapiens (human) | Ki | 0.0010 | 1 | 2 |
| Nitric oxide synthase, brain | Homo sapiens (human) | Ki | 2,350.0000 | 1 | 2 |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | Ki | 2,350.0000 | 1 | 2 |
| Nociceptin receptor | Homo sapiens (human) | IC50 | 0.0010 | 10 | 11 |
| Nociceptin receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0006 | 5 | 9 |
| Nociceptin receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0069 | 1 | 1 |
| Nociceptin receptor | Homo sapiens (human) | Ki | 0.0002 | 15 | 15 |
| Nociceptin receptor | Mus musculus (house mouse) | Ki | 10,000.0001 | 2 | 2 |
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | IC50 | 0.2000 | 1 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | IC50 | 0.0001 | 1 | 1 |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | IC50 | 0.0001 | 1 | 1 |
| Nuclear receptor ROR-alpha | Homo sapiens (human) | IC50 | 0.1995 | 1 | 1 |
| Nuclear receptor ROR-beta | Homo sapiens (human) | IC50 | 12.6224 | 2 | 2 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | IC50 | 0.1995 | 1 | 1 |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | IC50 | 7.9433 | 1 | 1 |
| Opioid receptor homologue | Danio rerio (zebrafish) | Ki | 0.0730 | 1 | 1 |
| Opioid receptor, delta 1b | Danio rerio (zebrafish) | Ki | 0.1100 | 1 | 2 |
| Ornithine transcarbamylase, mitochondrial | Homo sapiens (human) | Ki | 12,666.6667 | 3 | 3 |
| Orotidine 5'-phosphate decarboxylase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 765.0000 | 1 | 2 |
| Orotidine 5'-phosphate decarboxylase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 5,105.0000 | 1 | 2 |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | IC50 | 1.1258 | 3 | 4 |
| P2X purinoceptor 1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | Homo sapiens (human) | IC50 | 84.5000 | 1 | 2 |
| Peptide deformylase | Escherichia coli | IC50 | 1,000.0000 | 1 | 1 |
| Peptide deformylase 1A, chloroplastic/mitochondrial | Arabidopsis thaliana (thale cress) | IC50 | 1,000.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | IC50 | 0.8200 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Ki | 0.8200 | 1 | 1 |
| perilipin-1 | Homo sapiens (human) | IC50 | 9.6190 | 1 | 1 |
| perilipin-5 | Homo sapiens (human) | IC50 | 7.1330 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | IC50 | 1.6100 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Ki | 22.0000 | 1 | 1 |
| Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | Ki | 25,704,000,349.3700 | 9 | 10 |
| Phenylethanolamine N-methyltransferase | Homo sapiens (human) | Ki | 830.0000 | 1 | 1 |
| Phosphatidylinositol 4-kinase alpha | Homo sapiens (human) | IC50 | 87.8000 | 1 | 2 |
| Phosphatidylinositol 4-kinase alpha | Homo sapiens (human) | Ki | 59.6500 | 1 | 2 |
| Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | IC50 | 87.8000 | 1 | 2 |
| Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | Ki | 59.6500 | 1 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | Homo sapiens (human) | IC50 | 87.8000 | 1 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | Homo sapiens (human) | Ki | 59.6500 | 1 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | Homo sapiens (human) | IC50 | 87.8000 | 1 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | Homo sapiens (human) | Ki | 59.6500 | 1 | 2 |
| Phosphodiesterase | Bos taurus (cattle) | IC50 | 0.1000 | 1 | 1 |
| Phosphoglycerate kinase 1 | Homo sapiens (human) | IC50 | 3,000.0000 | 1 | 1 |
| Phosphoglycerate kinase 2 | Homo sapiens (human) | IC50 | 3,000.0000 | 1 | 1 |
| Phospholipase A-2-activating protein | Homo sapiens (human) | IC50 | 5.0000 | 1 | 3 |
| Plasma kallikrein | Homo sapiens (human) | IC50 | 0.0031 | 1 | 1 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | IC50 | 3,160.0000 | 1 | 1 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | Ki | 8.1900 | 1 | 1 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 100.0000 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 44.7500 | 3 | 4 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 12.0100 | 4 | 5 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | Ki | 27.0000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | IC50 | 8.0000 | 1 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 25.0000 | 1 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 17.9305 | 2 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | IC50 | 100.0000 | 1 | 2 |
| Potassium channel subfamily K member 2 | Bos taurus (cattle) | IC50 | 8.2000 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 1 | Homo sapiens (human) | IC50 | 96.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | IC50 | 6.1000 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 125.9125 | 6 | 6 |
| Progesterone receptor | Homo sapiens (human) | IC50 | 7.3000 | 1 | 1 |
| Progesterone receptor | Oryctolagus cuniculus (rabbit) | IC50 | 0.4400 | 2 | 2 |
| Proliferating cell nuclear antigen | Homo sapiens (human) | IC50 | 34.5333 | 1 | 3 |
| Proline--tRNA ligase | Plasmodium falciparum 3D7 | IC50 | 2.5000 | 1 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | Gallus gallus (chicken) | Ki | 5,354.5000 | 1 | 4 |
| Prostacyclin receptor | Homo sapiens (human) | IC50 | 36.7533 | 3 | 3 |
| Prostacyclin receptor | Homo sapiens (human) | Ki | 4.0900 | 4 | 5 |
| Prostaglandin D2 receptor | Homo sapiens (human) | IC50 | 4.5000 | 2 | 2 |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | IC50 | 0.1578 | 4 | 4 |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | Ki | 0.0121 | 3 | 3 |
| Prostaglandin E2 receptor EP1 subtype | Mus musculus (house mouse) | Ki | 0.0270 | 5 | 6 |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | IC50 | 13.7566 | 8 | 8 |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | IC50 | 0.0052 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | Ki | 0.0092 | 6 | 6 |
| Prostaglandin E2 receptor EP2 subtype | Mus musculus (house mouse) | Ki | 0.0392 | 5 | 6 |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | IC50 | 0.1090 | 4 | 4 |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | Ki | 0.0020 | 4 | 4 |
| Prostaglandin E2 receptor EP3 subtype | Mus musculus (house mouse) | Ki | 0.0050 | 5 | 5 |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | IC50 | 0.9357 | 9 | 9 |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | IC50 | 0.0021 | 1 | 1 |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | Ki | 0.0010 | 8 | 8 |
| Prostaglandin E2 receptor EP4 subtype | Mus musculus (house mouse) | Ki | 0.0032 | 5 | 6 |
| Prostaglandin F2-alpha receptor | Bos taurus (cattle) | IC50 | 0.1400 | 1 | 1 |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | IC50 | 0.0139 | 4 | 4 |
| Prostaglandin F2-alpha receptor | Bos taurus (cattle) | Ki | 0.1290 | 1 | 1 |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | Ki | 0.1190 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 0.1400 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 253.7506 | 2 | 4 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 2.5700 | 2 | 2 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | IC50 | 336.6000 | 1 | 3 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 0.0713 | 2 | 2 |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Protein cereblon | Homo sapiens (human) | IC50 | 2,057.3333 | 1 | 3 |
| Protein cereblon | Homo sapiens (human) | Ki | 301.0000 | 1 | 2 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | IC50 | 40.0000 | 3 | 4 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | IC50 | 40.0000 | 3 | 4 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | IC50 | 34.3333 | 2 | 3 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | IC50 | 34.3333 | 2 | 3 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | IC50 | 34.3333 | 2 | 3 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | IC50 | 40.0000 | 3 | 4 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | IC50 | 34.3333 | 2 | 3 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | IC50 | 34.3333 | 2 | 3 |
| Protein kinase domain-containing protein | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1.0000 | 1 | 1 |
| Protein mono-ADP-ribosyltransferase PARP15 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Protein skinhead-1 | Caenorhabditis elegans | IC50 | 100.0000 | 1 | 1 |
| Protein-L-isoaspartate(D-aspartate) O-methyltransferase | Homo sapiens (human) | Ki | 106.0000 | 2 | 2 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 34,287.1429 | 3 | 7 |
| Proton-coupled amino acid transporter 1 | Homo sapiens (human) | Ki | 24,053.3333 | 1 | 15 |
| Purine nucleoside phosphorylase | Homo sapiens (human) | IC50 | 5.0000 | 1 | 2 |
| Purine nucleoside phosphorylase | Homo sapiens (human) | Ki | 1,002.5000 | 1 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 805.5540 | 2 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 6.3000 | 1 | 1 |
| Retinoic acid receptor alpha | Homo sapiens (human) | IC50 | 2.2542 | 4 | 4 |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | IC50 | 0.0057 | 3 | 3 |
| Retinoic acid receptor alpha | Homo sapiens (human) | Ki | 0.0688 | 3 | 3 |
| Retinoic acid receptor beta | Homo sapiens (human) | IC50 | 0.7537 | 4 | 4 |
| Retinoic acid receptor beta | Mus musculus (house mouse) | IC50 | 0.0050 | 2 | 2 |
| Retinoic acid receptor beta | Homo sapiens (human) | Ki | 0.0095 | 3 | 3 |
| Retinoic acid receptor gamma | Mus musculus (house mouse) | IC50 | 0.0040 | 2 | 2 |
| Retinoic acid receptor gamma | Homo sapiens (human) | IC50 | 0.0064 | 3 | 3 |
| Retinoic acid receptor gamma | Homo sapiens (human) | Ki | 0.0056 | 4 | 4 |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Retinoic acid receptor RXR-alpha | Mus musculus (house mouse) | IC50 | 18.0000 | 3 | 3 |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | Ki | 1.7431 | 4 | 4 |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Retinoic acid receptor RXR-beta | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | Ki | 0.3118 | 3 | 3 |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | IC50 | 0.3500 | 1 | 1 |
| Retinoic acid receptor RXR-gamma | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | Ki | 0.1365 | 3 | 3 |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | IC50 | 12,800.0000 | 2 | 2 |
| Ribonuclease pancreatic | Bos taurus (cattle) | Ki | 844.2000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 7.6032 | 8 | 9 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Ki | 0.0422 | 2 | 2 |
| Ricin | Ricinus communis (castor bean) | IC50 | 900.0000 | 1 | 1 |
| S-adenosylmethionine decarboxylase proenzyme | Rattus norvegicus (Norway rat) | Ki | 180.0000 | 2 | 2 |
| S-ribosylhomocysteine lyase | Bacillus subtilis subsp. subtilis str. 168 | Ki | 61.0000 | 1 | 1 |
| Seminal ribonuclease | Bos taurus (cattle) | Ki | 1,557.9000 | 1 | 1 |
| Sensor protein kinase WalK | Staphylococcus aureus | IC50 | 7.1890 | 1 | 1 |
| Sepiapterin reductase | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Serine racemase | Homo sapiens (human) | IC50 | 667.4500 | 2 | 2 |
| Serine racemase | Mus musculus (house mouse) | IC50 | 958.5000 | 1 | 2 |
| Serine racemase | Homo sapiens (human) | Ki | 52.6667 | 3 | 3 |
| Serine racemase | Mus musculus (house mouse) | Ki | 49.0000 | 2 | 2 |
| Serum paraoxonase/arylesterase 1 | Homo sapiens (human) | Ki | 16.5000 | 1 | 1 |
| Sex hormone-binding globulin | Homo sapiens (human) | IC50 | 0.0038 | 1 | 1 |
| Sex hormone-binding globulin | Rattus norvegicus (Norway rat) | IC50 | 0.0230 | 1 | 1 |
| Shiga toxin subunit A | Shigella dysenteriae | IC50 | 11.5000 | 1 | 1 |
| Sialidase-1 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-3 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sialidase-4 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | Ki | 10.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 35.6000 | 1 | 1 |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | IC50 | 17.8889 | 5 | 9 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Homo sapiens (human) | IC50 | 15.8771 | 30 | 57 |
| Sodium- and chloride-dependent betaine transporter | Mus musculus (house mouse) | IC50 | 331.1310 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 0.0760 | 2 | 3 |
| Sodium- and chloride-dependent creatine transporter 1 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Sodium- and chloride-dependent creatine transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 1.6000 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | Homo sapiens (human) | IC50 | 5.2623 | 4 | 5 |
| Sodium- and chloride-dependent GABA transporter 1 | Mus musculus (house mouse) | IC50 | 847.6065 | 6 | 10 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 2.5271 | 7 | 18 |
| Sodium- and chloride-dependent GABA transporter 2 | Homo sapiens (human) | IC50 | 111.6667 | 3 | 3 |
| Sodium- and chloride-dependent GABA transporter 2 | Mus musculus (house mouse) | IC50 | 214.0772 | 5 | 8 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 1.3070 | 3 | 4 |
| Sodium- and chloride-dependent GABA transporter 3 | Homo sapiens (human) | IC50 | 15.6259 | 6 | 7 |
| Sodium- and chloride-dependent GABA transporter 3 | Mus musculus (house mouse) | IC50 | 58.4955 | 4 | 7 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 0.0760 | 2 | 3 |
| Sodium- and chloride-dependent glycine transporter 1 | Homo sapiens (human) | IC50 | 91.0000 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 2 | Homo sapiens (human) | IC50 | 0.4700 | 1 | 2 |
| Sodium- and chloride-dependent taurine transporter | Homo sapiens (human) | IC50 | 182.0000 | 1 | 2 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 6.0000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | Ki | 0.0120 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 6.9050 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 5.4860 | 1 | 1 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 7.8185 | 1 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 4.1535 | 1 | 2 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | IC50 | 4.4500 | 1 | 2 |
| Sodium/bile acid cotransporter | Rattus norvegicus (Norway rat) | IC50 | 6.0000 | 1 | 1 |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | IC50 | 5.6500 | 1 | 2 |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | Ki | 3.5000 | 1 | 2 |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | IC50 | 18.7500 | 1 | 2 |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | Ki | 18.1500 | 1 | 2 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | IC50 | 35,590.0000 | 2 | 4 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | Ki | 3,431.6667 | 2 | 6 |
| Solute carrier family 15 member 1 | Rattus norvegicus (Norway rat) | Ki | 3,126.0000 | 1 | 5 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | IC50 | 28.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | IC50 | 3,000.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | Ki | 41.3859 | 1 | 4 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 1,649.2000 | 1 | 5 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | IC50 | 300.0000 | 1 | 1 |
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | IC50 | 55.0000 | 1 | 1 |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | IC50 | 541.1750 | 4 | 4 |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | Ki | 471.8000 | 4 | 5 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 1,470.2667 | 3 | 3 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | Ki | 7.0200 | 1 | 1 |
| Solute carrier family 22 member 11 | Homo sapiens (human) | Ki | 199.2667 | 3 | 3 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 34.2000 | 1 | 1 |
| Solute carrier family 22 member 2 | Mus musculus (house mouse) | IC50 | 217.0000 | 1 | 1 |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | IC50 | 271.6333 | 5 | 6 |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | Ki | 172.6964 | 6 | 7 |
| Solute carrier family 22 member 20 | Mus musculus (house mouse) | Ki | 1,932.9681 | 1 | 22 |
| Solute carrier family 22 member 3 | Homo sapiens (human) | IC50 | 0.9450 | 2 | 2 |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | IC50 | 6.6500 | 1 | 2 |
| Solute carrier family 22 member 3 | Homo sapiens (human) | Ki | 140.0000 | 1 | 1 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | IC50 | 43.9500 | 2 | 2 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | Ki | 17.0367 | 3 | 3 |
| Solute carrier family 22 member 6 | Mus musculus (house mouse) | Ki | 1,575.5690 | 3 | 28 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 1,220.2500 | 4 | 4 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | Ki | 155.3250 | 4 | 4 |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | Ki | 399.5500 | 2 | 2 |
| Solute carrier family 28 member 3 | Homo sapiens (human) | IC50 | 4.3500 | 1 | 2 |
| Solute carrier family 28 member 3 | Homo sapiens (human) | Ki | 2.7500 | 1 | 2 |
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 10.1400 | 3 | 10 |
| Solute carrier organic anion transporter family member 1A3 | Rattus norvegicus (Norway rat) | Ki | 98.5500 | 1 | 2 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | IC50 | 765.2000 | 1 | 2 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | Ki | 97.7000 | 2 | 2 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 0.7044 | 2 | 4 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 0.4552 | 3 | 5 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 1.9178 | 2 | 4 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 1.8775 | 2 | 4 |
| Solute carrier organic anion transporter family member 1C1 | Mus musculus (house mouse) | Ki | 62.1000 | 1 | 3 |
| Solute carrier organic anion transporter family member 2A1 | Homo sapiens (human) | Ki | 16,000.0203 | 2 | 3 |
| Solute carrier organic anion transporter family member 2A1 | Mus musculus (house mouse) | Ki | 0.1010 | 1 | 2 |
| Solute carrier organic anion transporter family member 2A1 | Rattus norvegicus (Norway rat) | Ki | 0.0537 | 2 | 3 |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | IC50 | 0.1614 | 1 | 2 |
| Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | IC50 | 8.0000 | 1 | 1 |
| Sorbitol dehydrogenase | Homo sapiens (human) | IC50 | 400.0000 | 1 | 1 |
| Sortilin | Homo sapiens (human) | IC50 | 0.3600 | 1 | 1 |
| Spermidine synthase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 159.0000 | 1 | 1 |
| Sphingosine kinase 1 | Homo sapiens (human) | IC50 | 3.8600 | 1 | 1 |
| Sphingosine kinase 2 | Homo sapiens (human) | IC50 | 1.5600 | 1 | 1 |
| Sterol O-acyltransferase 1 | Cricetulus griseus (Chinese hamster) | IC50 | 224.4333 | 2 | 6 |
| Sterol O-acyltransferase 1 | Homo sapiens (human) | IC50 | 61.5000 | 2 | 4 |
| Sterol O-acyltransferase 1 | Rattus norvegicus (Norway rat) | IC50 | 160.0000 | 1 | 2 |
| Sterol regulatory element-binding protein 1 | Homo sapiens (human) | IC50 | 1.1760 | 1 | 1 |
| Sterol regulatory element-binding protein 2 | Homo sapiens (human) | IC50 | 0.3000 | 1 | 1 |
| Steryl-sulfatase | Homo sapiens (human) | IC50 | 22.0667 | 3 | 3 |
| Steryl-sulfatase | Homo sapiens (human) | Ki | 60.0000 | 1 | 1 |
| Stromelysin-1 | Homo sapiens (human) | IC50 | 500.0000 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | IC50 | 6.1250 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | Ki | 2.0420 | 1 | 1 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 500.0000 | 1 | 3 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | IC50 | 19.9526 | 1 | 1 |
| Tat | Human immunodeficiency virus 1 | IC50 | 11.7530 | 1 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | IC50 | 0.4588 | 8 | 10 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 98.2000 | 1 | 5 |
| Thromboxane A2 receptor | Homo sapiens (human) | IC50 | 5.0000 | 2 | 2 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 18.5940 | 1 | 1 |
| Thromboxane-A synthase | Homo sapiens (human) | Ki | 0.1000 | 1 | 1 |
| Thymidine kinase | Human alphaherpesvirus 1 strain SC16 | IC50 | 1.0000 | 1 | 1 |
| Thymidine kinase | Macacine alphaherpesvirus 1 | IC50 | 4.1000 | 1 | 1 |
| Thymidine kinase | Staphylococcus aureus | Ki | 257.0000 | 1 | 1 |
| Thymidine kinase 2 | Rattus norvegicus (Norway rat) | Ki | 320.0000 | 1 | 1 |
| Thymidine kinase, cytosolic | Homo sapiens (human) | IC50 | 163.4737 | 4 | 6 |
| Thymidine kinase, cytosolic | Homo sapiens (human) | Ki | 1.1000 | 2 | 2 |
| Thymidine phosphorylase | Mus musculus (house mouse) | Ki | 347,000.0000 | 1 | 1 |
| Thymidylate kinase | Homo sapiens (human) | Ki | 180.0000 | 2 | 2 |
| Thymidylate kinase | Mycobacterium tuberculosis H37Rv | Ki | 125.2857 | 6 | 7 |
| Thymidylate synthase | Homo sapiens (human) | IC50 | 395.0000 | 2 | 2 |
| Thymidylate synthase | Mus musculus (house mouse) | IC50 | 590.0000 | 2 | 2 |
| Thymidylate synthase | Homo sapiens (human) | Ki | 40.0000 | 1 | 1 |
| Thyroid hormone receptor alpha | Homo sapiens (human) | IC50 | 0.0006 | 7 | 8 |
| Thyroid hormone receptor alpha | Homo sapiens (human) | Ki | 0.0013 | 4 | 4 |
| Thyroid hormone receptor beta | Homo sapiens (human) | IC50 | 0.0006 | 8 | 9 |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | IC50 | 0.0031 | 1 | 2 |
| Thyroid hormone receptor beta | Homo sapiens (human) | Ki | 0.0012 | 5 | 5 |
| Thyroliberin receptor | Mus musculus (house mouse) | IC50 | 0.0070 | 2 | 2 |
| Thyroliberin receptor | Rattus norvegicus (Norway rat) | IC50 | 11.5115 | 2 | 2 |
| Thyroliberin receptor | Rattus norvegicus (Norway rat) | Ki | 0.0100 | 2 | 2 |
| Thyrotropin-releasing hormone receptor | Mus musculus (house mouse) | IC50 | 0.0119 | 3 | 3 |
| Thyrotropin-releasing hormone receptor | Homo sapiens (human) | Ki | 0.0200 | 1 | 1 |
| Thyrotropin-releasing hormone receptor | Mus musculus (house mouse) | Ki | 0.0165 | 2 | 2 |
| Thyrotropin-releasing hormone receptor | Rattus norvegicus (Norway rat) | Ki | 0.0311 | 2 | 2 |
| Tissue factor | Homo sapiens (human) | IC50 | 60.0000 | 1 | 4 |
| Toll-like receptor 2 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| trace amine-associated receptor 1 | Homo sapiens (human) | IC50 | 0.8818 | 1 | 1 |
| Trans-sialidase | Trypanosoma cruzi | Ki | 7,300.0000 | 2 | 2 |
| Transcription factor p65 | Homo sapiens (human) | IC50 | 0.0001 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 8 | Homo sapiens (human) | IC50 | 12.0000 | 2 | 2 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | IC50 | 4.6350 | 3 | 4 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | IC50 | 4.4212 | 2 | 8 |
| Translocator protein | Homo sapiens (human) | IC50 | 106,414.0000 | 1 | 1 |
| Transmembrane prolyl 4-hydroxylase | Homo sapiens (human) | IC50 | 105.7500 | 2 | 2 |
| Transporter | Rattus norvegicus (Norway rat) | Ki | 0.0256 | 2 | 2 |
| Transthyretin | Homo sapiens (human) | IC50 | 4.9626 | 2 | 3 |
| Trehalose-phosphatase | Brugia malayi | Ki | 10,000.0000 | 1 | 1 |
| Tripeptidyl-peptidase 2 | Rattus norvegicus (Norway rat) | Ki | 470.0000 | 1 | 1 |
| Trypsin | Sus scrofa (pig) | IC50 | 200.0000 | 1 | 3 |
| Tryptophan 2,3-dioxygenase | Homo sapiens (human) | Ki | 11,500.0000 | 1 | 1 |
| Tubulin alpha-1A chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin alpha-1A chain | Sus scrofa (pig) | IC50 | 2.2000 | 1 | 1 |
| Tubulin alpha-1B chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin alpha-1C chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin alpha-3C chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin alpha-3E chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin alpha-4A chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta chain | Sus scrofa (pig) | IC50 | 2.2000 | 1 | 1 |
| Tubulin beta-1 chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta-2A chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta-2B chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta-2B chain | Bos taurus (cattle) | IC50 | 1,786.1750 | 8 | 8 |
| Tubulin beta-3 chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta-3 chain | Homo sapiens (human) | IC50 | 0.0082 | 3 | 3 |
| Tubulin beta-4A chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta-4B chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta-6 chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Tubulin beta-8 chain | Homo sapiens (human) | GI50 | 0.0053 | 3 | 3 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | IC50 | 0.0055 | 2 | 2 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | Ki | 0.0004 | 4 | 4 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0020 | 6 | 6 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.0009 | 4 | 4 |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0018 | 7 | 7 |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.0008 | 5 | 5 |
| Type-2 angiotensin II receptor | Homo sapiens (human) | IC50 | 0.0011 | 3 | 3 |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0040 | 1 | 1 |
| Type-2 angiotensin II receptor | Homo sapiens (human) | Ki | 0.0005 | 4 | 4 |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.0019 | 1 | 1 |
| Tyrosinase | Homo sapiens (human) | IC50 | 8,400.0000 | 1 | 1 |
| Tyrosinase | Mus musculus (house mouse) | IC50 | 189.5000 | 1 | 2 |
| Tyrosinase | Mus musculus (house mouse) | Ki | 240.0000 | 1 | 1 |
| Tyrosine 3-monooxygenase | Homo sapiens (human) | IC50 | 0.7200 | 1 | 1 |
| Tyrosine 3-monooxygenase | Rattus norvegicus (Norway rat) | IC50 | 0.0014 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 13.0260 | 1 | 2 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | IC50 | 3.7290 | 1 | 1 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | IC50 | 4.9000 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | IC50 | 29.4375 | 4 | 4 |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | IC50 | 13.2850 | 2 | 2 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | IC50 | 13.7000 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens (human) | IC50 | 65.7750 | 2 | 4 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | IC50 | 6.3125 | 2 | 2 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | IC50 | 245.3267 | 1 | 15 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 217.0824 | 3 | 17 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | IC50 | 245.3267 | 1 | 15 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | IC50 | 245.3267 | 1 | 15 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | IC50 | 245.3267 | 1 | 15 |
| Uracil nucleotide/cysteinyl leukotriene receptor | Homo sapiens (human) | IC50 | 30.0000 | 1 | 2 |
| Urease subunit alpha | Helicobacter pylori 26695 | Ki | 6,470.0000 | 1 | 1 |
| Urease subunit beta | Helicobacter pylori 26695 | Ki | 6,470.0000 | 1 | 1 |
| Uridine 5'-monophosphate synthase | Homo sapiens (human) | Ki | 810.0000 | 1 | 2 |
| Vesicular glutamate transporter 3 | Rattus norvegicus (Norway rat) | Ki | 1,300.0000 | 1 | 1 |
| Vif | Human immunodeficiency virus 1 | IC50 | 1.6600 | 1 | 1 |
| Vitamin D3 receptor | Bos taurus (cattle) | IC50 | 0.0000 | 1 | 1 |
| Vitamin D3 receptor | Homo sapiens (human) | IC50 | 32.2297 | 22 | 32 |
| Vitamin D3 receptor | Rattus norvegicus (Norway rat) | Ki | 0.0001 | 11 | 11 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | IC50 | 0.0429 | 3 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 3.6995 | 6 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Mus musculus (house mouse) | IC50 | 1.2000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | IC50 | 0.0385 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | Ki | 0.0102 | 2 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | Ki | 0.0038 | 2 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Mus musculus (house mouse) | IC50 | 1.2000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Rattus norvegicus (Norway rat) | Ki | 0.0039 | 2 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 5.8550 | 4 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | Ki | 0.0147 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 7.3567 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Mus musculus (house mouse) | IC50 | 1.2000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | Ki | 0.0147 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 7.3567 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Mus musculus (house mouse) | IC50 | 1.2000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | Ki | 0.0147 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Rattus norvegicus (Norway rat) | Ki | 0.0038 | 2 | 4 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 95.5000 | 2 | 3 |
| Zn finger protein | Nicotiana tabacum (common tobacco) | Ki | 0.1000 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | Homo sapiens (human) | EC50 | 0.0030 | 1 | 1 |
| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | Escherichia coli K-12 | Kd | 38.0000 | 1 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | Burkholderia pseudomallei K96243 | Kd | 1,000.0000 | 1 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | Escherichia coli K-12 | Kd | 900.0000 | 1 | 1 |
| 2-dehydropantoate 2-reductase | Escherichia coli K-12 | Kd | 360.0000 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | EC50 | 0.6300 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | EC50 | 0.0282 | 3 | 5 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | EC50 | 0.0011 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Kd | 5.9356 | 4 | 8 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | EC50 | 0.0002 | 1 | 2 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | EC50 | 26.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Kd | 6.5007 | 2 | 6 |
| Adenosine receptor A1 | Cavia porcellus (domestic guinea pig) | EC50 | 3.3884 | 2 | 2 |
| Adenosine receptor A1 | Homo sapiens (human) | EC50 | 0.6588 | 8 | 8 |
| Adenosine receptor A1 | Homo sapiens (human) | Kd | 0.2951 | 1 | 1 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Kd | 1.9498 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | EC50 | 5.4125 | 9 | 9 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | EC50 | 40.0000 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | Kd | 0.0173 | 1 | 1 |
| Adenosine receptor A2b | Homo sapiens (human) | EC50 | 18.9935 | 9 | 9 |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | EC50 | 40.0000 | 1 | 1 |
| Adenosine receptor A3 | Homo sapiens (human) | EC50 | 0.3689 | 6 | 6 |
| Adenosine receptor A3 | Homo sapiens (human) | Kd | 0.7400 | 1 | 1 |
| Advanced glycosylation end product-specific receptor | Homo sapiens (human) | Kd | 0.0430 | 1 | 1 |
| Advanced glycosylation end product-specific receptor | Rattus norvegicus (Norway rat) | Kd | 0.0430 | 1 | 1 |
| Albumin | Bos taurus (cattle) | Kd | 30.0000 | 1 | 1 |
| Albumin | Homo sapiens (human) | Kd | 6.0256 | 1 | 1 |
| Albumin | Rattus norvegicus (Norway rat) | Kd | 7.9700 | 1 | 1 |
| alkaline phosphatase, germ cell type preproprotein | Homo sapiens (human) | EC50 | 100.0000 | 1 | 1 |
| alkaline phosphatase, intestinal | Homo sapiens (human) | EC50 | 100.0000 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | EC50 | 10.1550 | 1 | 2 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | EC50 | 10.1550 | 1 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | EC50 | 10.1550 | 1 | 2 |
| Alpha-crystallin B chain | Homo sapiens (human) | EC50 | 0.8700 | 1 | 2 |
| Androgen receptor | Homo sapiens (human) | EC50 | 0.0058 | 26 | 26 |
| Androgen receptor | Mus musculus (house mouse) | EC50 | 0.0040 | 1 | 1 |
| Androgen receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0019 | 2 | 2 |
| Androgen receptor | Homo sapiens (human) | Kd | 0.0002 | 1 | 1 |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | EC50 | 0.0060 | 2 | 7 |
| Apelin receptor | Homo sapiens (human) | EC50 | 0.0129 | 28 | 29 |
| Apelin receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0045 | 4 | 4 |
| Apelin receptor | Homo sapiens (human) | Kd | 0.0005 | 1 | 1 |
| Apelin receptor | Mus musculus (house mouse) | Kd | 0.0045 | 1 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | EC50 | 0.0059 | 1 | 1 |
| Aryl hydrocarbon receptor | Homo sapiens (human) | EC50 | 0.3000 | 1 | 1 |
| Avidin | Gallus gallus (chicken) | Kd | 117.0000 | 1 | 1 |
| Beta-lactamase | Klebsiella pneumoniae | Kd | 1,000.0000 | 1 | 1 |
| Beta-lactoglobulin | Bos taurus (cattle) | Kd | 0.0360 | 1 | 1 |
| Beta-secretase 1 | Homo sapiens (human) | Kd | 2,000.0000 | 1 | 1 |
| Bifunctional cytochrome P450/NADPH--P450 reductase | Priestia megaterium NBRC 15308 = ATCC 14581 | Kd | 0.1468 | 1 | 4 |
| Bile acid receptor | Homo sapiens (human) | EC50 | 22.7590 | 33 | 42 |
| Bile acid receptor | Mus musculus (house mouse) | EC50 | 16.8000 | 2 | 2 |
| Cannabinoid receptor 1 | Homo sapiens (human) | EC50 | 0.0230 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | EC50 | 0.0170 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Kd | 450,000.0000 | 1 | 1 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Kd | 150,000.0000 | 1 | 1 |
| Cellular retinoic acid-binding protein 1 | Mus musculus (house mouse) | Kd | 0.0004 | 2 | 2 |
| Cellular retinoic acid-binding protein 2 | Mus musculus (house mouse) | Kd | 0.0020 | 2 | 2 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | Homo sapiens (human) | Kd | 1.3000 | 1 | 2 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4 | Homo sapiens (human) | Kd | 3.3000 | 1 | 4 |
| Chain A, 2,2-dialkylglycine decarboxylase | Burkholderia cepacia | Kd | 600.0000 | 1 | 1 |
| Chain A, a non-biological ATP binding protein with two mutations N32D and D65V | unidentified | Kd | 0.4500 | 1 | 1 |
| Chain A, A-TYPE ATP SYNTHASE CATALYTIC SUBUNIT A | Pyrococcus horikoshii OT3 | Kd | 3.2300 | 1 | 1 |
| Chain A, abiotic ATP-binding, folding optimized protein | unidentified | Kd | 0.4940 | 1 | 1 |
| Chain A, Acetylcholinesterase | Mus musculus (house mouse) | Kd | 930.0000 | 1 | 7 |
| Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | Mus musculus (house mouse) | Kd | 4.4000 | 1 | 1 |
| Chain A, Akap18 Delta | Homo sapiens (human) | Kd | 194.0000 | 1 | 1 |
| Chain A, ALDOLASE | Oryctolagus cuniculus (rabbit) | Kd | 1.0000 | 1 | 1 |
| Chain A, Aspartate Aminotransferase | Escherichia coli | Kd | 409.3333 | 1 | 15 |
| Chain A, ATP Binding Protein-DX | unidentified | Kd | 0.3500 | 1 | 9 |
| Chain A, ATP synthase epsilon chain | Bacillus sp. PS3 | Kd | 1.4000 | 1 | 1 |
| Chain A, ATP-dependent RNA helicase A | Homo sapiens (human) | Kd | 18.0000 | 1 | 1 |
| Chain A, Avidin | Gallus gallus (chicken) | Kd | 102.6500 | 1 | 4 |
| Chain A, Beta-lactoglobulin | Bos taurus (cattle) | Kd | 92.6000 | 1 | 2 |
| Chain A, Biotin [acetyl-CoA-carboxylase] ligase | Aquifex aeolicus | Kd | 6.4500 | 1 | 4 |
| Chain A, Biotin transporter BioY | Lactococcus cremoris subsp. cremoris MG1363 | Kd | 0.0003 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | Homo sapiens (human) | Kd | 125.0000 | 1 | 1 |
| Chain A, Cellular retinoic acid-binding protein 2 | Homo sapiens (human) | Kd | 0.1200 | 1 | 2 |
| Chain A, Chloride Channel Protein 5 | Homo sapiens (human) | Kd | 100.0000 | 1 | 4 |
| Chain A, Choline-binding protein | Bacillus subtilis subsp. subtilis str. JH642 | Kd | 30.5000 | 1 | 1 |
| Chain A, Chromosomal replication initiator protein dnaA | Thermotoga maritima | Kd | 0.0240 | 1 | 1 |
| Chain A, Circular Permutant Of Avidin | Gallus gallus (chicken) | Kd | 0.2400 | 1 | 1 |
| Chain A, Competence Protein Pilm | Thermus thermophilus HB27 | Kd | 1,000.0000 | 1 | 1 |
| Chain A, Copper-transporting ATPase 1 | Homo sapiens (human) | Kd | 83.3000 | 1 | 1 |
| Chain A, Core-streptavidin | Streptomyces avidinii | Kd | 0.0300 | 1 | 16 |
| Chain A, Cyclin-dependent kinase 2 | Homo sapiens (human) | Kd | 51.3000 | 1 | 1 |
| Chain A, D-alanine-poly(phosphoribitol) ligase | Bacillus cereus | Kd | 1,100.0000 | 1 | 1 |
| Chain A, Dethiobiotin synthetase | Helicobacter pylori 26695 | Kd | 4.4333 | 1 | 9 |
| Chain A, Diacylglycerol Kinase DgkB | Staphylococcus aureus | Kd | 219.0000 | 1 | 1 |
| Chain A, Dihydrofolate reductase | Escherichia coli | Kd | 9.5100 | 1 | 1 |
| Chain A, Dutpase | Leishmania major | Kd | 140.0000 | 1 | 3 |
| Chain A, Endoplasmin | Canis lupus familiaris (dog) | Kd | 5.0000 | 1 | 1 |
| Chain A, Excinuclease ABC subunit A | Geobacillus stearothermophilus 10 | Kd | 0.0100 | 1 | 1 |
| Chain A, Fatty Acid-binding Protein, Brain | Homo sapiens (human) | Kd | 0.0534 | 1 | 2 |
| Chain A, FLAVODOXIN | Nitratidesulfovibrio vulgaris | Kd | 0.0018 | 1 | 11 |
| Chain A, Flavodoxin | Nitratidesulfovibrio vulgaris str. Hildenborough | Kd | 0.0023 | 1 | 8 |
| Chain A, FLAVODOXIN | Synechococcus elongatus PCC 7942 = FACHB-805 | Kd | 0.0011 | 1 | 15 |
| Chain A, Glucosyltransferase | Legionella pneumophila | Kd | 0.1000 | 1 | 1 |
| Chain A, Glutamine Binding Protein | Escherichia coli | Kd | 0.5000 | 1 | 1 |
| Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | Bacillus subtilis | Kd | 11.0000 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | Bacillus subtilis | Kd | 28.0000 | 1 | 4 |
| Chain A, Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 550.0000 | 1 | 4 |
| Chain A, Heat shock 70 kDa protein 1A/1B | Homo sapiens (human) | Kd | 1.5399 | 1 | 9 |
| Chain A, Heat Shock Protein 90 | Saccharomyces cerevisiae (brewer's yeast) | Kd | 29.0000 | 1 | 1 |
| Chain A, Heat shock protein homolog SSE1 | Saccharomyces cerevisiae (brewer's yeast) | Kd | 0.2000 | 1 | 1 |
| Chain A, HISTIDINE-BINDING PROTEIN | Escherichia coli | Kd | 0.0640 | 1 | 1 |
| Chain A, hypoxanthine phosphoribosyltransferase | Trypanosoma cruzi | Kd | 788.4000 | 1 | 4 |
| Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE | Toxoplasma gondii RH | Kd | 61.0000 | 1 | 2 |
| Chain A, Ionotropic glutamate receptor bacterial homologue | Nostoc punctiforme PCC 73102 | Kd | 25.0000 | 1 | 1 |
| Chain A, Malonyl CoA synthetase | Rhodopseudomonas palustris CGA009 | Kd | 0.3100 | 1 | 1 |
| Chain A, MALTOPORIN | Escherichia coli | Kd | 15,000.0000 | 1 | 1 |
| Chain A, maltose/maltodextrin-binding protein | Thermus thermophilus HB27 | Kd | 1.0000 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | Treponema pallidum | Kd | 0.2400 | 1 | 6 |
| Chain A, Methionyl-tRNA synthetase | Escherichia coli | Kd | 11.0000 | 1 | 2 |
| Chain A, Mll3241 protein | Mesorhizobium loti | Kd | 0.1070 | 1 | 1 |
| Chain A, Mll3241 protein | unidentified | Kd | 205.1000 | 1 | 1 |
| Chain A, MUSCLE FATTY ACID BINDING PROTEIN | Homo sapiens (human) | Kd | 0.9600 | 1 | 6 |
| Chain A, Myosin Ie Heavy Chain | Dictyostelium discoideum | Kd | 7.1000 | 1 | 1 |
| Chain A, NAD(P) transhydrogenase subunit alpha part 1 | Rhodospirillum rubrum | Kd | 700.0000 | 1 | 3 |
| Chain A, Nadh Oxidase | Thermus thermophilus HB8 | Kd | 0.0900 | 1 | 1 |
| Chain A, Nitrogen regulatory protein P-II | Mycobacterium tuberculosis | Kd | 1.9300 | 1 | 1 |
| Chain A, NITROGEN REGULATORY PROTEIN P-II | Synechococcus elongatus PCC 7942 = FACHB-805 | Kd | 9.6000 | 1 | 1 |
| Chain A, Nitrogen regulatory protein P-II (GlnB-2) | Archaeoglobus fulgidus | Kd | 40.9500 | 1 | 4 |
| Chain A, Ntpase P4 | Pseudomonas phage phi12 | Kd | 132.5000 | 1 | 4 |
| Chain A, nucleoside diphosphate kinase A | Homo sapiens (human) | Kd | 6.0000 | 1 | 1 |
| Chain A, Phenazine biosynthesis protein phzF | Pseudomonas fluorescens | Kd | 1.4000 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | Homo sapiens (human) | Kd | 180.0000 | 1 | 13 |
| Chain A, Phosphomannomutase/phosphoglucomutase | Pseudomonas aeruginosa | Kd | 1,200.0000 | 1 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | Homo sapiens (human) | Kd | 0.1900 | 1 | 1 |
| Chain A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | Homo sapiens (human) | Kd | 3.6000 | 1 | 1 |
| Chain A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Homo sapiens (human) | Kd | 0.8300 | 1 | 1 |
| Chain A, Preprotein translocase secA | Bacillus subtilis | Kd | 0.1000 | 1 | 1 |
| Chain A, Preprotein translocase subunit secA | Escherichia coli | Kd | 0.1900 | 1 | 1 |
| Chain A, PRKG1 protein | Homo sapiens (human) | Kd | 0.0270 | 1 | 2 |
| Chain A, Probable copper-exporting P-type ATPase A | Archaeoglobus fulgidus | Kd | 75.0000 | 1 | 3 |
| Chain A, Protein (aspartate Aminotransferase) | Escherichia coli | Kd | 1,500.0000 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | Rhipicephalus appendiculatus | Kd | 0.0017 | 1 | 1 |
| Chain A, Protein (fmn-binding Protein) | Nitratidesulfovibrio vulgaris str. 'Miyazaki F' | Kd | 0.0004 | 1 | 1 |
| Chain A, Protein (streptavidin) | Streptomyces avidinii | Kd | 0.0002 | 1 | 1 |
| Chain A, Protein argonaute 1 | Arabidopsis thaliana (thale cress) | Kd | 4,990.0000 | 1 | 4 |
| Chain A, Protein argonaute-2 | Homo sapiens (human) | Kd | 90.0000 | 1 | 2 |
| Chain A, Protein hipA | Escherichia coli | Kd | 18.0000 | 1 | 2 |
| Chain A, Protocatechuate 3,4-dioxygenase | Pseudomonas putida | Kd | 220.0000 | 1 | 1 |
| Chain A, putative amino-acid transporter periplasmic solute-binding protein | Campylobacter jejuni | Kd | 0.1400 | 1 | 1 |
| Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | Sinorhizobium meliloti | Kd | 2.3000 | 1 | 2 |
| Chain A, REDOX-SENSING TRANSCRIPTIONAL REPRESSOR REX | Bacillus subtilis | Kd | 70.0000 | 1 | 1 |
| Chain A, Retinaldehyde-binding protein 1 | Homo sapiens (human) | Kd | 0.0100 | 1 | 2 |
| Chain A, rhizavidin | Rhizobium etli CFN 42 | Kd | 0.2150 | 1 | 1 |
| Chain A, Rhodopsin kinase | Bos taurus (cattle) | Kd | 0.8800 | 1 | 1 |
| Chain A, Ribosome-inactivating protein 3 | Zea mays | Kd | 0.0063 | 1 | 1 |
| Chain A, Ribosome-inactivating protein alpha-trichosanthin | Trichosanthes kirilowii | Kd | 260.0000 | 1 | 1 |
| Chain A, Ricin A chain | Ricinus communis (castor bean) | Kd | 700.0000 | 1 | 1 |
| Chain A, Serine/threonine-protein kinase/endoribonuclease IRE1 | Saccharomyces cerevisiae (brewer's yeast) | Kd | 20.4000 | 1 | 1 |
| Chain A, SERUM ALBUMIN | Homo sapiens (human) | Kd | 0.0910 | 1 | 2 |
| Chain A, Sex Hormone-Binding Globulin | Homo sapiens (human) | Kd | 0.0009 | 1 | 1 |
| Chain A, Streptavidin | Streptomyces avidinii | Kd | 0.0000 | 1 | 15 |
| Chain A, Streptavidin Complex With Biotin | Streptomyces avidinii | Kd | 0.0000 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | Pyrobaculum aerophilum str. IM2 | Kd | 15.0000 | 1 | 1 |
| Chain A, Tamavidin2 | Pleurotus cornucopiae (cornucopia mushroom) | Kd | 0.0870 | 1 | 1 |
| Chain A, ThiT | Lactococcus cremoris subsp. cremoris NZ9000 | Kd | 0.0001 | 1 | 1 |
| Chain A, Toxin A | Clostridioides difficile | Kd | 11.4000 | 1 | 1 |
| Chain A, Transitional endoplasmic reticulum ATPase | Mus musculus (house mouse) | Kd | 0.2300 | 1 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | Haemophilus influenzae Rd KW20 | Kd | 641.0000 | 1 | 2 |
| Chain A, Trp Rna-binding Attenuation Protein | Geobacillus stearothermophilus | Kd | 7.5000 | 1 | 1 |
| Chain A, Type III pantothenate kinase | Thermotoga maritima | Kd | 3,000.0000 | 1 | 2 |
| Chain A, Tyrosine-protein kinase JAK2 | Homo sapiens (human) | Kd | 1.0000 | 1 | 4 |
| Chain A, Udp-n-acetylglucosamine--peptide N-acetylglucosaminyl Transferase 110 Kda Subunit | Homo sapiens (human) | Kd | 0.5400 | 1 | 1 |
| Chain A, Udp-n-acetylglucosamine--peptide N-acetylglucosaminyltrans Ferase 110 Kda Subunit | Homo sapiens (human) | Kd | 0.5400 | 1 | 1 |
| Chain A, Uncharacterized ABC transporter ATP-binding protein MJ0796 | Methanocaldococcus jannaschii DSM 2661 | Kd | 4.2000 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | Methanocaldococcus jannaschii | Kd | 641.0000 | 1 | 2 |
| Chain A, V-type ATP synthase beta chain | Methanosarcina mazei | Kd | 28.0000 | 1 | 1 |
| Chain A, Vitamin D Nuclear Receptor | Homo sapiens (human) | Kd | 0.0006 | 1 | 1 |
| Chain A, Xenavidin | Xenopus tropicalis (tropical clawed frog) | Kd | 0.0000 | 1 | 1 |
| Chain A, ykoF | Bacillus subtilis | Kd | 10.0000 | 1 | 1 |
| Chain A, YuaA protein | Bacillus subtilis | Kd | 0.0200 | 1 | 9 |
| Chain B, Aspartate aminotransferase | Escherichia coli | Kd | 305.0000 | 1 | 8 |
| Chain B, ATP synthase epsilon chain | Bacillus sp. PS3 | Kd | 1.4000 | 1 | 1 |
| Chain B, Avidin | Gallus gallus (chicken) | Kd | 205.0000 | 1 | 1 |
| Chain B, Circular Permutant Of Avidin | Gallus gallus (chicken) | Kd | 0.2400 | 1 | 1 |
| Chain B, Dutpase | Leishmania major | Kd | 140.0000 | 1 | 2 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | Homo sapiens (human) | Kd | 110,000.0000 | 1 | 1 |
| Chain B, Exotoxin A | Pseudomonas aeruginosa | Kd | 59.5667 | 1 | 9 |
| Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | Bacillus subtilis | Kd | 11.0000 | 1 | 1 |
| Chain B, Heat shock cognate | Bos taurus (cattle) | Kd | 0.2000 | 1 | 1 |
| Chain B, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE | Toxoplasma gondii RH | Kd | 61.0000 | 1 | 1 |
| Chain B, MALTOPORIN | Escherichia coli | Kd | 15,000.0000 | 1 | 1 |
| Chain B, Nitrogen regulatory protein P-II | Mycobacterium tuberculosis | Kd | 1.9300 | 1 | 1 |
| Chain B, Nitrogen regulatory protein P-II (GlnB-2) | Archaeoglobus fulgidus | Kd | 40.9500 | 1 | 4 |
| Chain B, nucleoside diphosphate kinase A | Homo sapiens (human) | Kd | 6.0000 | 1 | 1 |
| Chain B, Protein (fmn-binding Protein) | Nitratidesulfovibrio vulgaris str. 'Miyazaki F' | Kd | 0.0004 | 1 | 1 |
| Chain B, Protein (streptavidin) | Streptomyces avidinii | Kd | 0.0002 | 1 | 1 |
| Chain B, PyrR bifunctional protein | [Bacillus] caldolyticus | Kd | 30.0000 | 1 | 1 |
| Chain B, REDOX-SENSING TRANSCRIPTIONAL REPRESSOR REX | Bacillus subtilis | Kd | 70.0000 | 1 | 1 |
| Chain B, Streptavidin | Streptomyces avidinii | Kd | 0.0000 | 1 | 4 |
| Chain B, Structure of PAE2307 in complex with adenosine | Pyrobaculum aerophilum str. IM2 | Kd | 15.0000 | 1 | 1 |
| Chain B, Tamavidin2 | Pleurotus cornucopiae (cornucopia mushroom) | Kd | 0.0870 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | Deinococcus radiodurans | Kd | 30.0000 | 1 | 1 |
| Chain B, Type III pantothenate kinase | Thermotoga maritima | Kd | 3,000.0000 | 1 | 1 |
| Chain B, Uncharacterized ABC transporter ATP-binding protein MJ0796 | Methanocaldococcus jannaschii DSM 2661 | Kd | 4.2000 | 1 | 1 |
| Chain B, V-type ATP synthase beta chain | Methanosarcina mazei | Kd | 28.0000 | 1 | 1 |
| Chain B, ykoF | Bacillus subtilis | Kd | 10.0000 | 1 | 1 |
| Chain B, YuaA protein | Bacillus subtilis | Kd | 0.0200 | 1 | 6 |
| Chain C, Ntpase P4 | Pseudomonas phage phi12 | Kd | 132.5000 | 1 | 4 |
| Chain C, Nuclear protein SNF4 | Saccharomyces cerevisiae S288C | Kd | 63.5000 | 1 | 6 |
| Chain C, Tryptophanyl-tRNA synthetase II | Deinococcus radiodurans | Kd | 30.0000 | 1 | 1 |
| Chain D, Circularly Permuted Core-streptavidin E51/a46 | Streptomyces avidinii | Kd | 0.0439 | 1 | 1 |
| Chain D, Core-streptavidin | Streptomyces avidinii | Kd | 0.0300 | 1 | 16 |
| Chain D, DNA polymerase III subunit gamma | Escherichia coli | Kd | 3.0000 | 1 | 2 |
| Chain D, Streptavidin | Streptomyces avidinii | Kd | 0.0000 | 1 | 9 |
| Chain E, 5'-amp-activated Protein Kinase Subunit Gamma-1 | Rattus norvegicus (Norway rat) | Kd | 1.5000 | 1 | 4 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | Salmonella enterica subsp. enterica serovar Typhimurium | Kd | 0.5000 | 1 | 3 |
| Chain K, Trp Rna-binding Attenuation Protein | Geobacillus stearothermophilus | Kd | 7.5000 | 1 | 1 |
| Chain M, Protocatechuate 3,4-dioxygenase | Pseudomonas putida | Kd | 220.0000 | 1 | 1 |
| Chain X, MYOSIN-2 HEAVY CHAIN | Dictyostelium discoideum | Kd | 1.3000 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | Homo sapiens (human) | Kd | 0.0010 | 1 | 4 |
| Cholesterol 24-hydroxylase | Homo sapiens (human) | Kd | 0.0500 | 1 | 1 |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | EC50 | 0.0219 | 1 | 2 |
| Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | EC50 | 0.0066 | 1 | 2 |
| Cytochrome P450 144 | Mycobacterium tuberculosis CDC1551 | Kd | 0.7800 | 1 | 2 |
| Cytochrome P450 1A2 | Homo sapiens (human) | EC50 | 0.0005 | 1 | 1 |
| Cytochrome P450 2A13 | Homo sapiens (human) | Kd | 5.2000 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Kd | 2.3000 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | EC50 | 0.0006 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | EC50 | 0.0012 | 1 | 1 |
| Cytochrome P450 2D6 | Homo sapiens (human) | EC50 | 0.0002 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | EC50 | 0.0017 | 2 | 2 |
| Delta-type opioid receptor | Homo sapiens (human) | EC50 | 0.9372 | 11 | 12 |
| Delta-type opioid receptor | Mus musculus (house mouse) | EC50 | 0.0686 | 2 | 2 |
| Dihydrofolate reductase | Escherichia coli K-12 | Kd | 3.3367 | 3 | 3 |
| DNA polymerase subunit gamma-1 | Homo sapiens (human) | Kd | 0.8000 | 1 | 1 |
| DNA repair and recombination protein RadA | Pyrococcus furiosus DSM 3638 | Kd | 2,100.0000 | 1 | 1 |
| DNA repair protein RAD51 homolog 1 | Homo sapiens (human) | Kd | 2,100.0000 | 1 | 1 |
| Endoplasmic reticulum chaperone BiP | Homo sapiens (human) | Kd | 3.0000 | 2 | 2 |
| Endoplasmin | Canis lupus familiaris (dog) | EC50 | 21.0000 | 1 | 1 |
| Endoplasmin | Homo sapiens (human) | Kd | 50.0000 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | EC50 | 0.2876 | 10 | 10 |
| Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | 1 | 2 |
| Estrogen receptor beta | Homo sapiens (human) | EC50 | 0.2803 | 13 | 13 |
| Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | 1 | 2 |
| Fatty acid-binding protein 5 | Mus musculus (house mouse) | Kd | 0.0421 | 1 | 1 |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | Kd | 40.0900 | 1 | 2 |
| Free fatty acid receptor 1 | Homo sapiens (human) | EC50 | 38.0800 | 4 | 4 |
| Free fatty acid receptor 4 | Homo sapiens (human) | EC50 | 100.0000 | 1 | 1 |
| G protein-coupled receptor GPR35 | Rattus norvegicus (Norway rat) | EC50 | 66.0000 | 1 | 1 |
| G-protein coupled bile acid receptor 1 | Homo sapiens (human) | EC50 | 16.7364 | 16 | 50 |
| G-protein coupled receptor 35 | Homo sapiens (human) | EC50 | 199.8000 | 9 | 9 |
| G-protein coupled receptor 84 | Homo sapiens (human) | EC50 | 26.7756 | 17 | 26 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 15.9186 | 13 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | EC50 | 9.8600 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | EC50 | 8.1524 | 8 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | EC50 | 7.0567 | 8 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | EC50 | 10.7104 | 8 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | EC50 | 5.2959 | 7 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | EC50 | 6.7338 | 6 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | EC50 | 17.7943 | 6 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | EC50 | 4.5817 | 17 | 26 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | EC50 | 9.8250 | 3 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | EC50 | 20.1232 | 12 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | EC50 | 0.0755 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | EC50 | 12.7027 | 19 | 29 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | EC50 | 9.8250 | 3 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | EC50 | 12.3333 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit rho-1 | Homo sapiens (human) | EC50 | 0.5275 | 6 | 9 |
| Gamma-aminobutyric acid receptor subunit rho-1 | Homo sapiens (human) | Kd | 1.7000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit rho-2 | Homo sapiens (human) | Kd | 1.7000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit rho-3 | Homo sapiens (human) | Kd | 1.7000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | EC50 | 5.4486 | 2 | 3 |
| Gamma-aminobutyric acid type B receptor subunit 1 | Homo sapiens (human) | EC50 | 1.1150 | 2 | 2 |
| Gamma-aminobutyric acid type B receptor subunit 2 | Homo sapiens (human) | EC50 | 0.5300 | 1 | 1 |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0014 | 1 | 1 |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | Kd | 0.0217 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | EC50 | 298.7000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | EC50 | 10.0000 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | EC50 | 0.3867 | 6 | 6 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Kd | 80.0000 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | EC50 | 21.6667 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | EC50 | 0.4533 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Kd | 80.0000 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | EC50 | 35.3333 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | EC50 | 0.3267 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Kd | 80.0000 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | EC50 | 83.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | EC50 | 0.1833 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Kd | 80.0000 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | EC50 | 78.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | EC50 | 0.1700 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Kd | 80.0000 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | EC50 | 0.1800 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Kd | 80.0000 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | EC50 | 0.1800 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Kd | 80.0000 | 1 | 2 |
| Glutathione hydrolase 1 proenzyme | Rattus norvegicus (Norway rat) | EC50 | 15.0000 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 0.4000 | 1 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 3 |
| guanine nucleotide-binding protein subunit alpha-15 | Homo sapiens (human) | EC50 | 29.9020 | 1 | 1 |
| Heat shock 70 kDa protein 1A | Homo sapiens (human) | Kd | 0.5000 | 1 | 1 |
| Heat shock cognate 71 kDa protein | Bos taurus (cattle) | Kd | 0.1100 | 1 | 1 |
| Heat shock cognate 71 kDa protein | Homo sapiens (human) | Kd | 69.2759 | 2 | 7 |
| heat shock protein 90 | Candida albicans | EC50 | 5.6500 | 1 | 1 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | EC50 | 103.5000 | 2 | 2 |
| Heat shock protein HSP 90-alpha | Homo sapiens (human) | Kd | 50.0000 | 1 | 1 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | EC50 | 87.0000 | 1 | 1 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.1622 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | EC50 | 0.1511 | 8 | 8 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | EC50 | 4.4668 | 1 | 1 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.0008 | 1 | 3 |
| Histamine H1 receptor | Homo sapiens (human) | Kd | 0.0045 | 1 | 1 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.8074 | 5 | 5 |
| Histamine H2 receptor | Homo sapiens (human) | EC50 | 1.8055 | 15 | 15 |
| Histamine H2 receptor | Homo sapiens (human) | Kd | 0.0122 | 1 | 1 |
| Histamine H3 receptor | Homo sapiens (human) | EC50 | 0.0615 | 17 | 17 |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | EC50 | 500.0000 | 1 | 1 |
| Histamine H3 receptor | Homo sapiens (human) | Kd | 0.0030 | 1 | 1 |
| Histamine H4 receptor | Homo sapiens (human) | EC50 | 0.1124 | 20 | 20 |
| Histamine H4 receptor | Mus musculus (house mouse) | EC50 | 2.8596 | 5 | 5 |
| Histamine H4 receptor | Rattus norvegicus (Norway rat) | EC50 | 14.1624 | 4 | 4 |
| Histamine H4 receptor | Homo sapiens (human) | Kd | 0.0105 | 2 | 2 |
| Histamine H4 receptor | Mus musculus (house mouse) | Kd | 0.0420 | 1 | 1 |
| Histamine H4 receptor | Rattus norvegicus (Norway rat) | Kd | 0.1340 | 1 | 1 |
| Histidine triad nucleotide-binding protein 1 | Mus musculus (house mouse) | Kd | 1,150.0000 | 2 | 2 |
| Histidine-binding periplasmic protein | Escherichia coli K-12 | Kd | 0.1140 | 1 | 1 |
| HPr kinase/phosphorylase | Bacillus subtilis subsp. subtilis str. 168 | EC50 | 4,300.0000 | 1 | 1 |
| Hsf1 protein | Mus musculus (house mouse) | EC50 | 99.5355 | 2 | 2 |
| insulin-degrading enzyme isoform 1 | Homo sapiens (human) | EC50 | 2.4495 | 2 | 2 |
| Integrin alpha-V | Homo sapiens (human) | Kd | 0.0109 | 1 | 1 |
| Integrin beta-3 | Homo sapiens (human) | Kd | 0.0109 | 1 | 1 |
| Iodotyrosine deiodinase | Haliscomenobacter hydrossis DSM 1100 | Kd | 4.1450 | 1 | 2 |
| Iodotyrosine deiodinase 1 | Homo sapiens (human) | Kd | 4.1450 | 1 | 2 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.0000 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | EC50 | 2.2637 | 5 | 5 |
| Kappa-type opioid receptor | Mus musculus (house mouse) | EC50 | 0.0631 | 1 | 1 |
| Kelch-like ECH-associated protein 1 | Homo sapiens (human) | Kd | 3,200.0000 | 1 | 1 |
| L-lactate dehydrogenase A chain | Homo sapiens (human) | Kd | 2,825.0000 | 2 | 2 |
| L-lactate dehydrogenase A chain | Rattus norvegicus (Norway rat) | Kd | 650.0000 | 1 | 1 |
| Lanosterol 14-alpha demethylase | Mycobacterium tuberculosis H37Rv | Kd | 100.0000 | 1 | 1 |
| Melatonin receptor type 1A | Gallus gallus (chicken) | EC50 | 0.0226 | 1 | 1 |
| Melatonin receptor type 1A | Homo sapiens (human) | EC50 | 0.0008 | 11 | 11 |
| Melatonin receptor type 1B | Gallus gallus (chicken) | EC50 | 0.0226 | 1 | 1 |
| Melatonin receptor type 1B | Homo sapiens (human) | EC50 | 0.0025 | 12 | 12 |
| Melatonin receptor type 1C | Gallus gallus (chicken) | EC50 | 0.0226 | 1 | 1 |
| Melatonin receptor type 1C | Xenopus laevis (African clawed frog) | EC50 | 0.0001 | 3 | 3 |
| Met repressor | Escherichia coli | EC50 | 0.0173 | 1 | 1 |
| Met repressor | Escherichia coli | Kd | 0.0040 | 1 | 1 |
| Metabotropic glutamate receptor 1 | Homo sapiens (human) | EC50 | 1,000.0000 | 1 | 1 |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 1,000.0000 | 2 | 2 |
| Metabotropic glutamate receptor 2 | Homo sapiens (human) | EC50 | 35.0000 | 1 | 1 |
| Metabotropic glutamate receptor 2 | Rattus norvegicus (Norway rat) | EC50 | 35.0000 | 2 | 2 |
| Metabotropic glutamate receptor 4 | Homo sapiens (human) | EC50 | 1,000.7667 | 3 | 3 |
| Metabotropic glutamate receptor 4 | Rattus norvegicus (Norway rat) | EC50 | 1,526.0000 | 4 | 4 |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | EC50 | 333.7600 | 2 | 3 |
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | EC50 | 140.0000 | 1 | 1 |
| Metabotropic glutamate receptor 6 | Rattus norvegicus (Norway rat) | EC50 | 71.3500 | 2 | 2 |
| Metabotropic glutamate receptor 7 | Homo sapiens (human) | EC50 | 200.0000 | 1 | 1 |
| Metabotropic glutamate receptor 7 | Rattus norvegicus (Norway rat) | EC50 | 160.0000 | 1 | 1 |
| Methylosome protein 50 | Homo sapiens (human) | Kd | 0.6055 | 1 | 2 |
| Mineralocorticoid receptor | Homo sapiens (human) | EC50 | 0.0012 | 5 | 5 |
| Mineralocorticoid receptor | Homo sapiens (human) | Kd | 0.0005 | 1 | 2 |
| Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | Kd | 26.3750 | 2 | 4 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.0080 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | EC50 | 1.8946 | 7 | 8 |
| Mu-type opioid receptor | Mus musculus (house mouse) | EC50 | 0.0631 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0070 | 1 | 1 |
| Myelin basic protein | Mus musculus (house mouse) | Kd | 0.0006 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | EC50 | 1,000.0000 | 1 | 1 |
| Neurotensin receptor type 1 | Homo sapiens (human) | EC50 | 0.0632 | 5 | 5 |
| Neurotensin receptor type 1 | Mus musculus (house mouse) | EC50 | 0.0020 | 1 | 1 |
| Neurotensin receptor type 1 | Rattus norvegicus (Norway rat) | EC50 | 0.0000 | 1 | 1 |
| Neurotensin receptor type 1 | Homo sapiens (human) | Kd | 0.0006 | 2 | 2 |
| Neurotensin receptor type 2 | Homo sapiens (human) | EC50 | 0.1100 | 1 | 1 |
| Neurotensin receptor type 2 | Rattus norvegicus (Norway rat) | EC50 | 0.1000 | 1 | 1 |
| Nitric oxide synthase, brain | Homo sapiens (human) | Kd | 1.1200 | 1 | 1 |
| Nociceptin receptor | Homo sapiens (human) | EC50 | 0.0069 | 17 | 18 |
| Nociceptin receptor | Mus musculus (house mouse) | EC50 | 0.0061 | 4 | 6 |
| Nociceptin receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0160 | 6 | 9 |
| Nociceptin receptor | Homo sapiens (human) | Kd | 0.0001 | 2 | 2 |
| Nociceptin receptor | Rattus norvegicus (Norway rat) | Kd | 0.0004 | 5 | 5 |
| NPC1-like intracellular cholesterol transporter 1 | Homo sapiens (human) | EC50 | 6.6500 | 1 | 2 |
| NPYLR7B | Aedes aegypti (yellow fever mosquito) | EC50 | 0.0390 | 1 | 1 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | EC50 | 2.2906 | 6 | 8 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 55.6000 | 2 | 2 |
| Nuclear receptor subfamily 4 group A member 2 | Homo sapiens (human) | EC50 | 3.0000 | 2 | 2 |
| Nuclear receptor subfamily 4 group A member 2 | Mus musculus (house mouse) | EC50 | 3.0000 | 2 | 2 |
| Nuclear receptor subfamily 4 group A member 2 | Rattus norvegicus (Norway rat) | EC50 | 3.0000 | 2 | 2 |
| Nuclear receptor subfamily 4 group A member 2 | Homo sapiens (human) | Kd | 50.0000 | 1 | 1 |
| Olfactory receptor 51E2 | Homo sapiens (human) | EC50 | 9.2063 | 1 | 7 |
| Olfactory receptor class A-like protein 1 | Danio rerio (zebrafish) | EC50 | 18.4000 | 1 | 3 |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | EC50 | 0.1135 | 2 | 2 |
| Oxysterol-binding protein 2 | Homo sapiens (human) | Kd | 0.0200 | 1 | 2 |
| Oxysterols receptor LXR-alpha | Homo sapiens (human) | EC50 | 0.6267 | 2 | 6 |
| P2X purinoceptor 1 | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| P2X purinoceptor 1 | Rattus norvegicus (Norway rat) | EC50 | 6.5000 | 2 | 2 |
| P2X purinoceptor 2 | Homo sapiens (human) | EC50 | 69.7500 | 2 | 2 |
| P2X purinoceptor 3 | Homo sapiens (human) | EC50 | 100.0000 | 1 | 1 |
| P2X purinoceptor 4 | Rattus norvegicus (Norway rat) | EC50 | 123.5000 | 2 | 2 |
| P2X purinoceptor 5 | Rattus norvegicus (Norway rat) | EC50 | 18.0000 | 1 | 1 |
| P2X purinoceptor 6 | Rattus norvegicus (Norway rat) | EC50 | 11.0000 | 1 | 1 |
| P2Y purinoceptor 1 | Homo sapiens (human) | EC50 | 0.0207 | 3 | 3 |
| P2Y purinoceptor 1 | Meleagris gallopavo (turkey) | EC50 | 4.0500 | 2 | 2 |
| P2Y purinoceptor 11 | Homo sapiens (human) | EC50 | 1.7000 | 2 | 2 |
| P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | EC50 | 0.0690 | 1 | 1 |
| P2Y purinoceptor 14 | Homo sapiens (human) | EC50 | 0.3700 | 2 | 2 |
| P2Y purinoceptor 2 | Homo sapiens (human) | EC50 | 50.5400 | 2 | 2 |
| P2Y purinoceptor 6 | Homo sapiens (human) | EC50 | 65.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Kd | 0.8000 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | EC50 | 28.0000 | 1 | 3 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 15.9000 | 3 | 5 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Kd | 0.8050 | 2 | 4 |
| Phenylethanolamine N-methyltransferase | Homo sapiens (human) | Kd | 8.1000 | 6 | 6 |
| Phospholipase A2 | Homo sapiens (human) | Kd | 80.0000 | 1 | 2 |
| Platelet glycoprotein VI | Homo sapiens (human) | Kd | 0.0411 | 1 | 1 |
| POsterior Segregation | Caenorhabditis elegans | EC50 | 49.8320 | 1 | 1 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | EC50 | 396.0900 | 1 | 2 |
| Potassium voltage-gated channel subfamily A member 1 | Homo sapiens (human) | EC50 | 39.5000 | 2 | 2 |
| Proenkephalin-B | Homo sapiens (human) | Kd | 0.0071 | 1 | 1 |
| Progesterone receptor | Homo sapiens (human) | EC50 | 8.2000 | 1 | 1 |
| Prostacyclin receptor | Homo sapiens (human) | EC50 | 0.1744 | 2 | 2 |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | EC50 | 0.3018 | 2 | 2 |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | EC50 | 0.1381 | 5 | 5 |
| Prostaglandin E2 receptor EP2 subtype | Mus musculus (house mouse) | EC50 | 0.0026 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | EC50 | 0.0096 | 2 | 2 |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | EC50 | 1.1512 | 2 | 2 |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | EC50 | 0.0028 | 5 | 5 |
| Prostaglandin E2 receptor EP4 subtype | Mus musculus (house mouse) | EC50 | 0.0029 | 2 | 3 |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | EC50 | 0.0021 | 2 | 2 |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | EC50 | 0.1178 | 3 | 3 |
| Prostaglandin F2-alpha receptor | Mus musculus (house mouse) | EC50 | 0.0185 | 2 | 2 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Kd | 8.0700 | 1 | 1 |
| Protein arginine N-methyltransferase 5 | Homo sapiens (human) | Kd | 0.6055 | 1 | 2 |
| Protein argonaute-2 | Homo sapiens (human) | Kd | 15.0000 | 1 | 1 |
| Prothrombin | Homo sapiens (human) | EC50 | 0.0029 | 3 | 3 |
| Purine nucleoside phosphorylase | Bos taurus (cattle) | Kd | 0.9350 | 4 | 4 |
| Pyruvate kinase PKM | Homo sapiens (human) | EC50 | 1,300.0000 | 1 | 1 |
| recombinase A | Mycobacterium tuberculosis H37Rv | EC50 | 5.7660 | 2 | 2 |
| Retinoic acid receptor alpha | Homo sapiens (human) | EC50 | 0.1674 | 18 | 18 |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | EC50 | 0.0082 | 3 | 3 |
| Retinoic acid receptor alpha | Homo sapiens (human) | Kd | 0.0102 | 10 | 12 |
| Retinoic acid receptor alpha | Mus musculus (house mouse) | Kd | 0.0150 | 1 | 1 |
| Retinoic acid receptor beta | Homo sapiens (human) | EC50 | 0.0344 | 19 | 19 |
| Retinoic acid receptor beta | Mus musculus (house mouse) | EC50 | 0.0012 | 3 | 3 |
| Retinoic acid receptor beta | Homo sapiens (human) | Kd | 0.0086 | 11 | 13 |
| Retinoic acid receptor beta | Mus musculus (house mouse) | Kd | 0.0130 | 1 | 1 |
| Retinoic acid receptor gamma | Mus musculus (house mouse) | EC50 | 0.0004 | 2 | 2 |
| Retinoic acid receptor gamma | Mus musculus (house mouse) | Kd | 0.0180 | 1 | 1 |
| Retinoic acid receptor gamma | Homo sapiens (human) | EC50 | 0.0116 | 16 | 16 |
| Retinoic acid receptor gamma | Homo sapiens (human) | Kd | 0.0103 | 12 | 14 |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | EC50 | 2.1862 | 10 | 12 |
| Retinoic acid receptor RXR-alpha | Mus musculus (house mouse) | EC50 | 9.4000 | 2 | 2 |
| Retinoic acid receptor RXR-alpha | Homo sapiens (human) | Kd | 0.2975 | 7 | 10 |
| Retinoic acid receptor RXR-alpha | Mus musculus (house mouse) | Kd | 1.0000 | 1 | 1 |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | EC50 | 1.0496 | 4 | 4 |
| Retinoic acid receptor RXR-beta | Mus musculus (house mouse) | EC50 | 1.2110 | 1 | 1 |
| Retinoic acid receptor RXR-beta | Homo sapiens (human) | Kd | 0.0000 | 1 | 1 |
| Retinoic acid receptor RXR-beta | Mus musculus (house mouse) | Kd | 0.6530 | 2 | 2 |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | EC50 | 0.8568 | 4 | 4 |
| Retinoic acid receptor RXR-gamma | Mus musculus (house mouse) | EC50 | 0.4835 | 2 | 2 |
| Retinoic acid receptor RXR-gamma | Homo sapiens (human) | Kd | 0.1530 | 2 | 2 |
| Retinoic acid receptor RXR-gamma | Mus musculus (house mouse) | Kd | 0.3500 | 1 | 1 |
| Retinol-binding protein 4 | Homo sapiens (human) | Kd | 0.1820 | 1 | 1 |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | Kd | 2.3833 | 7 | 9 |
| Sex hormone-binding globulin | Homo sapiens (human) | Kd | 0.4144 | 1 | 19 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | EC50 | 0.0024 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 0.1060 | 1 | 1 |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | EC50 | 0.8300 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | EC50 | 0.1060 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | EC50 | 28.8950 | 1 | 1 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | EC50 | 230.0000 | 1 | 3 |
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 1 |
| Steroid C26-monooxygenase | Mycobacterium tuberculosis CDC1551 | Kd | 0.7800 | 1 | 4 |
| Sterol O-acyltransferase 1 | Mus musculus (house mouse) | EC50 | 14.3000 | 1 | 1 |
| Streptavidin | Streptomyces avidinii | Kd | 84.0000 | 2 | 2 |
| streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 76.2800 | 2 | 2 |
| Thiamine transporter ThiT | Lactococcus cremoris subsp. cremoris MG1363 | Kd | 2.4687 | 7 | 7 |
| Thiamine-binding periplasmic protein | Escherichia coli K-12 | Kd | 0.0038 | 1 | 1 |
| Thromboxane A2 receptor | Homo sapiens (human) | EC50 | 1.4000 | 1 | 1 |
| Thyroid hormone receptor alpha | Homo sapiens (human) | EC50 | 0.0084 | 14 | 17 |
| Thyroid hormone receptor alpha | Homo sapiens (human) | Kd | 0.0001 | 6 | 8 |
| Thyroid hormone receptor beta | Homo sapiens (human) | EC50 | 0.0256 | 11 | 14 |
| Thyroid hormone receptor beta | Homo sapiens (human) | Kd | 0.0001 | 6 | 8 |
| Thyroliberin receptor | Mus musculus (house mouse) | EC50 | 0.0014 | 3 | 3 |
| Thyroliberin receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0030 | 2 | 2 |
| Thyrotropin-releasing hormone receptor | Homo sapiens (human) | EC50 | 0.0030 | 1 | 1 |
| Thyrotropin-releasing hormone receptor | Mus musculus (house mouse) | EC50 | 0.0011 | 7 | 10 |
| Thyrotropin-releasing hormone receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0030 | 1 | 1 |
| Trace amine-associated receptor 1 | Homo sapiens (human) | EC50 | 0.5072 | 6 | 9 |
| Trace amine-associated receptor 1 | Mus musculus (house mouse) | EC50 | 0.1387 | 7 | 7 |
| Trace amine-associated receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 0.1663 | 6 | 8 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 | 20.7200 | 4 | 5 |
| Transient receptor potential cation channel subfamily A member 1 | Mus musculus (house mouse) | EC50 | 0.4000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | EC50 | 30.2492 | 1 | 2 |
| Transketolase | Homo sapiens (human) | Kd | 6,800.0000 | 1 | 1 |
| Translocator protein | Rattus norvegicus (Norway rat) | EC50 | 0.0015 | 1 | 1 |
| Transporter | Rattus norvegicus (Norway rat) | EC50 | 0.0039 | 1 | 2 |
| Tubulin alpha-1A chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin alpha-1A chain | Sus scrofa (pig) | EC50 | 0.5200 | 1 | 1 |
| Tubulin alpha-1B chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin alpha-1C chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin alpha-3C chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin alpha-3E chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin alpha-4A chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta chain | Sus scrofa (pig) | EC50 | 0.5200 | 1 | 1 |
| Tubulin beta-1 chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta-2A chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta-2B chain | Bos taurus (cattle) | EC50 | 0.8300 | 1 | 1 |
| Tubulin beta-2B chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta-3 chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta-4A chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta-4B chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta-6 chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Tubulin beta-8 chain | Homo sapiens (human) | EC50 | 0.6305 | 2 | 2 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | EC50 | 0.0033 | 3 | 4 |
| Type-1 angiotensin II receptor | Bos taurus (cattle) | Kd | 0.0058 | 1 | 1 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | Kd | 0.0020 | 1 | 1 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0040 | 2 | 2 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Kd | 50,000.0000 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | Kd | 1,000.0000 | 1 | 1 |
| UDP-3-O-acyl-N-acetylglucosamine deacetylase | Aquifex aeolicus VF5 | Kd | 100.0000 | 1 | 1 |
| Vitamin D-binding protein | Homo sapiens (human) | Kd | 0.0240 | 1 | 1 |
| Vitamin D3 receptor | Bos taurus (cattle) | EC50 | 0.0001 | 2 | 2 |
| Vitamin D3 receptor | Homo sapiens (human) | EC50 | 31.7052 | 39 | 49 |
| Vitamin D3 receptor | Mus musculus (house mouse) | EC50 | 0.5333 | 1 | 3 |
| Vitamin D3 receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0002 | 7 | 7 |
| Vitamin D3 receptor | Homo sapiens (human) | Kd | 7.1800 | 4 | 4 |
| Vitamin D3 receptor | Sus scrofa (pig) | Kd | 0.0001 | 1 | 1 |
| Vitamin D3 receptor A | Danio rerio (zebrafish) | EC50 | 0.0055 | 1 | 1 |
| Vitamin D3 receptor A | Danio rerio (zebrafish) | Kd | 1.2000 | 1 | 1 |
| Zinc finger protein mex-5 | Caenorhabditis elegans | EC50 | 28.8950 | 1 | 1 |